Search by Patent Identification

---

Patent: (prefix with "US" like US6078908)

Patent	Data	Patent Title	Organization	Deposition
US9682971	220	1,2,5-Substituted benzimidazoles as flap modulators	JANSSEN PHARMACEUTICA NV	02/14/18
US9682980	85	Positive allosteric modulators of mGluR2	Bristol-Myers Squibb Company	02/14/18
US9682976	324	Protein kinase C inhibitors and uses thereof	Rigel Pharmaceuticals, Inc.	02/14/18
US9682959	6	Ethynyl derivatives	HOFFMANN-LA ROCHE INC.	02/13/18
US9682965	75	Fumagillol heterocyclic compounds and methods of making and using same	Zafgen, Inc.	02/13/18
US9682966	563	Kappa opioid ligands	The Scripps Research Institute	02/13/18
US9682967	49	N-substituted-5-substituted phthalamic acids as sortilin inhibitors	H. Lundbeck A/S	02/13/18
US9682960	137	Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety	ENDORECHERCHE, INC.	02/13/18
US9682969	31	Phthalazinone compounds and methods for the treatment of cystic fibrosis	Flatley Discovery Lab, LLC	02/13/18
US9682968	110	Piperidinyl-indole derivatives complement factor B inhibitors and uses thereof	Novartis AG	02/13/18
US9682963	28	Pyridine derivatives as soft rock inhibitors	Redx Pharma PLC	02/13/18
US9682961	26	Quinazoline derivative	CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER	02/13/18
US9682953	166	Amide compounds, compositions and applications thereof	ADVINUS THERAPEUTICS LIMITED	02/07/18
US9687476	60	Bisaryl-bonded aryltriazolones and use thereof	Bayer Intellectual Property GmbH	02/07/18
US9682141	2516	Combination of kinase inhibitors and uses thereof	Intellikine LLC	02/07/18
US9682957	192	Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity	Theravance Respiratory Company, LLC	02/07/18
US9682940	502	Indazole derivatives useful as CB-1 inverse agonists	Janssen Pharmaceutica NV	02/07/18
US9682955	280	Quinazoline derivatives useful as CB-1 inverse agonists	Janssen Pharmaceutica NV	02/07/18
US9682910	35	Series of skin-whitening (lightening) compounds	Unigen, Inc.	02/07/18
US9695195	162	5-HT3 receptor antagonists	Takeda Pharmaceutical Company Limited	02/06/18
US9695205	53	Amide compounds for treatment of complement mediated disorders	Achillion Pharmaceuticals, Inc.	02/06/18
US9695197	11	Glycosidase inhibitors and uses thereof	Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.	02/06/18
US9695200	175	Heterocyclic ITK inhibitors for treating inflammation and cancer	Confluence Life Sciences, Inc.	02/06/18
US9695151	90	3,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds	Hoffmann-La Roche Inc.	01/26/18
US9695152	84	3,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds	Hoffmann-La Roche Inc.	01/26/18
US9695194	126	Benzoxazinone derivatives for treatment of skin diseases	SIXERA PHARMA AB	01/26/18
US9695172	15	Diazepane derivatives and uses thereof	Dana-Farber Cancer Institute, Inc.	01/26/18
US9695175	51	Highly selective c-Met inhibitors as anticancer agents	CB THERAPEUTICS INC.	01/26/18
US9695181	15	Hydroximic acid derivatives and medical applications therof	DOUBLE RIDER MEDICINE CO., LTD.	01/26/18
US9695174	21	Inhibitor of breast cancer resistance protein (BCRP)	Millennium Pharmaceuticals, Inc.	01/26/18
US9695165	82	Inhibitors of the fibroblast growth factor receptor	BLUEPRINT MEDICINES CORPORATION	01/26/18
US9695179	17	Methods and compositions for inhibition of bromodomain-containing proteins	ConverGene LLC	01/26/18
US9695170	217	Naphthyridine derivatives as inhibitors of Hypoxia inducible factor (HIF) hydroxylase	FibroGen, Inc.	01/26/18
US9695160	36	Piperazine derivatives for treating disorders	The University of Nottingham; NewSouth Innovations PTY Limited	01/26/18
US9695183	702	Substituted 7-azabicycles and their use as orexin receptor modulators	JANSSEN PHARMACEUTICA NV	01/26/18
US9695180	119	Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors	Incyte Corporation	01/26/18
US9695168	158	Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors	Incyte Corporation	01/26/18
US9695176	4	Substituted imidazo[1,5-a]pyrazines as CGRP receptor antagonists	Bristol-Myers Squibb Company	01/26/18
US9695167	13	Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors	Incyte Corporation	01/26/18
US9695185	5	Synthetic methods for spiro-oxindole compounds	Xenon Pharmaceuticals Inc.	01/26/18
US9695163	76	Thiazole orexin receptor antagonists	MERCK SHARP & DOHME CORP	01/26/18
US9695149	235	1,2,6-substituted benzimidazoles as flap modulators	JANSSEN PHARMACEUTICA NV	01/19/18
US9695118	394	Benzamide derivative	Chugai Seiyaku Kabushiki Kaisha	01/19/18
US9694016	2555	Biaryl amide compounds as kinase inhibitors	NOVARTIS AG	01/19/18
US9695128	13	Ethynyl derivatives	Hoffmann-La Roche Inc.	01/19/18
US9695132	194	Heteroaryl compounds and uses thereof	Celgene CAR LLC; Sanofi	01/19/18
US9694018	12	IBAT inhibitors for the treatment of liver disease	Albireo AB	01/19/18
US9694015	59	Methods for the treatment of locally advanced breast cancer	Celgene Corporation	01/19/18
US9694024	17	Methods of treating retroviral infections and related dosage regimes	Chimerix, Inc.	01/19/18
US9694012	76	Pyrazol derivatives	Hoffmann-La Roche Inc.	01/19/18
US9694011	6	Substituted pyrazolopyrimidines as kinases inhibitors	Jiangsu Medolution Ltd	01/19/18
US9695131	56	Substituted uracils as chymase inhibitors	Bayer Pharma Aktiengesellschaft	01/19/18
US9693997	356	Antiviral compounds	HOFFMANN-LA ROCHE INC.	01/14/18
US9693992	251	IRE-1α inhibitors	MannKind Corporation	01/14/18
US9694002	648	Substituted benzamides and methods of use thereof	GENENTECH, INC.; XENON PHARMACEUTICALS INC.	01/14/18
US9527838	54	2-pyridinecarboxamide derivatives, compositions containing such compounds, and methods of treatment	Merck Sharp & Dohme Corp.	12/04/17
US9540323	274	7-hydroxy-indolinyl antagonists of P2Y1 receptor	Bristol-Myers Squibb Company	12/04/17
US9522914	174	Azole derivative	TAISHO PHARMACEUTICAL CO., LTD	12/04/17
US9527839	25	Benzimidazole tetrahydropyran derivatives	Merck Sharp & Dohme Corp.	12/04/17
US9527857	217	HSPC-sparing treatments for RB-positive abnormal cellular proliferation	GI Therapeutics, Inc.	12/04/17
US9533969	6	Materials and method for inhibiting replication protein A and uses thereof	Indiana University Research and Technology Corporation	12/04/17
US9533992	75	PDE9 inhibitors with imidazo triazinone backbone	TBA	12/04/17
US9532990	119	Polyfluorinated compounds acting as bruton tyrosine kinase inhibitors	Zhejiang DTRM Biopharma Co. Ltd.	12/04/17
US9527851	130	Pyrrole six-membered heteroaryl ring derivative, preparation method thereof, and medicinal uses thereof	Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd.	12/04/17
US9504692	48	Selective inhibition of MALT1 protease by phenothiazine derivatives	HELMHOLTZ ZENTRUM MUNCHEN, DEUTSCHES FORSCHUNGSZENTRUM FUR GESUNDHEIT UND UMWELT (GMBH)	12/04/17
US9533989	123	Substituted pyrimidine-5-carboxamides as spleen tyrosine kinase inhibitors	Ziarco Pharma Ltd.	12/04/17
US9533985	193	Sulfonamide derivative and medicinal use thereof	EA Pharma Co., Ltd.	12/04/17
US9522881	71	Hydroxyindole carboxylic acid based inhibitors for oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2)	Indiana University Research and Technology Corporation	11/27/17
US9512115	58	Inhibitors	PROBIODRUG AG	11/27/17
US9505766	158	Kinase inhibitors	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA	11/27/17
US9522910	16	Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon	OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYOU “FUSION PHARMA”	11/27/17
US9505762	338	Purine derivatives as CB2 receptor agonists	HOFFMANN-LA ROCHE INC.	11/27/17
US9512141	84	Pyrazine derivatives as CB2 receptor agonists	HOFFMANN-LA ROCHE INC.	11/27/17
US9512132	76	Pyrazole compounds as CB2 agonists	Hoffmann-La Roche Inc.	11/27/17
US9522886	195	Pyridine derivatives	HOFFMANN-LA ROCHE INC.	11/27/17
US9505749	527	Quinazolinone compounds and derivatives thereof	AMGEN INC.	11/27/17
US9505780	114	Thienopyranones as kinase and epigenetic inhibitors	SignalRx Pharmaceuticals, Inc.	11/27/17
US9512121	47	[1,2,4] triazol [4,3-A] pyridine derivative, preparation method therefor or medical application thereof	Jiangsu Hansoh Pharmaceutical Co., Ltd.	11/27/17
US9499492	130	4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfoximine group	Bayer Pharma Aktiengesellschaft	11/20/17
US9499502	733	5-substituted iminothiazines and their mono- and dioxides as BACE inhibitors, compositions, and their use	Merck Sharp & Dohme Corp.	11/20/17
US9512084	40	Amino pyrimidine derivatives	Novartis AG	11/20/17
US9499547	110	Amino-substituted imidazopyridazines	BAYER INTELLECTUAL PROPERTY GMBH	11/20/17
US9493490	60	Boron-containing small molecules	Anacor Pharmaceuticals, Inc.	11/20/17
US9493486	113	Diazaspirocycloalkane and azaspirocycloalkane	Hoffmann-La Roches Inc.	11/20/17
US9505745	110	Enhancer of zeste homolog 2 inhibitors	GlaxoSmithKline Intellectual Property (No. 2) Limited	11/20/17
US9526727	30	Inhibitors of beta-secretase	Vitae Pharmaceutical, Inc.	11/20/17
US9499482	247	Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists	Bristol-Myers Squibb Company	11/20/17
US9512114	52	Substituted aminopyrimidine compounds and methods of use	CALITOR SCIENCES, LLC; SUNSHINE LAKE PHARMA CO., LTD.	11/20/17
US9512126	25	Substituted imidazopyridazines	Bayer Intellectual Property GmbH	11/20/17
US9512169	23	3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments	BAYER PHARMA AKTIENGESELLSCHAFT	11/13/17
US9512068	14	Augmenting moieties for anti-inflammatory compounds	RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY; LEHIGH UNIVERSITY	11/13/17
US9493448	168	Cycloalkane derivatives	DAIICHI SANKYO COMPANY, LIMITED	11/13/17
US9511061	6	Incontinence treatment methods	IXALTIS	11/13/17
US9505753	69	Inhibitors of D-amino acid oxidase	THE JOHNS HOPKINS UNIVERSITY	11/13/17
US9512082	7	Inhibitors of glutaminyl cyclase	PROBIODRUG AG	11/13/17
US9493446	1134	Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives	ACTELION PHARMACEUTICALS LTD.	11/13/17
US9512065	5	Polymorphs of N-[(R)-1-[(S)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(4-ethoxy-phenyl)-ethyl]-benzamide hydrochloride	Kalvista Pharmaceuticals Limited	11/13/17
US9493485	178	Spirocyclic dihydro-thiazine and dihydro-oxazine BACE inhibitors, and compositions and uses thereof	Imago Pharmaceuticals, Inc.	11/13/17
US9505786	59	Substituted annulated triazines and use thereof	BAYER PHARMA AKTIENGESELLSCHAFT; BAYER INTELLECTUAL PROPERTY GMBH	11/13/17
US9522888	952	Substituted bicyclic compounds	Bristol-Myers Squibb Company	11/13/17
US9512130	4	Substituted imidazopyridazines	BAYER PHARMA AKTIENGESELLSCHAFT	11/13/17
US9493441	222	Acyclic cyanoethylpyrazoles as janus kinase inhibitors	Merck Sharp & Dohme Corp.	11/06/17
US9489013	194	C6-azaspiro iminothiadiazine dioxides as bace inhibitors, compositions, and their use	Merck Sharp & Dohme Corp.	11/06/17
US9493440	239	Compounds inhibiting leucine-rich repeat kinase enzyme activity	Merck Sharp & Dohme Corp.	11/06/17
US9493432	214	Cyclopentylbenzamide derivatives and their use for the treatment of psychotic and cognitive disorders	Takeda Pharmaceuticals Company Limited	11/06/17
US9487511	375	Cyclopropanamine compound and use thereof	Takeda Pharmaceutical Company Limited	11/06/17
US9522883	1	Glycosidase inhibitors and uses thereof	Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.	11/06/17
US9505736	16	Histone deacetylase inhibitors and compositions and methods of use thereof	CHDI Foundation, Inc.	11/06/17
US9493435	182	IRE-1α inhibitors	MannKing Corporation	11/06/17
US9492453	77	Protein kinase B inhibitors	AstraZeneca AB	11/06/17
US9505773	18	Rapamycin analogues and their pharmaceutical use	Isomerase Therapeutics Ltd.	11/06/17
US9504684	11	Syk inhibitors	Gilead Sciences, Inc.	11/06/17
US9487512	159	(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors	Oryzon Genomics S.A.	10/30/17
US9487490	63	3-cyclohexenyl and cyclohexyl substituted indole and indazole compounds as RORgammaT inhibitors and uses thereof	Merck Sharp & Dohme Corp.	10/30/17
US9481672	253	Bicyclically substituted uracils and the use thereof	Bayer Pharma Aktiengesellschaft	10/30/17
US9487483	128	Complement pathway modulators and uses thereof	Novartis AG	10/30/17
US9505754	4	Compound useful for the treatment of degenerative and inflammatory diseases	GALAPAGOS NV	10/30/17
US9487462	114	Inhibitors of matrix metalloproteinases	PharmaHungary 2000 Kft.; TargetEx Kft.	10/30/17
US9481648	347	Kinase inhibitors	Respivert Limited; Topivert Pharma Limited	10/30/17
US9505743	3	Matrix metalloproteinase inhibitors and methods for the treatment of pain and other diseases	TBA	10/30/17
US9487501	114	Pyrazole carboxamide compounds and uses thereof	Hoffmann-La Roche Inc.	10/30/17
US9475815	228	Substituted benzothienyl-pyrrolotriazines and uses thereof	BAYER INTELLETUAL PROPERTY GMBH	10/30/17
US9487488	60	Sulfonamide compound	MITSUBISHI TANABE PHARMA CORPORATION	10/30/17
US9481688	24	(Thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity H1 inverse agonists/5-HT2A antagonists	Eli Lilly and Company	10/23/17
US9499493	51	2,4-pyrimidinediamine compounds and their uses	Rigel Pharmaceuticals, Inc.	10/23/17
US9499570	14	Boron containing small molecules	Anacor Pharmaceuticals, Inc.	10/23/17
US9499561	46	Fused pyrimidine compound, and preparation method, intermediate, composition, and uses thereof	Shanghai Yingli Pharmaceutical Co., Ltd.	10/23/17
US9499486	7	Kinase inhibitor	Respivert Limited; Topivert Pharma Limited	10/23/17
US9499523	63	Phosphatidylinositol 3-kinase inhibitors	GILEAD SCIENCES, INC.	10/23/17
US9475817	402	Pyrazole substituted imidazopyrazines as casein kinase 1 d/e inhibitors	Bristol-Myers Squibb Company	10/23/17
US9475819	702	Substituted 7-azabicycles and their use as orexin receptor modulators	Janssen Pharmaceutica NV	10/23/17
US9481682	221	Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitors	MERCK SHARP & DOHME CORP.	10/23/17
US9499534	42	Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors	Merck Sharp & Dohme Corp.	10/23/17
US9475813	268	Tricyclic pyrrolopyridine compound, and JAK inhibitor	Nissan Chemical Industries, Ltd.	10/23/17
US9469597	210	(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors	Oryzon Genomics S.A.	10/16/17
US9505765	36	4-alkoxy/aralkoxy-5-substituted-pyrrolopyrimidine compounds as TAK1 inhibitors in disease treatment	CONFLUENCE LIFE SCIENCES INC.	10/16/17
US9499542	46	Arylpyrrolopyridine derived compounds as LRRK2 inhibitors	H. Lundbeck A/S; Vernalis (R&D) Ltd.	10/16/17
US9475775	160	Benzazepine dicarboxamide compounds	Hoffmann-La Roche Inc.	10/16/17
US9493483	6	Benzo [C] isoxazoloazepine bromodomain inhibitors and uses thereof	Constellation Pharmaceuticals, Inc.	10/16/17
US9487554	62	Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, processes for their preparation, pharmaceutical preparations comprising them and their use for preparing medicaments	Bayer Intellectual Property GmbH; Bayer Pharma Aktiengesellschaft	10/16/17
US9469631	130	N-cyclopropyl-N-piperidinyl-amides, pharmaceutical compositions containing them, and uses thereof	Boehringer Ingelheim International GmbH	10/16/17
US9464084	843	P2X7 modulators	Janssen Pharmaceutica NV	10/16/17
US9505734	2	Phenyl C-glucoside derivative containing deoxyglucose structure, preparation method and use thereof	Tianjin Institute of Pharmaceutical Research	10/16/17
US9468661	123	Pyrrolidine derivatives and their use as complement pathway modulators	Novartis AG	10/16/17
US9493412	34	Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors	Bristol-Myers Squibb Company	10/16/17
US9493472	34	Substituted benzoxazoles	Bayer Pharma Aktiengesellschaft	10/16/17
US9481677	37	Biaryl ether sulfonamides and their use as therapeutic agents	XENON PHARMACEUTICALS INC.	10/10/17
US9493457	3	4,5,6,7-tetrahyroimidazo[4,5-c]pyridine compounds	Proximagen Limited	10/09/17
US9481673	141	6-alkynyl-pyridine derivatives	Boehringer ingelheim International GmbH	10/09/17
US9493431	44	Apoptosis-inducing agent for the treatment of cancer and immune and autoimmune diseases	ABBVIE INC.	10/09/17
US9493430	41	Biaryl- or heterocyclic biaryl-substituted cyclohexene derivative compounds as CETP inhibitors	Chong Kun Dang Pharmaceutical Corp.	10/09/17
US9493474	60	Inhibitors of the renal outer medullary potassium channel	Merck Sharp & Dohme Corp.	10/09/17
US9458201	162	Melanocortin receptor-specific heptapeptides	Palatin Technologies, Inc.	10/09/17
US9458171	572	Pyrrolidinyl sulfone RORγ modulators	Bristol-Myers Squibb Company	10/09/17
US9505739	11	Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease	Merck Sharp & Dohme Corp.	10/09/17
US9464092	229	Transient protection of normal cells during chemotherapy	G1 Therapeutics, Inc.	10/09/17
US9459250	254	Use of T1R3 venus flytrap region polypeptide to screen for taste modulators	SENOMYX, INC.	10/09/17
US9464076	131	Benzothiophene derivative	Daiichi Sankyo Company, Limited	10/02/17
US9487494	9	Cyclic hydrocarbon compounds for the treatment of diseases	LEO PHARMA A/S	10/02/17
US9481685	8	Imaging neuroinflammation	GE Healthcare Limited	10/02/17
US9493447	14	Optically active PDE10 inhibitor	Omeros Corporation	10/02/17
US9480684	35	Orvinol and thevinol derivatives useful in the treatment of anxiety or a compulsive disorder	The University of Bath	10/02/17
US9458110	632	Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitors	Bristol-Myers Squibb Company	10/02/17
US9458172	180	Pyridinyl and pyrimidinyl sulfoxide and sulfone derivatives	TBA	10/02/17
US9493429	9	Substituted benzoxazoles and methods of use thereof	GENENTECH, INC.; XENON PHARMACEUTICALS INC.	10/02/17
US9458113	187	Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity	Boehringer Ingelheim International GmbH	10/02/17
US9458176	245	Tetrahydroimidazo(1,5-D)[1,4]oxazepine derivative	Eisai R&D Management Co., Ltd.	10/02/17
US9469608	44	Thrombin inhibitors	Merck Sharp & Dohme Corp.	10/02/17
US9452986	683	6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use	AbbVie Inc.	09/25/17
US9453031	272	Chemical entities	Fundación Centro Nacional de Investigaciones Oncológicas Carlos III	09/25/17
US9475814	83	Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof	Euroscreen S.A.	09/25/17
US9475806	21	Complement factor B inhibitors and uses there of	Novartis AG	09/25/17
US9452990	131	Complement pathway modulators and uses thereof	NOVARTIS AG	09/25/17
US9464060	136	Compounds	Takeda Pharmaceutical Company Limited	09/25/17
US9468642	46	Imidazopyrazines	BAYER INTELLECTUAL PROPERTY GMBH	09/25/17
US9447148	197	Melanocortin-1 receptor-specific cyclic peptides	Palatin Technologies, Inc.	09/25/17
US9469653	23	Pharmaceutical compositions for preventing or treating degenerative brain disease and method of screening the same	KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY	09/25/17
US9452998	274	Protein kinase C inhibitors and methods of their use	NOVARTIS AG	09/25/17
US9481668	1	Quinoline inhibitor of the macrophage stimulating 1 receptor MSTR1	Merck Patent GmbH	09/25/17
US9475779	63	Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity	Boehringer Ingelheim International GmbH	09/25/17
US9475809	16	Substituted oxopyridine derivatives and use thereof as factor xia/plasma	Bayer Pharma Aktiengesellschaft	09/25/17
US9469613	4	(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide	GILEAD SCIENCES, INC.	09/18/17
US9464044	101	Compound having ability to inhibit 11Beta-HSD1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient	AHN-GOOK PHARMACEUTICAL CO., LTD.; BAMICHEM CO., LTD; INCHEON UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION	09/18/17
US9447087	91	Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders	UNIVERSITY OF UTAH RESEARCH FOUNDATION	09/18/17
US9469644	7	Inhibitors of Bruton's tyrosine kinase	Hoffmann-La Roche Inc.	09/18/17
US9469639	14	Naphthylurea derivatives and medical applications thereof	Radiant Pharma & Tech. Co., Ltd.	09/18/17
US9469627	3	Phenyloxadiazole derivatives as PGDS inhibitors	Sanofi	09/18/17
US9434697	144	Pyrimidine FGFR4 inhibitors	EISAI R&D MANAGEMENT CO., LTD.	09/18/17
US9464103	12	Spirocyclic sulfones as gamma secretase inhibitors	MERCK SHARP & DOHME CORP.	09/18/17
US9434727	247	Substituted 4-phenylpiperidines, their preparation and use	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK	09/18/17
US9447038	205	Substituted B-amino acid derivatives as CXCR3 receptor antagonists	Sanofi	09/18/17
US9452980	625	Substituted benzamides	Hoffmann-La Roche Inc.	09/18/17
US9447106	218	Substituted pyrazolo[1,5-a]pyrimidines as bruton's tyrosine kinase modulators	BeiGene, Ltd.	09/18/17
US9475795	111	Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases	Takeda Pharmaceutical Company Limited	09/18/17
US9457039	24	2′-disubstituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases	Merck Sharp & Dohme Corp.	09/11/17
US9434725	762	5-azaindazole compounds and methods of use	F. HOFFMANN-LA ROCHE AG	09/11/17
US9458145	111	Benzimidazole derivatives as bromodomain inhibitors	Gilead Sciences, Inc.	09/11/17
US9453034	72	C2-azaspiro iminothiazine dioxides as BACE inhibitors, compositions, and their use	Merck Sharp & Dohme Corp.	09/11/17
US9458136	1	Crystalline forms and processes for the preparation of cannabinoid receptor modulators	Arena Pharmaceuticals, Inc.	09/11/17
US9458135	60	Dihydroquinoline-2-one derivatives	Hoffmann-La Roche Inc.	09/11/17
US9464062	6	Disubstituted oxazolidin-2-ones 5-hydroxytryptamine receptor 2B activity modulators	TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION	09/11/17
US9458140	29	Furanone compounds as kinase inhibitors	Eternity Bioscience Inc.	09/11/17
US9453038	42	Glucokinase activator compounds, compositions containing such compounds, and methods of treatment	Merck Sharp & Dohme Corp.	09/11/17
US9453048	38	IAP antagonists	Bristol-Myers Squibb Company	09/11/17
US9458105	10	Inhibitors of Bruton's tyrosine kinase	Hoffmann-La Roche Inc.	09/11/17
US9464073	16	Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors	Acetylon Pharmaceuticals, Inc.	09/11/17
US9464081	23	Pyrrolidine derivatives and their use as complement pathway modulators	Novartis AG	09/11/17
US9434711	709	Sulfonamides as TRPM8 modulators	Janssen Pharmaceutica, N.V.	09/11/17
US9463192	43	Trk-inhibiting compound	ONO PHARMACEUTICAL CO., LTD.	09/11/17
US9434719	783	3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH	NOVARTIS AG	09/05/17
US9453017	12	Antiviral therapies with phospholipase D inhibitors	Vanderbilt University	09/05/17
US9447029	38	Fluorinated arylalkylaminocarboxamide derivatives	NEWRON PHARMACEUTICALS S.P.A.	09/05/17
US9447090	34	Imidazopyridine compounds	Astellas Pharma Inc.	09/05/17
US9447085	33	Iminothiadiazine dioxides containing a thioamide, amidine, or amide oxime group as BACE inhibitors, compositions, and their use	Merck Sharp & Dohme Corp.	09/05/17
US9446026	20	Ocular formulations for drug-delivery to the posterior segment of the eye	PanOptica, Inc.	09/05/17
US9434733	75	PDE9 inhibitors with imidazo triazinone backbone	H. LUNDBECK A/S	09/05/17
US9447092	48	Pharmaceutically active compounds	CANCER RESEARCH TECHNOLOGY LIMITED	09/05/17
US9447091	40	Protein kinase inhibitors	ORION CORPORATION	09/05/17
US9447095	30	Pyrimidine derivatives as phosphodiesterase 10 inhibitors (PDE-10)	PALOBIOFARMA S.L.	09/05/17
US9453018	22	Pyrimidinones as factor XIa inhibitors	Bristol-Myers Squibb Company	09/05/17
US9453021	17	Pyrimidodiazepinone compound	Kyowa Hakko Kirin Co., Ltd.	09/05/17
US9434724	377	Quinuclidines for modulating alpha 7 activity	ALPHARMAGEN, LLC	09/05/17
US9453023	39	Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof	Sanofi	09/05/17
US9452985	8	Tau imaging probe	GE Healthcare Limited	09/05/17
US9428508	324	2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as FAK/Pyk2 inhibitors	Centaurus BioPharma Co., Ltd.	08/28/17
US9446130	25	BTK inhibitors	Merck Sharp & Dohme Corp.	08/28/17
US9433609	144	Benzimidazole-imidazole derivatives	Janssen Sciences Ireland UC	08/28/17
US9428514	208	Bromodomain inhibitors	AbbVie Inc.	08/28/17
US9446044	107	DYRK1 inhibitors and uses thereof	DIAXONHIT	08/28/17
US9447132	2	Highly active nucleoside derivative for the treatment of HCV	Achillion Pharmaceuticals, Inc.	08/28/17
US9428503	315	Imidazo[4,5-c]quinolin-2-one compounds and their use in treating Cancer	AstraZeneca AB	08/28/17
US9428511	152	Imidazopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases	Bristol-Myers Squibb Company	08/28/17
US9434692	4	Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto	Arena Pharmaceuticals, Inc.	08/28/17
US9433622	330	Pyrimidine compounds useful in the treatment of diseases mediated by IKKE and/or TBK1 mechanisms	Case Western Reserve University	08/28/17
US9447057	29	Schiff bases of thiazoles: a new class of ureases inhibitors	TBA	08/28/17
US9434690	357	Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders	Bayer Pharma Aktiengesellschaft	08/28/17
US9434693	45	Substituted pyrazoles as N-type calcium channel blockers	Janssen Pharmaceutica NV	08/28/17
US9447114	29	Thieno- and furo[2,3-d]pyrimidine-2,4[1H,3H]-dione derivatives	Hydra Biosciences, Inc.	08/28/17
US9428513	29	Triazolopyrazine	Boehringer Ingelheim International GmbH	08/28/17
US9428505	22	Hydantoin derivative	Chugai Seiyaku Kabushiki Kaisha	08/24/17
US9428469	30	Antiviral compounds	HOFFMANN-LA ROCHE	08/22/17
US9447055	2	α-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof	Merck Serono S.A.	08/21/17
US9428456	501	1-[m-carboxamido(hetero)aryl-methyl]-heterocyclyl-carboxamide derivatives	ACTELION PHARMACEUTICALS LTD	08/21/17
US9428504	172	7-hydroxy-spiropipiperidine indolinyl antagonists of P2Y1 receptor	Bristol-Myers Squibb Company	08/21/17
US9428500	117	Alpha-carbolines for the treatment of cancer	UNIVERSITA DEGLI STUDI DI MILANO—BICOCCA; UNIVERSITE DE GENEVE; UNIVERSITE CLAUDE BERNARD—LYON	08/21/17
US9427428	138	Benzimidazole-imidazole derivatives	Janssen Sciences Ireland UC	08/21/17
US9428501	53	Bicyclic nitrogen-containing aromatic heterocyclic amide compound	Astellas Pharma Inc.	08/21/17
US9446064	9	Combination therapy for treating cancer	Epizyme, Inc.	08/21/17
US9428502	338	Heterocyclic modulators of lipid synthesis	3-V Biosciences, Inc.	08/21/17
US9427440	69	Macrocyclic indole derivatives useful as hepatitis C virus inhibitors	Janssen Sciences Ireland UC	08/21/17
US9428460	40	N-[4-(quinolin-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides as androgen receptor antagonists, production and use thereof as medicinal products	BAYER PHARMA AKTIENGESELLSCHAFT	08/21/17
US9428478	66	Piperazine derivatives, compositions, and uses related thereto	Emory University	08/21/17
US9428476	17	S-imino-S-oxo-iminothiadiazine compounds as BACE inhibitors, compositions, and their use	Merck Sharp & Dohme Corp.	08/21/17
US9428492	54	Secondary alcohol substituted triazoles as PDE10 inhibitors	Merck Sharp & Dohme Corp.	08/21/17
US9428491	12	Substituted azoles, antiviral active component, pharmaceutical composition, method for preparation and use thereof	TBA	08/21/17
US9422293	771	Tetrahydro-pyrimidoazepines as modulators of TRPV1	Janssen Pharmaceutica NV	08/21/17
US9422331	108	2-oxo-2,3,4,5-tetrahydro-1 H-benzo[B]diazepines and their use in the treatment of cancer	HOFFMANN-LA ROCHE INC.	08/14/17
US9422332	92	Azaheterocycles as BIR2 and/or BIR3 inhibitors	HOFFMANN-LA ROCHE INC.	08/14/17
US9428447	29	Bis-(aryl/heteroaryl)-methylene compounds, pharmaceutical compositions containing same and their use for treating cancer	The Royal Institution for the Advancement of Learning/McGill University	08/14/17
US9415055	223	Cyclic amines	H. Lundbeck A/S	08/14/17
US9422318	37	Epoxyeicosatrienoic acid analogs and methods of making and using the same	The Medical College of Wisconsin, Inc.; The Board of Regents of the University of Texas System	08/14/17
US9427442	58	Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds	Bristol-Myers Squibb Company	08/14/17
US9422240	52	Partially saturated nitrogen-containing heterocyclic compound	TAISHO PHARMACEUTICAL CO., LTD	08/14/17
US9422255	40	S-imino-S-oxo-iminothiazine compounds as BACE inhibitors, compositions, and their use	Merck Sharp & Dohme Corp.	08/14/17
US9422299	205	Substituted [1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists	EUROSCREEN SA	08/14/17
US9416132	120	Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitors	Tolero Pharmaceuticals, Inc.	08/14/17
US9422235	171	Sulfonamide derivatives with therapeutic indications	Pharmos Corporation	08/14/17
US9422290	38	Triazolopyridazine	Boehringer Ingelheim International GmbH	08/14/17
US9422297	65	Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof	Duquesne University of the Holy Ghost	08/14/17
US9416129	244	Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their use	Merck Sharp & Dohme Corp.	08/14/17
US9422277	170	Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their use	Merck Sharp & Dohme Corp.	08/14/17
US9394331	44	2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections	Gilead Pharmasset LLC	08/07/17
US9409892	368	4-hydroxy-isoquinoline compounds as HIF hydroxylase inhibitors	FibroGen, Inc.	08/07/17
US9416154	45	5′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases	Merck Sharp & Dohme Corp.	08/07/17
US9428465	17	Acid ceramidase inhibitors and their use as medicaments	Fondazione Istituto Italiano Di Technologia	08/07/17
US9409895	69	Autotaxin inhibitors	Novartis AG	08/07/17
US9409908	443	Dihydropyridone p1 as factor XIa inhibitors	Bristol-Myers Squibb Company	08/07/17
US9409888	53	Dimeric compounds	Hoffmann-La Roche Inc.	08/07/17
US9422333	28	HCV protease inhibitors and uses thereof	Celgene Avilomics Research, Inc.	08/07/17
US9409917	118	Heterocyclic amide derivatives as P2X7 receptor antagonists	ACTELION PHARMACEUTICALS LTD.	08/07/17
US9421177	72	Imidamide sphingosine kinase inhibitors	University of Virginia Patent Foundation	08/07/17
US9409907	205	Inhibitor compounds	Cancer Research Technology Limited	08/07/17
US9416123	85	Kinase modulators for the treatment of cancer	Synovo GmbH	08/07/17
US9428466	9	Methods for reducing uric acid levels using barbiturate derivatives	TBA	08/07/17
US9416139	72	Spiro ring compound as hepatitis C virus (HCV) inhibitor and uses thereof	SUNSHINE LAKE PHARMA CO., LTD.	08/07/17
US9409915	90	Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators	Janssen Pharmaceutica NV	08/07/17
US9422307	17	2,4,7-substituted thieno[3,2-d]pyrimidine compounds as protein kinase inhibitors	KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY	08/01/17
US9422324	8	6-substituted demethyl-estradiol derivatives as selective ER-β agonists	Endece LLC	08/01/17
US9422312	21	Azabenzimidazole derivatives	Boehringer Ingelheim International GmbH	08/01/17
US9422273	40	Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response	ALLERGAN, INC.	08/01/17
US9422243	55	3-phenyl-isoquinolin-1(2H)-one derivatives as PARP-1 inhibitors	NERVIANO MEDICAL SCIENCES S.R.L. a corporation	07/31/17
US9403813	270	Azetidine amide derivatives as orexin receptor antagonists	ACTELION PHARMACEUTICALS LTD.	07/31/17
US9403843	72	Cysteine protease inhibitors and uses thereof	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK; THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS	07/31/17
US9422263	19	Fluoro-substituted 3,5-dicyano-4-(1H-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof	BAYER PHARMA AKTIENGESELLSCHAFT	07/31/17
US9422261	11	Heterocyclic resorcinol derivatives, preparation of same and cosmetic uses thereof	PIERRE FABRE DERMO-COSMETIQUE	07/31/17
US9422231	5	Method for inhibiting Trypanosoma cruzi	HOWARD UNIVERSITY	07/31/17
US9403808	195	Pyrazine derivatives	Hoffmann-La Roche Inc.	07/31/17
US9409882	96	Pyridine derivatives	Hoffmann-La Roche Inc.	07/31/17
US9409866	620	Pyridine-2-amides useful as CB2 agonists	HOFFMANN-LA ROCHE INC.	07/31/17
US9409924	26	Selective glycosidase inhibitors and uses thereof	Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.	07/31/17
US9403767	182	Substituted 4-aminocyclohexane derivatives	GRUENENTHAL GMBH	07/31/17
US9403801	81	Substituted heteroaryl compounds and methods of use	CALITOR SCIENCES, LLC; SUNSHINE LAKE PHARMA CO., LTD.	07/31/17
US9394309	198	Substituted phenylimidazopyrazoles and their use	Bayer Pharma Aktiengesellschaft; Bayer Intellectual Property GmbH	07/31/17
US9416127	72	Triazole carboxamides and uses thereof	Hoffmann-La Roche Inc.	07/31/17
US9394311	136	Triazolo compounds as PDE10 inhibitors	Hoffmann-La Roche Inc.	07/31/17
US9403810	48	Carboxamide derivatives	Novartis AG	07/25/17
US9409931	8	3-O-acyl-ingenol analogues	LEO LABORATORIES LIMITED	07/24/17
US9408863	13	5′-substituted nucleoside analogs and methods of use thereof for the treatment of viral diseases	Merck Sharp & Dohme Corp.	07/24/17
US9409845	22	Alpha-(3,5-dimethoxybenzylidene)-alpha′-hydrocarbyl methylene cyclic ketone and preparation method thereof	PHARMAXYN LABORATORIES LTD.	07/24/17
US9394297	934	Amides as pim inhibitors	AMGEN INC.	07/24/17
US9403846	28	Carbocyclic- and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds	Pfizer Inc.	07/24/17
US9403833	17	Carboxamide derivatives	Novartis AG	07/24/17
US9409900	4	Compound for increasing kinase active and application thereof	FUJIAN HAIXI PHARMACEUTICALS, INC.; BETTA PHARMACUETICALS CO., LTD.	07/24/17
US9416126	394	Compounds inhibiting leucine-rich repeat kinase enzyme activity	Merck Sharp & Dohme Corp.	07/24/17
US9403803	15	Indole-3-carboxamides as kinase inhibitors	Allergan, Inc.	07/24/17
US9403768	24	Indolines	Hoffmann-La Roche Inc.	07/24/17
US9409868	44	Inhibitors of rho associated protein kinases (ROCK) and methods of use	H. Lee Moffin Cancer Center and Research Institute, Inc.	07/24/17
US9409858	37	Selective histone deactylase 6 inhibitors	H. Lee Moffitt Cancer Center and Research Institute, Inc.; Board of Trustees of the University of Illinois	07/24/17
US9408850	74	Substituted indazole derivatives active as kinase inhibitors	NERVIANO MEDICAL SCIENCES S.R.L.	07/24/17
US9403827	32	Substituted purinone compounds	NOVARTIS AG	07/24/17
US9403831	42	Triazolopyrazine derivative and use thereof	KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY; HANDOK INC.	07/24/17
US9416103	25	Use of the aminoalkylindole JWH-073-M4 and related compounds as neutral CB1 receptor antagonists for the treatment of alcoholism, drug abuse, obesity, and obesity-related diseases	The Board of Trustees of the University of Arkansas; The University of Kansas	07/24/17
US9394275	191	Diamide compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity	Theravance Respiratory Company, LLC	07/18/17
US9394273	118	Therapeutic prostaglandin receptor agonists	ALLERGAN, INC.	07/18/17
US9403797	2	5-(pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use	Cancer Research Technology Limited	07/17/17
US9394291	20	Benzoxazinone amides as mineralocorticoid receptor modulators	AstraZeneca AB	07/17/17
US9403774	6	Guanidine and amine substituted tetrahydroisoquinoline compounds as factor xia inhibitors	Bristol-Myers Squibb Company	07/17/17
US9394285	186	Indole and indazole compounds that activate AMPK	Pfizer Inc.	07/17/17
US9394289	44	Inhibitors of c-fms kinase	Janssen Pharmaceutica NV	07/17/17
US9403804	10	Inhibitors of c-fms kinase	Janssen Pharmaceutica NV	07/17/17
US9388165	22	Isoquinoline-5-carboxamide derivative having inhibitory activity for protein kinase	HANMI PHARM. CO., LTD.	07/17/17
US9402837	20	Method for the treatment of neurological disorders by enhancing the activity of β-glucocerebrosidase	Amicus Therapeutics, Inc.	07/17/17
US9409887	14	Mutant-selective EGFR inhibitors and uses thereof	Celgene Avilomics Research, Inc.	07/17/17
US9388210	17	Neuroactive 17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same	WASHINGTON UNIVERSITY	07/17/17
US9394282	406	Pyrazole carboxamides as Janus kinase inhibitors	Merck Sharp & Dohme Corp.	07/17/17
US9394290	90	Selective CYP11B1 inhibitors for the treatment of cortisol dependent diseases	UNIVERSITAET DES SAARLANDES CAMPUS SAARBRUECKEN	07/17/17
US9394303	31	Small molecule inhibitors of MCL-1 and uses thereof	THE REGENTS OF THE UNIVERSITY OF MICHIGAN	07/17/17
US9393232	171	Substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones	BeiGene, Ltd.	07/17/17
US9394263	237	Substituted hetero-azepinones	F. HOFFMANN-LA ROCHE AG	07/17/17
US9394250	56	Substituted pyrrolidines as factor xia inhibitors for the treatment thromboembolic diseases	ONO PHARMACEUTICAL CO., LTD.	07/17/17
US9402842	12	Synthesis and use of dual tyrosyl-DNA phosphodiesterase I (Tdp1)—topoisomerase I (Top1) inhibitors	Purdue Research Foundation	07/17/17
US9394293	17	TRPV1 antagonists including dihydroxy substituent and uses thereof	Purdue Pharma L.P.	07/17/17
US9394254	6	Antibiotic and anti-parasitic agents that modulate class II fructose 1,6-bisphosphate aldolase	The University of Denver and Regis University	07/10/17
US9403822	5	Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases	ABBVIE INC.	07/10/17
US9365589	82	C5, C6 oxacyclic-fused thiazine dioxide compounds as BACE inhibitors, compositions, and their use	Merck Sharp & Dohme Corp.	07/10/17
US9402878	2	Depsipeptide and uses thereof	NovoBiotic Pharmaceuticals, LLC	07/10/17
US9388139	97	Derivatives of celeboxib, use thereof and preparation thereof	German University; Southern Research Institute	07/10/17
US9388149	69	Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases	GALDERMA RESEARCH & DEVELOPMENT	07/10/17
US9394307	6	Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation	ChemoCentryx, Inc.	07/10/17
US9388197	76	Heterocyclic amide derivatives as P2X7 receptor antagonists	ACTELION PHARMACEUTICALS LTD.	07/10/17
US9388198	17	Heterocyclic amide derivatives as P2X7 receptor antagonists	ACTELION PHARMACEUTICALS LTD.	07/10/17
US9394304	18	Imidazopyridine derivatives	Hoffmann-La Roche Inc.	07/10/17
US9365582	24	Macrocyclic inhibitors of hepatitis C virus	Janssen Sciences Ireland UC	07/10/17
US9388176	119	Method of treating conditiions with kinase inhibitors	ALLERGAN, INC.	07/10/17
US9365572	65	PI3K and/or mTOR inhibitor	Xuanzhu Pharma Co., Ltd.	07/10/17
US9403799	14	Pyrimidinyl-pyridazinone derivatives for treating a disease which is influenced by inhibition of met kinase	MERCK PATENT GMBH	07/10/17
US9388199	44	Pyrrolidine derivatives and their use as complement pathway modulators	NOVARTIS AG	07/10/17
US9388189	81	Pyrrolotriazinone derivatives as PI3K inhibitors	Almirall, S.A.	07/10/17
US9388171	28	Serine/threonine kinase inhibitors	GENETECH, INC.; ARRAY BIOPHARMA INC.	07/10/17
US9394276	16	Substituted 1,2,3,4-tetrahydro-2,6-naphthyridines as factor XIa inhibitors	Bristol-Myers Squibb Company	07/10/17
US9388181	15	Substituted 1,2,3,4-tetrahydropyrido[3,4-E] pyrrolo[1,2-A]pyrimidines as kinase	Allergan, Inc.	07/10/17
US9388140	120	Substituted benzimidazoles	Bayer Intellectual Property GmbH	07/10/17
US9388162	146	Substituted morphinans and the use thereof	Purdue Pharma L.P.	07/10/17
US9388136	35	Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereof	Chroma Therapeutics Ltd	07/10/17
USRE46024	22	Thyroid hormone analogs	Hoffmann-La Roche Inc.	07/10/17
US9365562	126	1,3 substituted azetidine PDE10 inhibitors	Merck Sharp & Dohme Corp.	07/03/17
US9364459	43	3-(indolyl)- or 3-(azaindolyl)- 4-arylmaleimide derivatives for use in the treatment of colon and gastric adenocarcinoma	Johannes Gutenberg-Universität Mainz; Universitätsmedizin der Johannes Gutenberg-Universität Mainz	07/03/17
US9365508	26	Aroyl thiourea derivatives	University Court of the University of St Andrews; University Court of the University of Dundee	07/03/17
US9365534	43	Arylated camphenes, processes for their preparation and uses thereof	YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.	07/03/17
US9365529	68	Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics	GALDERMA RESEARCH & DEVLOPMENT	07/03/17
US9359371	77	Bicyclic substituted pyrimidine compounds	XUANZHU PHARMA CO., LTD.	07/03/17
US9365511	26	Biphenyl-ethyl-pyrrolidine derivatives as histamine H3 receptor modulators for the treatment of cognitive disorders	ARENA PHARMACEUTICALS, INC.	07/03/17
US9359372	60	Hexahydrodibenzo[a,g]quinolizine compound, preparation method thereof, pharmaceutical composition and use thereof	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES	07/03/17
US9359361	20	Immune system modulators	JANUS BIOTHERAPEUTICS, INC.	07/03/17
US9365575	25	Kinase inhibitors	Allergan, Inc.	07/03/17
US9365853	7	Matriptase inhibitors and uses thereof against orthomyxoviridae infections	TBA	07/03/17
US9365502	18	Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors	WASHINGTON UNIVERSITY	07/03/17
US9365539	11	Prolylcarboxypeptidase inhibitors	Merck Sharp & Dohme Corp.	07/03/17
US9365576	279	Pyrrolopyrrolidinone compounds	Novartis AG	07/03/17
US9388137	9	Quaternized amines as sodium channel blockers	Purdue Pharma L.P.	07/03/17
US9394283	2	Salt form of a human histone methyltransferase EZH2 inhibitor	Epizyme, Inc.; Eisai R&D Management Co., LTD.	07/03/17
US9364482	134	Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases	Merck Sharp & Dohme Corp.	07/03/17
US9394281	12	Substituted heteroaryl compounds and methods of use	CALITOR SCIENCES, LLC; SUNSHINE LAKE PHARMA CO., LTD.	07/03/17
US9365546	8	Substituted pyridinone-pyridinyl compounds	CONFLUENCE LIFE SCIENCES INC.	07/03/17
US9359399	71	Synthetic peptide amides	Cara Therapeutics, Inc.	07/03/17
US9365563	228	TRPV1 antagonists including dihydroxy substituent and uses thereof	Purdue Pharma L.P.	07/03/17
US9359338	366	Cyclopropanecarboxamido-substitute aromatic compounds as anti-tumor agents	CROWN BIOSCIENCE INC. (Taiwan)	06/27/17
US9388160	4	Quinazoline derivatives as kinases inhibitors and methods of use thereof	Teligene Ltd	06/27/17
US9388170	7	Substituted aminoquinazolines useful as kinases inhibitors	TBA	06/27/17
US9353084	49	2-amino 3,5,5-trifluoro-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treatment of Alzheimer's disease	H. Lundbeck A/S	06/26/17
US9359337	12	Acetamide derivatives	Hoffmann-La Roche Inc.	06/26/17
US9359341	11	Aldehyde derivative of substitute oxazolidinones	WANBURY LTD.	06/26/17
US9353089	180	Compositions and methods for the treatment of malaria	Saint Louis University; Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences	06/26/17
US9353101	64	Cyclic amine substituted heterocyclic CETP inhibitors	Merck Sharp & Dohme Corp.	06/26/17
US9359348	11	Cyclopropyl imidazopyridine PDE10 inhibitors	Merck Sharp & Dohme Corp.	06/26/17
US9365558	99	Dihydropyridinone MGAT2 inhibitors	Bristol-Myers Squibb Company	06/26/17
US9359339	19	Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use	Merck Sharp & Dohme Corp.	06/26/17
US9353093	63	Indole-1-carboxamides as kinase inhibitors	Allergan, Inc.	06/26/17
US9353116	62	Methods and compositions for kinase inhibition	The Regents of the University of California	06/26/17
US9353102	88	Non-annulated thiophenylamides	Hoffmann-La Roche Inc.	06/26/17
US9353104	130	Substituted pyridizinone derivatives as PDE10 inhibitors	Merck Sharp & Dohme Corp.	06/26/17
US9359345	12	Thiazole derivatives as inhibitors of Bruton's tyrosine kinase	HOFFMANN-LA ROCHE INC.	06/26/17
US9393245	88	Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors	vTv Therapeutics LLC	06/26/17
US9353061	28	3,5,N-trihydroxy-alkanamide and derivatives: method for making same and use thereof	ACADEMIA SINICA; NATIONAL TAIWAN UNIVERSITY	06/19/17
US9346829	31	5-HT3 receptor antagonists	Takeda Phamaceutical Company Limited	06/19/17
US9353081	132	Bicyclic dihydroquinoline-2-one derivatives	Hoffmann-La Roche Inc.	06/19/17
US9353075	66	Disubstituted beta-lactones as inhibitors of N-acylethanolamine acid amidase (NAAA)	The Regents of the University of California; Fondazione Istituto Italiano Di Technologia; Universita Degli Studi Di Parma; Universita Degli Studi Di Urbino “Carlo Bo”	06/19/17
US9359301	14	Ethynyl derivatives	Hoffmann-La Roche Inc.	06/19/17
US9346814	250	FAP inhibitors	Universiteit Antwerp; Fox Chase Cancer Center	06/19/17
US9346821	66	Heterocyclic carboxylic acid ester derivative	AJINOMOTO CO., INC.	06/19/17
US9353090	331	Heterocyclic carboxylic acids as activators of soluble guanylate cyclase	Boehringer Ingelheim International GmbH	06/19/17
US9351965	152	Indazole derivatives useful as ERK inhibitors	Merck Sharp & Dohme Corp.	06/19/17
US9359293	24	Methods of treatment using modulators of SIRT2	CORNELL UNIVERSITY	06/19/17
US9346786	123	Pyrrolidine compounds	Hoffmann-La Roche Inc.	06/19/17
US9353066	228	Substituted phenyl-Spleen Tyrosine Kinase (Syk) inhibitors	Merck Sharp & Dohme Corp.; Merck Canada Inc.	06/19/17
US9359330	25	Substituted piperidines as sodium channel blockers	Purdue Pharma L.P.	06/19/17
US9346815	934	5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereof	Genentech, Inc.	06/12/17
US9345742	42	Aminostatin derivatives for the treatment of arthrosis	MERCK PATENT GMBH	06/12/17
US9346770	29	Compounds having activating effect on subtypes of peroxisome proliferator-activated receptors and its preparation method and uses	ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.	06/12/17
US9353067	3	Heterocyclic compounds and uses thereof in the treatment of sexual disorders	ATIR Holding S.A.	06/12/17
US9353115	11	Immune system modulators	JANUS BIOTHERAPEUTICS, INC.	06/12/17
US9353083	4	Oxazetidine derivatives, process for preparing them and use in human medicine and in cosmetics	GALDERMA RESEARCH & DEVELOPMENT	06/12/17
US9358227	12	Pharmaceutical uses of 6-amino quinazoline or 3-cyano quinoline derivatives	Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd.	06/12/17
US9346839	11	Phosphonate derivatives and methods of use thereof in the treatment of Alzheimer's disease	University of Kansas	06/12/17
US9351973	15	Pyrazolopyridyl compounds as aldosterone synthase inhibitors	Merck Sharp & Dohme Corp.	06/12/17
US9346794	85	Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity	Boehringer Ingelheim International GmbH	06/12/17
US9346795	186	Substituted sulfonamides useful as antiapoptotic Bcl inhibitors	Bristol-Myers Squibb Company	06/12/17
US9353113	13	Tetrahydrocarboline derivative	ONO PHARMACEUTICAL CO., LTD.	06/12/17
US9346827	11	5-amino-oxazepine and 5-amino-thiazepane compounds as beta secretase antagonists and methods of use	Amgen Inc.	06/05/17
US9346782	60	Alkyl linked quinolinyl modulators of RORγt	Janssen Pharmaceutica NV	06/05/17
US9346818	42	Benzodioxole derivative and preparation method and use thereof	Zhejiang Hisun Pharmaceutical Co., Ltd.	06/05/17
US9345700	53	Compositions and methods useful for treating diseases	Eutropics Pharmaceuticals, Inc.	06/05/17
US9346798	678	Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors	AMGEN INC.	06/05/17
US9346803	44	Indomethacin analogs for the treatment of castrate-resistant prostate cancer	Vanderbilt University; The Trustees of the University of Pennsylvania	06/05/17
US9340574	25	Inhibitors of protein tyrosine phosphatases	Indiana University Research and Technology Corporation	06/05/17
US9340549	193	Oxazolidinone compounds and derivatives thereof	AMGEN INC.	06/05/17
US9346787	28	Piperidine compound or salt thereof	TAIHO PHARMACEUTICAL CO., LTD.	06/05/17
US9339501	54	17a-hydroxylase/C17,20-lyase inhibitors	NOVARTIS AG	05/31/17
US9346797	14	2-amino 6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors	H. Lundbeck A/S	05/31/17
US9340500	154	Aromatic heterocyclic derivative having TRPV4-inhibiting activity	SHIONOGI & CO., LTD.	05/31/17
US9340537	173	Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1	NOVATIS AG	05/31/17
US9334269	337	Carboxamides as inhibitors of voltage-gated sodium channels	AMGEN INC.	05/31/17
US9346793	15	Hydroxylated aminotriazole derivatives as ALX receptor agonists	Actelion Pharmaceuticals, LTD.	05/31/17
US9340517	531	Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor	Mimetica PTY LTD	05/31/17
US9334286	108	Pharmacologically active compounds	Cancer Research Technology Limited	05/31/17
US9340530	84	Preparation and use of bicyclic himbacine derivatives as PAR-1 receptor antagonists	Merck Sharp & Dohme Corp.	05/31/17
US9340507	111	Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity	Boehringer Ingelheim International GmbH	05/31/17
US9353062	2	Substituted quinolines as bruton's tyrosine kinases inhibitors	HangzhouDeRenYuCheng Biotechnology Ltd	05/31/17
US9334290	152	Substituted tetrahydrocarbazole and carbazole carboxamide compounds	Bristol-Myers Squibb Company	05/31/17
US9340510	245	Tetrahydroisoquinoline derivatives, pharmaceutical compositions and uses thereof	Boehringer Ingelheim International GmbH	05/31/17
US9346822	4	Thienopyrimidine compounds and use thereof	Takeda Pharmaceutical Company Limited	05/31/17
US9340506	38	Acetamide derivatives as glucokinase activators, their process and medicinal applications	ADVINUS THERAPEUTICS LIMITED	05/22/17
US9340573	28	Azaindolines	Hoffmann-La Roche Inc.	05/22/17
US9340555	180	Compounds as tyrosine kinase modulators	Allergan, Inc.	05/22/17
US9345793	20	Compounds for binding to the platelet specific glycoprotein IIB/IIIA and their use for imaging of thrombi	PIRAMAL IMAGING SA	05/22/17
US9334279	129	Hepatitis C virus inhibitors	Bristol-Myers Squibb Company	05/22/17
US9345740	24	IAP antagonists	Bristol-Myers Squibb Company	05/22/17
US9340521	130	Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives	GREEN CROSS CORPORATION	05/22/17
US9340542	20	Propellane-based compounds and the use thereof	Purdue Pharma L.P.	05/22/17
US9340504	6	Pyridine and piperidine derivatives as novel sodium channel blockers	Purdue Pharma L.P.	05/22/17
US9346810	249	Pyrrolopyrimidine compounds and uses thereof	HUTCHISON MEDIPHARMA LIMITED	05/22/17
US9334288	34	Selective β-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents	The University of North Carolina at Chapel Hill	05/22/17
US9345789	13	Specific inhibitors and active site probes for legumain	The Board of Trustees of the Leland Stanford Junior University	05/22/17
US9328099	1336	Cyanomethylpyrazole carboxamides as janus kinase inhibitors	Merck Sharp & Dohme Corp.	05/18/17
US9333195	34	Quinuclidine derivatives and medicinal compositions containing the same	ALMIRALL, S.A.	05/18/17
US9334268	25	4-amino-imidazoquinoline compounds	HOFFMAN-LA ROCHE INC.	05/15/17
US9340534	4	Compounds and methods for treating ocular diseases	ALLERGAN, INC.	05/15/17
US9328106	297	Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use	GENENTECH, INC.	05/15/17
US9339486	15	Heterocyclic modulators of cannabinoid receptors	The Cleveland Clinic Foundation	05/15/17
US9333217	10	Inhibitors of human EZH2, and methods of use thereof	Epizyme, Inc.	05/15/17
US9333205	6	Isoxazolo-quinazolines as modulators of protein kinase activity	NERVIANO MEDICAL SCIENCES S.R.L.	05/15/17
US9333199	13	Methods of treatment of histamine H-4 receptor-related pruritus associated with nerve disorders	BRIDGE PHARMA, INC.	05/15/17
US9340511	7	Process for making isoquinoline compounds	FibroGen, Inc.	05/15/17
US9334271	32	Purine derivatives and their use in the treatment of disease	Novarits AG	05/15/17
US9321790	119	Pyrimidinone derivatives as antimalarial agents	Sanofi	05/15/17
US9334278	38	Pyrrolo[2,3-B]pyrazines as SYK inhibitors	Hoffmann-La Roche Inc.	05/15/17
US9328096	800	Tropomyosin-related kinase inhibitors	Pfizer Inc.	05/15/17
US9328120	34	6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders	Boehringer Ingelheim International GmbH	05/08/17
US9321791	46	8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions	Boehringer Ingelheim International GmbH	05/08/17
US9326978	16	A3 adenosine receptor allosteric modulators	The United States of America, Represented by the Secretary, Dept. of Health and Human Services; Universiteit Leiden	05/08/17
US9321760	243	Aminopyrimidine derivatives for use as modulators of kinase activity	Merck Patent GmbH	05/08/17
US9333197	9	Apoptosis signal-regulating kinase inhibitor	Gilead Sciences, Inc.	05/08/17
US9321756	823	Azole compounds as PIM inhibitors	AMGEN INC.	05/08/17
US9328124	3	BACE inhibitors	Eli Lilly and Company	05/08/17
US9321773	21	Compounds	Respivert, Ltd.	05/08/17
US9328070	8	Ethynyl derivatives	Hoffmann-La Roche Inc.	05/08/17
US9328118	159	Nitrogen-containing bicyclic aromatic heterocyclic compound	Astellas Pharma Inc.	05/08/17
US9328123	5	Rotenone derivatives and a use thereof	Korea Atomic Energy Research Institute	05/08/17
US9328111	39	Substituted cycloocta[5,6]pyrido[4,3,2-de]phthalazines as PARP inhibitors	BeiGene Ltd.	05/08/17
US9328112	193	Tetracyclic CDK9 kinase inhibitors	AbbVie Inc.	05/03/17
US9315520	135	2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides	Pfizer Inc.	05/01/17
US9321748	59	Aminopyridine derived compounds as LRRK2 inhibitors	H. Lundbeck A/S; Vernalis (R&D) Ltd.	05/01/17
US9321728	33	Beta-alanine derivatives, pharmaceutically acceptable salts thereof, and pharmaceutical composition comprising same as active ingredient	KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY; HANDOK PHARMACEUTICALS CO., LTD.	05/01/17
US9320741	14	Compositions and methods for treating neoplasia, inflammatory disease and other disorders	DANA-FARBER CANCER INSTITUTE, INC.	05/01/17
US9321743	25	Compositions and methods of inhibiting N-acylethanolamine-hydrolyzing acid amidase	The Regents of the University of California; Universita Degli Studi Di Parma; Universita Degli Studi Di Urbino “Carlo Bo”	05/01/17
US9321766	10	Kinase inhibitors	Allergan, Inc.	05/01/17
US9321738	28	N-alkyltriazole compounds as LPAR antagonists	HOFFMAN-LA ROCHE INC.	05/01/17
US9321752	10	Pyrazole derivative	GREEN TECH CO., LTD.	05/01/17
US9321750	5	ROR modulators and their uses	INNOV17 LLC	05/01/17
US9320722	81	Regulators of aldehyde dehydrogenase ALDH3A1 and related therapeutic methods	Indiana University Research and Technology Corporation	05/01/17
US9320734	110	Small molecule inhibitors of the pleckstrin homology domain and methods for using same	Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona	05/01/17
US20160326143	65	Compounds and uses	Astrazeneca Ab	04/27/17
US9320732	21	1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase	Incyte Corporation; Incyte Holdings Corporation	04/24/17
US9315514	32	1,3-dioxanomorphides and 1,3-dioxanocodides	Rhodes Technologies	04/24/17
US9321747	21	Acid addition salt of substituted pyridine compound	DAIICHI SANKYO COMPANY, LIMITED; UBE INDUSTRIES, LTD.	04/24/17
US9315498	174	Arlethynyl derivatives	HOFFMAN-LA ROCHE INC.	04/24/17
US9315500	26	Bicyclic heteroaryl cycloalkyldiamine derivatives	NOVARTIS AG	04/24/17
US9315489	98	Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1	Novartis AG	04/24/17
US9315499	41	Cytomegalovirus inhibitor compounds	Boehringer Ingelheim International GmbH	04/24/17
US9315519	6	Guanidine substituted tetrahydroisoquinoline compounds as factor XIa inhibitors	Bristol-Myers Squibb Company	04/24/17
US9315518	40	Imidazopyridin-2-one derivatives	Merck Sharp & Dohme Corp.	04/24/17
US9321721	8	Kinase inhibitors	Allergan, Inc.	04/24/17
US9315493	18	Phenylpyridine derivative and drug containing same	KOWA COMPANY, LTD.	04/24/17
US9315491	129	Pyrimidine compounds as mTOR and PI3K inhibitors	DEVELOPMENT CENTER FOR BIOTECHNOLOGY; DCB-USA LLC	04/24/17
US9320737	32	Substituted imidazopyridazines	BAYER INTELLECTUAL PROPERTY GMBH	04/24/17
US9315508	3	Treating diabetes with dipeptidyl peptidase-IV inhibitors	Merck sharp & Dohme Corp.	04/24/17
US9303017	131	2,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereof	Georgetown University; Duke University	04/10/17
US9303045	162	5-HT3 receptor antagonists	Takeda Pharmaceutical Company Limited	04/10/17
US9303025	407	Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases	AbbVie Inc.	04/10/17
US9314468	140	Chemokine receptor modulators	Altiris Therapeutics, Inc.	04/10/17
US9314464	22	Compounds and compositions as protein kinase inhibitors	Novartis AG	04/10/17
US9315463	30	Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities	Almirall, S.A.	04/10/17
US9303015	151	Heteroaryl linked quinolinyl modulators of RORγt	JANSSEN PHARMACEUTICA NV	04/10/17
US9315492	29	Heterocyclic group contained amino-methanol derivative, and salt, synthetic method and use thereof	Beijing Foreland Biopharma Co., Ltd.	04/10/17
US9315438	10	Optically pure benzyl-4-chlorophenyl-C-glucoside derivative	XUANZHU PHARMA CO., LTD	04/10/17
US9303023	145	Pyrazole and imidazole derivatives useful as orexin antagonists	ACTELION PHARMACEUTICALS LTD.	04/10/17
US9303012	304	Pyridine-2-amides useful as CB2 agonists	HOFFMAN-LA ROCHE INC.	04/10/17
US9303035	36	Substituted pyrazino[1′,2′:1,2]pyrrolo[3,4-d]pyrimidines, pyrimido[4′,5′:3,4]pyrrolo[2,1-c][1,4]oxazines and pyrimido[4′,5′:3,4]pyrrolo[1,2-d][1,4]oxazepines for inhibiting the CFTR channel	Novartis AG	04/10/17
US9284322	30	Nicotinic receptor compounds	Research Triangle Institute	04/04/17
US9296759	188	Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use	Amgen Inc.	04/03/17
US9290488	165	Azetidine-substituted quinoxalines as opioid receptor like-1 modulators	Purdue Pharma L.P.	04/03/17
US9271961	119	Bifunctional AKR1C3 inhibitors/androgen receptor modulators and methods of use thereof	The Trustees of the University of Pennsylvania	04/03/17
US9296741	698	Bromodomain inhibitors	AbbVie Inc.	04/03/17
US9296708	17	Chimeric small molecules for the recruitment of antibodies to cancer cells	YALE UNIVERSITY	04/03/17
US9302996	148	Continuous arycyclic compound	MITSUBISHI TANABE PHARMA CORPORATION	04/03/17
US9278100	149	Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors	Pharmacyclics LLC	04/03/17
US9290476	160	Methylene linked quinolinyl modulators of RORγt	JANSSEN PHARMACEUTICA NV	04/03/17
US9271963	95	Selective inhibitors of human corticosteroid synthases	UNIVERSITAT DES SAARLANDES	04/03/17
US9278925	146	Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one	BAYER INTELLECTUAL PROPERTY GMBH	04/03/17
US9302986	97	Substituted 3-haloallylamine inhibitors of ASSAO and uses thereof	BOEHRINGER INGELHEIM INTERNATIONAL GMBH	04/03/17
US9303033	2239	Pyrazolopyrimidines and related heterocycles as CK2 inhibitors	SENHWA BIOSCIENCES, INC.	03/30/17
US9302985	17	Benzyl sulfonamide derivatives as RORc modulators	Genentech, Inc.	03/21/17
US9212182	776	Bicyclic sulfonamide compounds as sodium channel inhibitors	Amgen Inc.	03/21/17
US9296681	36	Cycloalkylmethylamines	REVIVA PHARMACEUTICALS, INC.	03/21/17
US9289400	6	D3 dopamine receptor agonists to treat dyskinesia in parkinson's disease	Drexel University; Rutgers, The State University of New Jersey	03/21/17
US9284333	390	Fused pyrroledicarboxamides and their use as pharmaceuticals	Sanofi	03/21/17
US9249087	156	HDAC inhibitors and therapeutic methods using the same	THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS; THE CHILDREN'S HOSPITAL OF PHILADELPHIA	03/21/17
US9290501	16	Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase	Albert Einstein College of Medicine, Inc.; Victoria Link Limited	03/21/17
US9296757	92	Substituted benzothienopyrimidines	BAYER PHARMA AKTIENGESELLSCHAFT	03/21/17
US9260435	16	Substituted imidazopyrazines as Akt kinase inhibitors	BAYER PHARMA AKTIENGESELLSCHAFT	03/21/17
US9303018	23	Inhibitors of leukotriene production	Boehringer Ingelheim International GmbH	03/13/17
US9302989	1657	NAMPT and rock inhibitors	AbbVie Inc.	03/13/17
US9303019	12	Amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome	UNIVERSITE DE STRASBOURG	03/06/17
US9296745	236	Diacylglycerol acyltransferase 2 inhibitors	Pfizer Inc.	03/06/17
US9296734	722	Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use	Amgen Inc.	03/06/17
US9296736	497	Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer	Amgen INC.	03/06/17
US9296748	113	Pyridinones	Boehringer Ingelheim International GmbH	03/06/17
US9302981	6	Synthesis, methods of using, and compositions of cycloalkylmethylamines	REVIVA PHARMACEUTICALS, Inc.	03/06/17
US9303005	4	Use of dibenzofuranone derivatives to inhibit kinases	TBA	03/06/17
US9296747	30	Piperidylpyrimidine derivatives as modulators of protein kinase inhibitors and of vascular endothelial growth factor receptor 2	Allergan, Inc.	02/28/17
US9296703	2	Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors	University of Utah Research Foundation	02/28/17
US9296728	26	Therapeutic compounds	Regents of the University of Minnesota	02/28/17
US9284330	29	1,4-dihydro-naphthyridine derivative and pharmaceutical composition and use thereof	Jiangsu Simovay Pharmaceutical Co., Ltd.	02/27/17
US9296693	133	Acyl piperidine inhibitors of soluble epoxide hydrolase	The Regents of the University of California	02/27/17
US9284319	34	Heterocyclyl aminoimidazopyridazines	BAYER INTELLECTUAL PROPERTY GMBH	02/27/17
US9283222	773	Inhibitors of poly(ADP-ribose)polymerase	AbbVie Inc.	02/27/17
US9295672	37	Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof	Ambit Biosciences Corporation	02/27/17
US9278978	83	6-Alkynyl Pyridine	Boehringer Ingelheim International GmbH	02/21/17
US9278976	8	Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes	Merck Sharp & Dohme Corp.	02/21/17
US9278981	551	Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1	Novartis AG	02/21/17
US9284302	4	Cyclobutyl benzimidazoles as PDE 10 inhibitors	Merck Sharp & Dohme Corp.	02/21/17
US9278968	106	Imidazopyridine compounds	Astellas Pharma Inc.	02/21/17
US9284284	64	Oxazine derivatives and their use in the treatment of disease	NOVARTIS AG	02/21/17
US9296775	3	Pyrazole compounds	ELI LILLY AND COMPANY	02/21/17
US9284298	8	Pyrazolyl-pyrimidine derivatives as kinase inhibitors	NERVIANO MEDICAL SCIENCES S.R.L.	02/21/17
US9283225	2	Pyrido-pyrimidine derivatives	Merck Patent GmbH	02/21/17
US9284299	58	Substituted 1H-indazol-1-ol analogs as inhibitors of beta catenin/Tcf protein-protein interactions	University of Utah Research Foundation	02/21/17
US9284317	29	Substituted imidazo[1,2-a]pyrazines as MPS-1 inhibitors	Bayer Intellectual Property GmbH	02/21/17
US9284315	32	Three-ring PI3K and/or mTOR inhibitor	ZUANZHU PHARMA CO., LTD.	02/21/17
US9290517	25	Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives	Merck Sharp & Dohme Corp.	02/14/17
US9278963	124	Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors	Acetylon Pharmaceuticals, Inc.	02/14/17
US9278960	315	Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use	Merck Sharp & Dohme Corp.	02/14/17
US9278093	8	Aldosterone synthase inhibitors	Merck Sharp & Dohme Corp.; ElexoPharm GmbH	02/13/17
US9278953	14	Antagonists of prostaglandin EP3 receptor	Pfizer Inc.	02/13/17
US9278930	32	Methods for increasing the stabilization of hypoxia inducible factor-α	AERPIO THERAPEUTICS, INC.	02/13/17
US9278944	131	Nitrogen-containing saturated heterocyclic compound	MITSUBISHI TANABE PHARMA CORPORATION; SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.	02/13/17
US8772490	5	Optically active diazabicyclooctane derivatives and process for preparing the same	Meiji Seika Pharma Co., Ltd.	02/13/17
US9278954	172	Pyrrolidine derivatives, pharmaceutical compositions and uses thereof	Boehringer Ingelheim International GmbH	02/13/17
US9278914	5	SARMs and method of use thereof	University of Tennessee Research Foundation	02/13/17
US9278918	32	Urea derivatives and their use as fatty-acid binding protein (FABP) inhibitors	Hoffmann-La Roche Inc.	02/13/17
US9290482	8	Amino-substituted imidazopyridazines	BAYER PHARMA AKTIENGESELLSCHAFT	02/06/17
US9290490	33	Aminopyrimidines as Syk inhibitors	Merck Sharp & Dohme Corp.	02/06/17
US9290507	137	B-RAF kinase inhibitors	Boehringer Ingelheim International GmbH	02/06/17
US9290481	13	Monocyclic heteroaryl cycloalkyldiamine derivatives	NOVARTIS AG	02/06/17
US9290485	183	N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides	NOVARTIS AG	02/06/17
US9290487	74	Pharmaceutical composition for treating diabetes	AJINOMOTO CO., INC.	02/06/17
US9290459	353	Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity	Boehringer Ingelheim International GmbH	02/06/17
US9290457	215	Substituted dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity	Boehringer Ingelheim International GmbH	02/06/17
US9290505	22	Substituted imidazo[1,2-a]pyrazines as Syk inhibitors	Gilead Sciences, Inc.	02/06/17
US9247759	464	Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in compositions and use thereof	Senomyx, Inc.	02/02/17
US9290467	51	Cyclic amides	HOFFMANN—LA ROCHE INC.	01/30/17
US9273046	116	Fused tricyclic compounds as Raf kinase inhibitors	BeiGene, LTD.	01/30/17
US9290477	7	Inhibitors of β-secretase	Vitae Pharmaceuticals, Inc.	01/30/17
US9290456	68	Pyridazinone compounds and their use as DAAO inhibitors	Takeda Pharmaceutical Company Limited	01/30/17
US9290451	758	Pyridine derivatives as agonists of the CB2 receptor	Hoffmann-La Roche Inc.	01/30/17
US9290463	5	Radiolabeled compounds and uses thereof	The Trustees of Columbia University in the City of New York	01/30/17
US9290454	27	Substituted isoquinolines as CRTH2 receptor modulators	Merck Sharp & Dohme Corp.	01/30/17
US9273053	82	Sulfur-containing heterocyclic derivative having Beta secretase inhibitory activity	Shionogi & Co., Ltd.	01/30/17
US9273043	82	TRPV1 antagonists including dihydroxy substituent and uses thereof	Purdue Pharma L.P.; Shionogi & Co., Ltd.	01/30/17
US9249124	141	Aurora kinase inhibitors and methods of making and using thereof	H. Lee Moffitt Cancer Center and Research Institute, Inc.	01/27/17
US9273042	9	5-amino[1,4]thiazines as BACE 1 inhibitors	HOFFMANN-LA ROCHE INC.	01/25/17
US9273014	82	Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof	Bristol-Myers Squibb Company	01/24/17
US9266877	359	Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases	ABBVIE INC.	01/23/17
US9271969	134	Compounds as inhibitors of diacylglycerol O-acyltransferase type 1 enzyme	KAINOS MEDICINE, INC.	01/23/17
US9273021	6	Dibenzofuran derivatives as inhibitors of fructose 1,6-bisphosphatase and methods of use thereof	TRUSTEES OF BOSTON COLLEGE	01/23/17
US9273052	5	Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof	Jiangsu Hansoh Pharmaceutical Co., Ltd.	01/23/17
US9273029	119	Pyridine-and pyrazine derivatives	Merck Patent GmbH	01/23/17
US9266890	24	Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders	Dana-Farber Cancer Institute, Inc.	01/23/17
US9271981	7	Pyrrolo[2,3-D]pyrimidine compounds	Zoetis Services LLC	01/23/17
US9266883	144	Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors	Novartis AG	01/23/17
US9266891	61	Substituted [1,2,4]triazolo[4,3-A]pyrazines that are BRD4 inhibitors	Boehringer Ingelheim International GmbH	01/23/17
US9273011	14	Substituted pyridazines for the treatment of pain	Inhibitaxin Limited	01/23/17
US9273033	142	Substituted pyridone derivatives as PDE10 inhibitors	Merck Sharp & Dohme Corp.	01/23/17
US9243038	35	Macrocyclic insulin-degrading enzyme (IDE) inhibitors and uses thereof	President and Fellows of Harvard College	01/18/17
US9233167	124	Oligomer-opioid agonist conjugates	Nektar Therapeutics	01/18/17
US9233947	11	Sulfamides as TRPM8 modulators	Janssen Pharmaceutica, NV	01/18/17
US9266876	244	4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives	Actelion Pharmaceuticals Ltd.	01/17/17
US9266870	96	Heteroaromatic methyl cyclic amine derivative	TAISHO PHARMACEUTICAL CO., LTD	01/17/17
US9266878	656	Phosphatidylinositol 3-kinase inhibitors	Gilead Calistoga LLC	01/17/17
US9266880	8	Substituted azaindazole compounds	Bristol-Myers Squibb Company	01/17/17
US9266869	118	Substituted dialkyl(oxido)-lambda4-sulfanylidene nicotinamide derivatives as kinase inhibitors	Allergan, Inc.	01/17/17
US9266895	33	Substituted pyrazolo[3,4-d]pyrimidines as kinase inhibitors	Principia Biopharma Inc.	01/17/17
US9266881	22	Triazolopyridinone PDE10 inhibitors	Merck Sharp & Dohme Corp.	01/17/17
US9266835	362	Quinoline derivatives useful as CB-1 inverse agonists	Janssen Pharmaceutica NV	01/16/17
US9265773	422	Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases	Merck Sharp & Dohme Corp.; MSD Italia S.R.L.	01/16/17
US9233921	34	Potent poxvirus inhibitor	THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA	01/14/17
US9266848	37	4-alkoxy-N-(2-hydroxycarbamoyl-2-piperidinyl-ethyl)-benzamide compounds as selective TACE-inhibitors for the treatment of inflammatory diseases	GALDERMA RESEARCH & DEVELOPMENT	01/09/17
US9260455	15	Alkyl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds	Pfizer Inc.	01/09/17
US9265734	416	Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors	BIOMARIN PHARMACEUTICAL INC.	01/09/17
US9266832	90	Compounds for the treatment of neurodegenerative diseases	Katholieke Universiteit Levun; K. U. Leuven R&D reMYND	01/09/17
US9260439	575	Dihydropyrrolopyrimidine derivatives	PFIZER INC.	01/09/17
US9260440	123	Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors	BeiGene, Ltd.	01/09/17
US9266828	5	Inhibitors of Furin and other pro-protein convertases	SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE	01/09/17
US9266853	8	Orally available viridiofungin derivative possessing anti-HCV activity	Chugai Seiyaku Kabushiki Kaisha	01/09/17
US9260450	18	Therapeutic pyrazolyl thienopyridines	THESAN PHARMACEUTICALS, INC.	01/09/17
US9266839	2	Trifluoromethyl pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof	Lycera Corporation	01/09/17
US9233965	111	3,4-dihydropyrrolo[1,2-A]pyrazine-2,8(1H)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof for diseases involving casein kinase 1 epsilon and/or casein kinase 1 delta	SANOFI	01/07/17
US9249163	241	PDE10a inhibitors for the treatment of type II diabetes	JANSSEN PHARMACEUTICA NV.	12/31/16
US9492405	97	Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas	The United States of America, as represented by the Secretary, Department of Health and Human Services; SRI International	12/31/16
US9260415	17	Heteroaryl pyridone and aza-pyridone compounds with electrophilic functionality	Genentech, Inc.	12/28/16
US9260413	5	Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders	Merck Sharp & Dohme Corp.	12/28/16
US9259422	35	Orvinol and thevinol derivatives useful in the treatment of depression	The University of Bath	12/28/16
US9260410	8	P38 MAP kinase inhibitors	Respivert Ltd.	12/28/16
US9260425	412	Pyrazolo[3,4-c]pyridine compounds and methods of use	Genetech, Inc.	12/28/16
US9259470	42	Serine/threonine kinase inhibitors	Array BioPharma Inc.; Genentech, Inc.	12/28/16
US9260446	5	Synthetic methods for spiro-oxindole compounds	Xenon Pharmaceuticals Inc.	12/28/16
US9260448	11	Thienopyrimidinone derivatives as mGluR1 antagonists	KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY	12/28/16
US9253997	33	Alkylamine derivative	AJINOMOTO CO., INC.	12/20/16
US9255091	15	Benzothiazole-based pyridinium compounds	The University of Montana	12/20/16
US9255107	8	Heteroaryl alkyne compound and use thereof	NANJING SANHOME PHARMACEUTICAL CO., LTD.	12/20/16
US9255090	449	Heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators	ACTELION PHARMACEUTICALS LTD.	12/20/16
US9255110	229	Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators	ROCHE PALO ALTO LLC; HOFFMANN-LA ROCHE INC.	12/20/16
US9255096	26	Substituted 1,2,3,4-tetrahydrobenzo[C][2,7] naphthyridines and derivatives thereof as kinase inhibitors	Allergan, Inc.	12/20/16
US9255106	46	Substituted [1,2,4]triazolo[4,3-a]pyrazines as PARP-1 inhibitors	Shanghai Institute of Materia Medica, Chinese Academy of Sciences	12/20/16
US9255103	59	Substituted pyrazolo[1,5-a]pyrazines as mGluR5 receptor modulators	Vanderbilt University	12/20/16
US9255098	6	Xanthine derivative	Chengdu Easton Pharmaceutical Co., Ltd.	12/20/16
US9260417	14	Therapeutic methods and compositions involving allosteric kinase inhibition	AMITECH THERAPEUTIC SOLUTIONS, INC.	12/15/16
US9249085	61	Aniline derivatives, their preparation and their therapeutic application	FOVEA PHARMACEUTICALS	12/12/16
US9249151	126	Bis-amido pyridines	Boehringer Ingelheim International GmbH	12/12/16
US9248140	66	Chemical compounds	AstraZeneca AB	12/12/16
US9249139	9	Indolizinone based derivatives as potential phosphodiesterase 3 (PDE3) inhibitors and a process for the preparation thereof	Council of Scientific & Industrial Research	12/12/16
US9249125	371	Pyrazole derivatives as p38 MAP inhibitors	RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED	12/12/16
US9249123	8	Pyridinones/pyrazinones, method of making, and method of use thereof	Genentech, Inc.; Gilead Connecticut, Inc.	12/12/16
US9249096	30	Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors	Bristol-Myers Squibb Company	12/12/16
US9243020	20	Selective glycosidase inhibitors and uses thereof	Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.	12/12/16
US9255087	12	Substituted indazole derivatives active as kinase inhibitors	NERVIANO MEDICAL SCIENCES S.R.L.	12/12/16
US9249114	74	Thiazole derivatives	Merck Patent GmbH	12/12/16
US9227979	64	Fluorescent antagonists of the A3 adenosine receptor	The United States of America, as represented by The Secretary, Department of Health and Human Services; Universita Degli Studi Di Trieste; Universita Degli Studi Di Padova	12/08/16
US9260454	41	Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals	SANOFI	12/08/16
US9242977	42	Trk-inhibiting compound	ONO PHARMACEUTICAL CO., LTD.	12/06/16
US9242988	7	2′-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases	Merck Sharp & Dohme Corp.	12/05/16
US9242996	573	Aminoheteroaryl benzamides as kinase inhibitors	Novartis AG	12/05/16
US9242973	532	Chromane compounds	COMENTIS, INC.	12/05/16
US9242998	118	Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C	Merck Sharp & Dohme Corp.	12/05/16
US9243002	192	Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C	Merck Sharp & Dohme Corp.	12/05/16
US9221809	356	Aminopyrimidinones as interleukin receptor-associated kinase inhibitors	MERCK SHARP & DOHME CORP.	11/29/16
US9242943	66	1,4 oxazines as BACE1 and/or BACE2 inhibitors	SIENA BIOTECH S.P.A.; HOFFMANN-LA ROCHE INC.	11/28/16
US9242969	416	Biaryl amide compounds as kinase inhibitors	Novartis AG	11/28/16
US9238625	33	Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives	REVIVA PHARMACEUTICALS, INC.	11/28/16
US9242981	44	Fused pyrazole derivatives as novel ERK inhibitors	Merck Sharp & Dohme Corp.	11/28/16
US9242975	27	Heterocyclic-substituted pyridyl compounds useful as kinase inhibitors	Bristol-Myers Squibb Company	11/28/16
US9242995	3	Isoxazolopyridine orexin receptor antagonists	MERCK SHARP & DOHME CORP.	11/28/16
US9242970	930	Lactam derivatives useful as orexin receptor antagonists	ACTELION PHARMACEUTICALS LTD.	11/28/16
US9242960	4	P38MAP kinase inhibitors	Respivert, Ltd.	11/28/16
US9242982	7	Pyridopyrimidine based derivatives as potential phosphodiesterase 3 (PDE3) inhibitors and a process for the preparation thereof	COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH	11/28/16
US9242957	72	Thiophene-2-carboximidamide based selective neuronal nitric oxide inhibitors	Northwestern University	11/28/16
US9238651	72	1-H-pyrrolo[2,3-b]pyridine derivatives	MERCK PATENT GMBH	11/21/16
US9238626	42	Beta-amyloid-directed multitarget compounds for the treatment of alzheimer's disease	UNIVERSITAT DE BARCELONA; PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE	11/21/16
US9233979	458	Compounds that are ERK inhibitors	Merck Sharp & Dohme Corp.	11/21/16
US9238629	88	Heteroaryl compounds and uses thereof	Celgene Avilomics Research, Inc.	11/21/16
US9241942	494	IRE-1α inhibitors	MannKind Corporation	11/21/16
US9238619	76	Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy	AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.	11/21/16
US9233983	152	Substituted hetero-bicyclic compounds, compositions and medicinal applications thereof	ADVINUS THERAPEUTICS LIMITED	11/21/16
US9233981	33	Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds	Pfizer Inc.	11/21/16
US9238658	49	Substituted piperidinyl-carboxamide derivatives useful as SCD 1 inhibitors	Janssen Pharmaceutica NV	11/21/16
US9238644	143	VEGFR3 inhibitors	CANCER THERAPEUTICS CRC PTY LIMITED	11/21/16
US9187424	434	Aryl dihydropyridinones and piperidinone MGAT2 inhibitors	Bristol-Myers Squibb Company	11/15/16
US9227969	101	Compounds and compositions as inhibitors of MEK	NOVARTIS AG	11/14/16
US9233108	30	Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities	ALMIRALL, S.A.	11/14/16
US9233953	161	Derivatives of 4-(piperazinylcarbonyl)thiane-1, 1-dione which inhibit GlyT1	Boehringer Ingelheim International GmbH	11/14/16
US9226927	15	Gamma secretase inhibitors	MERCK SHARP & DOHME CORP.	11/14/16
US9233086	100	Inhibition of WDR5 interaction with its binding partners	THE REGENTS OF THE UNIVERSITY OF MICHIGAN	11/14/16
US9233968	97	Kinase inhibitors	Allergan, Inc.	11/14/16
US9227975	60	Method of treatment using substituted imidazo[1,2B]pyridazine compounds	Array BioPharma, Inc.	11/14/16
US9227977	14	Phosphoinositide 3-kinase inhibitors	Respivert Ltd.	11/14/16
US9227973	16	Pyridine CGRP receptor antagonists	Merck Sharp & Dohme Corp.	11/14/16
US9233111	72	Pyrrolo pyrimidine derivatives	NOVARTIS AG	11/14/16
US9227956	98	Substituted amide compounds	Pfizer Inc.	11/14/16
US9233946	59	Sulfonamide compounds	KANCERA AB	11/14/16
US9227970	43	Triazolopyridine compounds	Hoffmann-La Roche, Inc.	11/14/16
US9227982	56	4-oxo-3,5,7,8-tetrahydro-4H-pyrano[4,3-d]pyrminidinyl compounds for use as tankyrase inhibitors	NOVARTIS AG	11/08/16
US9227930	16	Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy	AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG	11/08/16
US9234000	417	Benzylamine derivatives as inhibitors of plasma kallikrein	Kalvista Pharmaceuticals Limited	11/08/16
US9221831	451	Buprenorphine analogs	Purdue Pharma, L.P.	11/08/16
US9226922	476	Compounds that are ERK inhibitors	Merck Sharp & Dohme Corp.	11/08/16
US9227959	8	Ethynyl derivatives	Hoffman-La Roche Inc.	11/08/16
US9227949	188	Heteroarylcarboxylic acid ester derivative	AJINOMOTO CO., INC.	11/08/16
US9221808	178	Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinase (ROCK) and methods of use	H. Lee Moffitt Cancer Center and Research Institute, Inc.	11/08/16
US9226923	19	Spirocyclic molecules as protein kinase inhibitors	Nanjing Allgen Pharma Co. Ltd.	11/08/16
US9216998	56	Tricyclic indole derivatives useful endothelial lipase inhibitors	Janssen Pharmaceutica NV	11/08/16
US9217012	22	Inhibitors of protein tyrosine phosphatases	Indiana University Research and Technology Corporation	11/02/16
US9221802	10	Arylethynyl derivatives	Hoffman-La Roche Inc.	10/31/16
US9221839	30	C5-C6 oxacyclic-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their use	Merck Sharp & Dohme Corp.	10/31/16
US9221832	152	Heterocyclic amide derivatives as P2X7 receptor antagonists	ACTELION PHARMACEUTICALS LTD.	10/31/16
US9221824	5	Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitors	Incyte Holdings Corporation; Incyte Corporation	10/31/16
US9221797	93	Inhibitors of c-fms kinase	Janssen Pharmaceutica NV	10/31/16
US9221791	18	Metalloenzyme inhibitor compounds	Viamet Pharmaceuticals, Inc.	10/31/16
US9221828	21	N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)phenyl]sulfonamides as pharmaceuticals	SANOFI	10/31/16
US9221796	174	Selective NR2B antagonists	Bristol-Myers Squibb Company	10/31/16
US9216999	1840	Substituted pyrrolo[2,3-h][1,6]naphthyridines and compositions thereof as JAK inhibitors	Nissan Chemical Industries, Ltd.	10/31/16
US9216984	12	3-[4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane—or heptane-nitrile as JAK inhibitors	Incyte Corporation; Incyte Holdings Corporation	10/24/16
US9216985	41	3-aryl-2-((arylamino)methyl)quinazolin-4-(3H)-ones	SciFluor Life Sciences, Inc.	10/24/16
US9221790	16	Benzamide derivatives	Dong-A Pharm. Co., Ltd.	10/24/16
US9216988	210	Benzyl sulfonamide derivatives as RORc modulators	Genentech, Inc.	10/24/16
US9216968	239	Heterocyclic derivative and pharmaceutical drug	NIPPON SHINYAKU CO., LTD.	10/24/16
US9221795	143	Phosphatidylinositol 3-kinase inhibitors	Gilead Sciences, Inc.	10/24/16
US9216981	88	Purinylpyridinylamino-2,4-difluorophenyl sulfonamide derivative, pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition with inhibitory activity against Raf kinase, containing same as active ingredient	Medpacto, Inc.	10/24/16
US9216986	52	Quinoline derivatives as PDE10A enzyme inhibitors	H. Lundbeck A/S	10/24/16
US9221767	26	Substituted phthalazinones as rock inhibitors	Bristol-Myers Squibb Company	10/24/16
US9216962	216	Thiazole compounds, methods for preparation and use thereof	Shanghai Puyi Chemical Co., Ltd.	10/24/16
US9216997	21	Tri-heterocyclic derivatives, preparation process and uses thereof	Shanghai De Novo Pharmatech Co Ltd.	10/24/16
US9216972	69	Tricyclic heterocyclic compounds	Bristol-Myers Squibb Company	10/24/16
US9090621	104	Tyrosine kinase inhibitors	Principia Biopharma Inc.	10/19/16
US9212206	8	4-Fluoro-Thio-containing inhibitors of APP2, compositions thereof and method of use	TBA	10/18/16
US9216182	192	Carbamate/urea derivatives containing piperidin and piperazin rings as H3 receptor inhibitors	Novartis AG	10/18/16
US9206164	111	Pyrazole compounds as CRTH2 antagonists	Boehringer Ingelheim International GmbH	10/18/16
US9212144	43	2-aminoquinoline-based compounds for potent and selective neuronal nitric oxide synthase inhibition	Northwestern University	10/17/16
US9212184	4	6-thio-substituted imidazo[1,2-a]pyrazines as Mps-1 inhibitors	BAYER INTELLECTUAL PROPERTY GMBH	10/17/16
US9212192	59	Bicyclic carboxamide inhibitors of kinases	AbbVie Inc.	10/17/16
US9212186	25	Bicyclic pyrazole LRRK2 small molecule inhibitors	Genentech, Inc.	10/17/16
US9212147	64	Dihydroxy aromatic heterocyclic compound	Takeda Pharmaceutical Company Limited	10/17/16
US9212171	46	Ethynyl compounds	HOFFMANN-LA ROCHE INC.	10/17/16
US9212196	105	Hypophosphorous acid derivatives having antihyperalgic activity and biological applications thereof	UNIVERSITE PARIS DESCARTES; UNIVERSITE D'AUVERGNE	10/17/16
US9212187	13	Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation	OTSUKA PHARMACEUTICAL CO., LTD.	10/17/16
US9212173	37	Pyrazole aminopyrimidine derivatives as LRRK2 modulators	Genentech, Inc.	10/17/16
US9212178	35	Substituted pyrimidine compounds and their use as SYK inhibitors	Genosco; Oscotec, Inc.	10/17/16
US9212145	3	Urea derivatives and uses thereof	Kala Pharmaceuticals, Inc.	10/17/16
US9212140	12	(5s,8s)-3-(4′-chlor-3′-fluor-4-methlybiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5] dec-3-en-2-one (compound A) for treatment	Bayer Intellectual Property GmbH	10/11/16
US9212139	88	Aryl substituted indoles and their use as blockers of sodium channels	Purdue Pharma, L.P.	10/11/16
US9212165	28	Bicarbocyclic and tricarbocyclic ethynyl derivatives and uses of same	H. Lundbeck A/S	10/11/16
US9206201	4	Boronic acid bearing liphagane compounds as inhibitors of P13K-α and/or β	Counsel of Scientific & Industrial Research	10/11/16
US9212130	181	Heterocyclic derivative and pharmaceutical composition comprising the same	SHIONOGI & CO., LTD.	10/11/16
US9206199	217	Inhibitors of the renal outer medullary potassium channel	Merck Sharp & Dohme Corp.	10/11/16
US9206232	203	Organic compounds and their uses	Novartis AG	10/11/16
US9206188	228	Substituted pyrrolo[2,3-b]pyridines as ITK and JAK inhibitors	ARRIEN PHARMACEUTICALS LLC	10/11/16
US9211296	35	Therapeutic compounds for blocking DNA synthesis of POX viruses	The Trustees of the University of Pennsylvania	10/11/16
US9206173	137	Heterocyclic compounds for the treatment of stress-related conditions	OTSUKA PHARMACEUTICAL CO., LTD.	10/10/16
US9216974	16	Phenoxazine derivatives and methods of use thereof	WASHINGTON UNIVERSITY	10/04/16
US9206129	53	Agent for treatment of eye diseases	Daito Chemix Corporation; Kyoto University	10/03/16
US9206139	65	Aggrecanase inhibitors	Eli Lilly and Company	10/03/16
US9206184	219	Disubstituted benzothienyl-pyrrolotriazines and uses thereof	BAYER INTELLECTUAL PROPERTY GmbH	10/03/16
US9212153	549	Inhibitors of beta-secretase	Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH	10/03/16
US9206198	113	Inhibitors of the renal outer medullary potassium channel	Merck Sharp & Dohme Corp.	10/03/16
US9206167	122	Piperazine-substituted benzothiophenes for treatment of mental disorders	OTSUKA PHARMACEUTICAL CO., LTD.	10/03/16
US9206162	53	Triazole compounds that modulate Hsp90 activity	Synta Pharmaceuticals Corp.	10/03/16
US9205085	73	Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction	Emory University	10/03/16
US9200020	75	6-oxopurine phosphoribosyltransferase inhibitors	THE UNIVERSITY OF QUEENSLAND; INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY ASCR, V.V.I.	09/27/16
US9199981	176	Compounds and compositions as C-kit kinase inhibitors	NOVARTIS AG	09/27/16
US9200268	5	Compounds and methods for purification of serine proteases	Portola Pharmaceuticals, Inc.	09/27/16
US9199976	17	Haematopoietic-prostaglandin D2 synthase inhibitors	The University of Queensland	09/27/16
US9205078	4	N-methyl-2-[3-((E)-2-pyridin-2-yl-vinyl)-1H-indazol-6-ylsulfanyl]-benzamide for the treatment of chronic myelogenous leukemia	PFIZER INC.	09/27/16
US9200006	26	Protease inhibitors	MEDIVIR AB	09/27/16
US9199997	3	Purinone derivative hydrochloride	ONO PHARMACEUTICAL CO., LTD.	09/27/16
US9200016	173	Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)	Allergan, Inc.; Exonhit Therapeutics, SA	09/27/16
US9199999	76	Substituted imidazopyrazines	Bayer Intellectual Property GmbH	09/27/16
US9200001	119	Triazolyl PDE10 inhibitors	Merck Sharp & Dohme Corp.	09/27/16
US9199947	140	Biaryl-propionic acid derivatives and their use as pharmaceuticals	Sanofi	09/20/16
US9199927	112	Guanidinobenzoic acid compound	Astellas Pharma Inc.	09/20/16
US9199944	157	N2,N4-bis(4-(piperazine-1-yl)phenyl)pirimidine-2,4-diamine derivative or pharmaceutically acceptable salt thereof, and composition containing same as active ingredient for preventing or treating cancer	KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY	09/20/16
US9199949	11	Selective glycosidase inhibitors and uses thereof	Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp.	09/20/16
US9193689	18	3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use	INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE)	09/19/16
US9187487	46	Azaindole derivatives as tyrosine kinase inhibitors	PRINCIPIA BIOPHARMA, INC.	09/19/16
US9192603	67	Heterocyclic sulfone mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction	Vanderbilt University	09/19/16
US9193697	39	Oxazole derivatives useful as modulators of FAAH	MERCK SHARP & DOHME CORP.	09/19/16
US9193736	311	PDE 10a inhibitors for the treatment of type II diabetes	Janssen Pharmaceutica, NV	09/19/16
US9193762	57	Selective inhibitors of prolylcarboxypeptidase	UNIVERSITY OF MISSISSIPPI	09/19/16
US9193726	73	Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders	Pfizer Inc.	09/19/16
US9187470	12	Anti-mucus drugs and uses therefor	Washington University	09/12/16
US9187477	16	Azabenzimidazole derivatives	Boehringer Ingelheim International GmbH	09/12/16
US9187486	205	Bicyclic pyridazine compounds as Pim inhibitors	AMGEN INC.	09/12/16
US9187466	60	Bisaryl-bonded aryltriazolones and use thereof	Bayer Intellectual Property GmbH	09/12/16
US9187469	20	Morpholinylbenzotriazines for use in cancer therapy	Merck Patent GmbH	09/12/16
US9187480	48	Peripherally restricted diphenyl purine derivatives	Research Triangle Institute	09/12/16
US9187459	10	Quinazoline-7-ether compounds and methods of use	NewGen Therapeutics, Inc.	09/12/16
US9187474	8	Raf inhibitor compounds	Deciphera Pharmaceuticals, LLC; Eli Lilly and Company	09/12/16
US9187437	45	Substituted oxadiazole compounds	BRISTOL-MYERS SQUIBB COMPANY	09/12/16
US9187450	56	Substituted pyridine compound	Daiichi Sankyo Company, Limited	09/12/16
US9187462	122	Substituted quinazolines as serine/threonine kinase inhibitors	Array BioPharma Inc.; Genentech, Inc.	09/12/16
US9187441	88	p53-Mdm2 antagonists	University of Pittsburgh—Of the Commonwealth System of Higher Education	09/12/16
US9187406	25	Curcumin analogues as zinc chelators and their uses	The Research Foundation of State University of New York; Chem-Master International, Inc.	09/06/16
US9182402	47	Hepsin inhibitors	Fred Hutchinson Cancer Research Center	09/06/16
US9181263	149	Inhibitors of bruton's tyrosine kinase	PHARMACYCLICS LLC	09/06/16
US9187413	6	Peripherally restricted FAAH inhibitors	The Regents of the University of California; Universita Degli Studi Di Parma; Universita Degli Studi Di Urbino	09/06/16
US9187429	211	Phenyl-tetrahydroisoquinoline derivatives	HOFFMANN-LA ROCHE INC.	09/06/16
US9187430	9	Poly (ADP-ribose) polymerase inhibitor	CHENGDU DI'AO PHARMACEUTICAL GROUP CO., LTD.	09/06/16
US9186318	31	Quinolyl-containing hydroxamic acid compound and preparation method thereof, and pharmaceutical composition containing this compound and use thereof	Beijing Konruns Pharmaceutical Co., Ltd	09/06/16
US9187428	150	Substituted dicyanopyridines and use thereof	Bayer Intellectual Property GmbH	09/06/16
US9187397	23	Therapeutic curcumin derivatives	STC.UNM	09/06/16
US9186360	490	Treatment of respiratory disorders using TRPA1 antagonists	GLENMARK PHARMACEUTICALS S.A.	09/06/16
US9181266	321	2-piperidin-1-yl-acetamide compounds for use as tankyrase inhibitors	NOVARTIS AG	08/29/16
US9181236	290	2-spiro-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions and their use	Merck Sharp & Dohme Corp.	08/29/16
US9181253	52	Adenosine receptor agonists, partial agonists, and antagonists	The United States of America, as represented by the Secretary, Department of Health and Human Services	08/29/16
US9181272	300	Aldosterone synthase inhibitors	Boehringer Ingelheim International GmbH	08/29/16
US9181279	16	Cyclic amine derivatives as EP4 receptor antagonists	ROTTAPHARM BIOTECH S.R.L.	08/29/16
US9181233	28	Inhibitors of glutaminyl cyclase	PROBIODRUG AG	08/29/16
US9181275	4	Mercaptoamidine derivatives and methods of use	AbbVie Inc.	08/29/16
US9181258	130	Substituted 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-ones as protein kinase inhibitors	NERVIANO MEDICAL SCIENCES S.R.L.	08/29/16
US9181249	142	Substituted pyrido[3,4-b]pyrazines as GPR6 modulators	Takeda Pharmaceutical Company Limited	08/29/16
US9181261	10	TrkA kinase inhibitors, compositions and methods thereof	Merck Sharp & Dohme Corp.	08/29/16
US9181181	77	2-substituted-3-phenylpropionic acid derivatives and their use in the treatment of inflammatory bowel disease	Albireo AB	08/15/16
US9180122	35	5- or 6-substituted 3-hydroxy-2 (1 H)-pyridinones as D-amino acid oxidase (DAAO) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and pain	Takeda Pharmaceutical Company Limited	08/15/16
US9181219	48	Compounds of modulating TRPV3 function	HYDRA BIOSCIENCES, INC.	08/15/16
US9180116	72	Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions	Cayman Chemical Company, Inc.	08/15/16
US9175357	23	Fragment ligated inhibitors selective for the polo box domain of PLK1	UNIVERSITY OF SOUTH CAROLINA	08/15/16
US9181185	25	Heteroaryl compounds as sodium channel blockers	Purdue Pharma L.P.	08/15/16
US9181184	18	Method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives	Amicus Therapeutics, Inc.	08/15/16
US9181230	110	Morpholine compounds and uses thereof	Hoffmann-La Roche Inc.	08/15/16
US9180183	18	Phospholipid drug analogs	Telormedix SA	08/15/16
US9181182	40	S1P receptors modulators	Akaal Pharma PTY LTD	08/15/16
US9180120	38	Substituted N-phenethyltriazoloneacetamides and use thereof	Bayer Intellectual Property GmbH	08/15/16
US9181187	12	Therapeutic agent for urinary excretion disorder	ONO PHARMACEUTICAL CO., LTD.	08/15/16
US9180192	46	mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction	Vanderbilt University	08/15/16
US9174997	29	4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof	Bayer Intellectual Property GmbH	08/08/16
US9174982	360	Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases	ABBVIE INC.; GENENTECH, INC.; THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH	08/08/16
US9175000	27	Buprenorphine analogs	Purdue Pharma L.P.	08/08/16
US9174969	73	Indoline scaffold SHP-2 inhibitors and cancer treatment method	UNIVERSITY OF SOUTH FLORIDA	08/08/16
US9175331	256	Inhibitors of human EZH2, and methods of use thereof	Epizyme, Inc.	08/08/16
US9174974	85	Macrocyclic factor VIIa inhibitors	Bristol-Myers Squibb Company	08/08/16
US9174999	20	Methods and compositions for studying, imaging, and treating pain	The Board of Trustees of the Leland Stanford Junior University	08/08/16
US9174993	27	N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals	SANOFI	08/08/16
US9175320	1	Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereof	Arena Pharmaceuticals, Inc.	08/08/16
US9175003	234	Substituted azoanthracene derivatives and intermediates for preparation thereof	vTv Therapeutics LLC	08/08/16
US9173884	107	Inhibitors of phosphodiesterase 11 (PDE11)	Trustees of Boston College	08/02/16
US9173935	18	Phospholipid drug analogs	Telormedix SA	08/02/16
US9174965	6	Pyrimidinylpiperidinyloxypyridone analogues as GPR119 modulators	Bristol-Myers Squibb Company	08/02/16
US9174940	29	TSH receptor antagonizing tetrahydroquinoline compounds	Merck Sharp & Dohme B.V.	08/02/16
US9169270	120	1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators	Actelion Pharmaceuticals Ltd.	08/01/16
US9169260	399	Amidopyrazole inhibitors of interleukin receptor-associated kinases	MERCK SHARP & DOHME CORP.	08/01/16
US9173879	6	Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a ]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof	Bristol-Myers Squibb Company	08/01/16
US9173869	43	Mediators of hedgehog signaling pathways, compositions and uses related thereto	CURIS, INC.	08/01/16
US9169246	207	Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof	SANOFI	08/01/16
US9073941	179	Compounds and methods for treating tuberculosis infection	Academia Sinica	07/26/16
US9169224	209	Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase	Janssen Pharmaceutica NV	07/26/16
US9169243	45	Apoptosis signal-regulating kinase inhibitors	Gilead Sciences, Inc.	07/25/16
US9169209	118	Compounds and compositions for the inhibition of NAMPT	FORMA TM, LLC	07/25/16
US9169252	645	Heteroaryl substituted nicotinamide compounds	Bristol-Myers Squibb Company	07/25/16
US9169259	92	Imidazopyridazine compounds	HOFFMANN-LA ROCHE INC.	07/25/16
US9169240	92	Ketone linked benzothiazole inhibitors of endothelial lipase	Bristol-Myers Squibb Company	07/25/16
US9079895	129	Morpholino compounds, uses and methods	University of Dundee	07/25/16
US9169234	24	Sepiapterin reductase inhibitors for the treatment of pain	Children's Medical Center Corporation	07/25/16
US9163017	17	Anti-viral compounds	ABBVIE INC.	07/18/16
US9168247	6	Beta carboline derivatives useful in the treatment of proliferative disorders	FACULTES UNIVERSITAIRES NOTRE DAME DE LA PAIX; UNIVERSITE LIBRE BRUXELLES	07/18/16
US9163012	94	Carbamate and urea inhibitors of 11β-hydroxysteroid dehydrogenase 1	Vitae Pharmaceuticals, Inc.	07/18/16
US9163011	106	Oxazine derivatives and their use in the treatment of disease	NOVARTIS AG	07/18/16
US9163042	24	Prodrugs of pyridone amides useful as modulators of sodium channels	VERTEX PHARMACEUTICALS INCORPORATED	07/18/16
US9163015	90	Pyrazolopyridine, pyrarolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction	Vanderbilt University	07/18/16
US9169205	200	Pyrrolidine derivatives, pharmaceutical compositions and uses thereof	Boehringer Ingelheim International GmbH	07/18/16
US9163021	236	Pyrrolo[3,2-c]pyridine tropomyosin-related kinase inhibitors	Pfizer Limited	07/18/16
US9168248	27	Spiro compounds useful as inhibitors of stearoyl-coenzyme A delta-9 desaturase	Merck Canada Inc.	07/18/16
US9163040	1	Substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitors	NOVARTIS AG	07/18/16
US9163013	34	Use of 1H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors	AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A.	07/18/16
US9162979	50	1,5-Diary1-2-alkylpyrrole-3-substituted nitro esters, selective COX-2 inhibitors and nitric oxide donors	ROTTAPHARM BIOTECH S.R.L.	07/11/16
US9161945	2	4-isopropyl-6-methoxyphenyl glucitol compound	TAISHO PHARMACEUTICAL CO., LTD.	07/11/16
US9163003	106	4-piperidinyl compounds for use as tankyrase inhibitors	NOVARTIS AG	07/11/16
US9163007	94	5-substituted indazoles as kinase inhibitors	AbbVie Inc.	07/11/16
US9169182	4	Chrysophaentin analogs that inhibit FtsZ protein	THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES; UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION	07/11/16
US9162991	55	Cinnamoyl inhibitors of transglutaminase	University of Ottawa	07/11/16
US9156822	144	Functionally selective ligands of dopamine D2 receptors	The University of North Carolina at Chapel Hill	07/11/16
US9163010	3	Indolinone protein kinase inhibitors	Beta Pharma, Inc.	07/11/16
US9163008	122	Pyrimidines as sodium channel blockers	Purdue Pharma, L.P.	07/11/16
US9161939	7	Pyrrolo[2,3-d]pyrimidine compounds	Zoetis Services LLC	07/11/16
US9168255	39	Quinazoline compounds as sodium channel blockers	Purdue Pharma L.P.	07/11/16
US9162983	5	Reactivators of organophosphorous inhibited acetylcholinesterase	SOUTHWEST RESEARCH INSTITUTE	07/11/16
US9156845	422	4-(substituted amino)-7H-pyrrolo[2,3-d] pyrimidines as LRRK2 inhibitors	Pfizer Inc.	06/30/16
US9161922	34	Amine oxidase inhibitors	Case Western Reserve University	06/30/16
US9156856	44	Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases	AbbVie Inc.	06/30/16
US9156831	41	Chemical compounds	AstraZeneca AB	06/30/16
US9156829	308	Cycloalkyl and heterocycloalkyl compounds as orexin receptor antagonists	TAKEDA PHARMACEUTICAL COMPANY LIMITED	06/30/16
US9161924	6	Factor IXa inhibitors	Merck Sharp & Dohme Corp.	06/30/16
US9156830	87	Heterocyclic compounds	SHIONOGI & CO., LTD.	06/30/16
US9156852	39	Thieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinases	HANMI PHARM. CO., LTD	06/30/16
US9156848	4	Treating diabetes with dipeptidyl peptidase-IV inhibitors	Merck Sharp & Dohme Corp.	06/30/16
US9156836	5	Tricyclic triazole compounds that modulate HSP90 activity	Synta Pharmaceuticals Corp.	06/30/16
US9150566	561	2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-YL)picolinamide derivatives as orexin receptor antagonists	ACTELION PHARMACEUTICALS LTD.	06/20/16
US9150578	174	5,8-dihydro-6H-pyrazolo[3,4-h]quinazolines as IGF-1R/IR inhibitors	Boehringer Ingelheim International GmbH	06/20/16
US9150526	208	Biaryl-propionic acid derivatives and their use as pharmaceuticals	Sanofi	06/20/16
US9155743	90	Bicyclic heterocycle compounds and their uses in therapy	ASTEX THERAPEUTICS LIMITED	06/20/16
US9150583	8	Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation	Boehringer Ingelheim International GmbH	06/20/16
US9150577	239	Heterocyclic compounds containing an indole core	Boehringer Ingelheim International GmbH	06/20/16
US9156811	829	N-myristoyl transferase inhibitors	Univeristy of Dundee	06/20/16
US9150581	30	Nicotinic receptor compounds	RESEARCH TRIANGLE INSTITUTE; THE REGENTS OF THE UNIVERSITY OF MICHIGAN; VIRGINIA COMMONWEALTH UNIVERSITY	06/20/16
US9150579	6	Selective PI3K delta inhibitors	RHIZEN PHARMACEUTICALS SA	06/20/16
US9156810	66	Treatment of inflammatory bowel disease	Allergan, Inc.	06/20/16
US9150519	242	6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis	MERCK SERONO SA	06/14/16
US9145414	77	1,2,4-triazine-6-carboxamide derivative	TAIHO PHARMACEUTICAL CO., LTD.	06/13/16
US9149477	5	5-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta	ICOS Corporation	06/13/16
US9145402	38	Aminopyrimidine derivatives as LRRK2 modulators	Genentech, Inc.	06/13/16
US9145391	266	Bipyridylaminopyridines as Syk inhibitors	Merck Sharp & Dohme Corp.; Merck Canada Inc.	06/13/16
US9145380	240	Bis-(sulfonylamino) derivatives for use in therapy	Astrazeneca AB	06/13/16
US9144538	75	Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin	The Procter & Gamble Company	06/13/16
US9145392	772	Imidazole amines as modulators of kinase activity	Merck Patent GmbH	06/13/16
US9145419	10	Imidazopyridazinyl compounds	Bristol-Myers Squibb Company	06/13/16
US9150527	8	Metalloenzyme inhibitor compounds	Innocrin Pharmaceuticals, Inc.	06/13/16
US9149492	26	Method for selectively inhibiting ACAT1 in the treatment of alzheimer's disease	Trustees of Dartmouth College	06/13/16
US9145354	231	Pharmaceutical compounds	ASTEX THERAPEUTICS LIMITED	06/13/16
US9145426	38	Pyrrolidine-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their use	Merck Sharp & Dohme Corp.	06/13/16
US9145412	77	Selective HDAC1 and HDAC2 inhibitors	ACETYLON PHARMACEUTICALS, INC.	06/13/16
US9145418	10	Substituted 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-ones as protein kinase inhibitors	NERVIANO MEDICAL SCIENCES S.R.L.	06/13/16
US9145408	44	Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulators	Purdue Pharma L.P.; Shionogi & Co., Ltd.	06/13/16
US9150544	176	Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application	Sanofi	06/13/16
US9150546	325	Triazine derivative and pharmaceutical composition comprising the same	SHIONOGI & CO., LTD.	06/13/16
US9139578	26	Amide or urea containing benzothiazole inhibitors of endothelial lipase	Bristol-Myers Squibb Company	06/06/16
US9139593	21	Azetidine compounds, compositions and methods of use	HOFFMANN-LA ROCHE INC.	06/06/16
US9138393	75	Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin	The Procter & Gamble Company	06/06/16
US9139568	167	Heterocyclic carboxamides as modulators of kinase activity	Merck Patent GmbH	06/06/16
US9139585	51	Inhibitors of the Renal Outer Medullary Potassium channel	Merck Sharp & Dohme Corp.	06/06/16
US9138431	13	Methods of treatment of histamine H-4 receptor-related pruritus	BRIDGE PHARMA, INC.	06/06/16
US9138494	8	Radiolabeled PDE10A ligands	AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG	06/06/16
US9139529	80	Substituted quinoxalines as sodium channel modulators	VERTEX PHARMACEUTICALS INCORPORATED	06/06/16
US9139577	328	Sulfoximine substituted quinazolines for pharmaceutical compositions	Boehringer Ingelheim International GmbH	06/06/16
US9139546	32	Tri-aryl/heteroaromatic cannabinoids and use thereof	The University of Tennessee Research Foundation	06/06/16
US9138423	2	Use of inhibitors of porphobilinogen deaminase in the treatment of congenital erythropoietic porphyria	Asociación Centro de Investigación Cooperativa en Biociencias—CIC Biogune	06/06/16
US9133180	33	Aurora and FLT3 kinases modulators	SAREUM LIMITED	05/23/16
US8772323	260	Benzoxazole- and tetrahydrobenzoxazole-substituted pyridazinones as GPR119 agonists	Boehringer Ingelheim International GmbH	05/23/16
US9133171	193	Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group	Bayer Intellectual Property GmbH	05/23/16
US8829029	164	Dual modulators of 5HT2A and D3 receptors	Hoffmann-La Roche Inc.	05/23/16
US9133183	27	Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities	Deciphera Pharmaceuticals, LLC	05/23/16
US9133201	12	Inhibitors of Bruton's tyrosine kinase	PHARMACYCLICS, INC.	05/23/16
US9133197	12	Oxidated derivatives of triazolylpurines useful as ligands of the adenosine A2A receptor and their use as medicaments	SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.	05/23/16
US8865745	19	Pyrazolone derivatives as PDE4 inhibitors	Takeda GmbH	05/23/16
US9133199	2	Pyrimidine derivatives as protein kinase inhibitors	Cyclacel Limited	05/23/16
US9133182	37	Selective androgen receptor modulators	Radius Health, Inc.	05/23/16
US9133187	85	Serine/threonine kinase inhibitors	ARRAY BIOPHARMA INC.; GENENTECH, INC.	05/23/16
US9132129	8	Antiviral compounds	KATHOLIEKE UNIVERSITEIT LEUVEN	05/16/16
US9133148	91	Carbamate compounds and of making and using same	The Scripps Research Institute; Abide Therapeutics, Inc.	05/16/16
US9133157	134	HIV protease inhibitors	Merck Canada Inc.	05/16/16
US9133134	1	Inhibitors of bruton's tyrosine kinase	PHARMACYCLICS LLC	05/16/16
US9132134	10	Methods for treating GI tract disorders	Neurogastrx, Inc.	05/16/16
US9133125	72	Morphan and morphinan analogues, and methods of use	ALKERMES PHARMA IRELAND LIMITED	05/16/16
US9133168	168	Pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors	SANOFI	05/16/16
US9133131	27	Pyrimidine diol amides as sodium channel blockers	Purdue Pharma L.P.	05/16/16
US9133160	15	Substituted benzimidazole and imidazopyridine compounds useful as CYP17 modulators	Bristol-Meyers Squibb Company	05/16/16
US9133162	13	Substituted quinoline compounds and methods of use	SUNSHINE LAKE PHARMA CO., LTD.; CALITOR SCIENCES, LLC	05/16/16
US9133105	4	Transcription factor modulators	C&C BIOPHARMA, LLC	05/16/16
US9126978	10	1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties	The Regents of the University of Michigan	05/09/16
US9126979	24	Compounds for inhibiting the interaction of BCL2 with binding partners	Novartis AG	05/09/16
US9126980	90	Compounds for inhibiting the interaction of BCL2 with binding partners	Novartis AG	05/09/16
US9127027	37	Epoxyeicosatrienoic acid analogs and methods of making and using the same	The Medical College of Wisconsin, Inc.; The Board of Regents of the University of Texas System	05/09/16
US9126987	25	Inhibitors of glutaminyl cyclase	PROBIODRUG AG	05/09/16
US9127005	20	Isoform selective phospholipase D inhibitors	Vanderbilt University	05/09/16
US9126952	67	Morpholinylquinazolines	Merck Patent GmbH	05/09/16
US9126973	76	Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases	CAYMAN CHEMICAL COMPANY, INCORPORATED	05/09/16
US9126957	10	Selective glycosidase inhibitors and uses thereof	MERCK SHARP & DOHME CORP.; ALECTOS THERAPEUTICS, INC.	05/09/16
US9127001	68	Substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them	Sanofi	05/09/16
US9126976	41	Substituted benzopiperazines as CETP inhibitors	Merck Sharp & Dohme Corp.	05/09/16
US9125915	17	Antitumor agent	Mitsubishi Tanabe Pharma Corporation	05/02/16
US9125913	853	Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases	AbbVie Inc.	05/02/16
US9126948	14	Pyrimidine-4,6-diamine derivatives as PI3K inhibitors	Incyte Holdings Corporation; Incyte Corporation	05/02/16
US9120812	515	Pyrimidooxazocine derivatives as mTOR-inhibitors	Sanofi	05/02/16
US9120838	4	Saccharide conjugates	Curators of the University of Missouri	05/02/16
US9120808	141	Substituted clavulanic acid	NABRIVA THERAPEUTICS AG	05/02/16
US9126947	6	Substituted pyridazine carboxamide compounds	Xcovery Holding Company LLC	05/02/16
US9126931	266	Tetracyclic compound	Chugai Seiyaku Kabushiki Kaisha	05/02/16
US9126941	39	Treatment of hyperproliferative disorders with diarylhydantoin compounds	The Regents of the University of California	05/02/16
US9120798	50	Amino-heteroaryl 7-hydroxy-spiropiperidine indolinyl antagonists of P2Y1 receptor	Bristol-Myers Squibb Company	04/25/16
US9120769	172	Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline	Boehringer-Ingelheim International GmbH	04/25/16
US9120771	46	Azetidine derivative and antidepressant composition including the same	KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY	04/25/16
US9120772	6	Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases	GALDERMA RESEARCH & DEVELOPMENT	04/25/16
US9120780	37	Indole or indazole derivative or salt thereof	TAIHO PHARMACEUTICAL CO., LTD.	04/25/16
US9120791	119	Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them	LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD	04/25/16
US9120797	66	Process for preparing spirocyclic cyclohexane compounds, compositions containing such compounds and method of using such compounds	Gruenenthal GmbH	04/25/16
US9120785	12	Pyridyl aminopyridines as Syk inhibitors	Merck Sharp & Dohme Corp.	04/25/16
US9120781	7	Selective glycosidase inhibitors and uses thereof	Simon Fraser University; Merck Sharp & Dohme Corp.; Alectos Therapeutics Inc.	04/25/16
US9120807	28	Thienopyrimidine compounds	Vernalis (R&D) Ltd.	04/25/16
US9120786	14	Triazine carboxamides as sodium channel blockers	Purdue Pharma, L.P.	04/25/16
US9115121	70	1,3,5-triazine-2-amine derivatives, preparation thereof and diagnostic and therapeutic use thereof	Sanofi	04/18/16
US9119845	20	Method for the treatment of neurological disorders by enhancing the activity of beta-glucocerebrosidase	Amicus Therapeautics, Inc.	04/18/16
US9115122	39	Non-ATP dependent inhibitors of extracellular signal-regulated kinase (ERK)	UNIVERSITY OF MARYLAND, BALTIMORE	04/18/16
US9120744	43	Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism	THE REGENTS OF THE UNIVERSITY OF MICHIGAN; EASTERN MICHIGAN UNIVERSITY	04/18/16
US9120752	40	Pyridine compounds as sodium channel blockers	Purdue Pharma, L.P.	04/18/16
US9120749	650	Quinoline derivatives and MELK inhibitors containing the same	ONCOTHERAPY SCIENCE, INC.	04/18/16
US9120761	34	Selective FAK inhibitors	Cancer Therapeutics CRC PTY LTD	04/18/16
US9120756	63	Substituted phenylureas and phenylamides as vanilloid receptor ligands	Gruenenthal GmbH	04/18/16
US9120745	4	Triazole compounds that modualte HSP90 activity	Synta Pharmaceuticals Corp.	04/18/16
US9115089	2	Methyl/fluoro-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds and fluoro-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds	CONFLUENCE LIFE SCIENCES, INC.	04/12/16
US9115140	33	Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof	SANOFI	04/12/16
US9115126	10	1H-[1,2,3]triazolo[4,5-c]pyridine-4-carbonitrile derivatives	Merck Sharp & Dohme B.V.	04/11/16
US9096593	403	Compounds and methods for kinase modulation, and indications therefor	Plexxikon Inc.	04/11/16
US9115083	75	Compounds from Antrodia cinnamomea and use thereof	SIMPSON BIOTECH CO., LTD.	04/11/16
US9115085	1	Crystalline forms of a prolyl hydroxylase inhibitor	FIBROGEN, INC.	04/11/16
US9115082	9	Dipeptidyl-peptidase-IV inhibitors for treatment of type 2 diabetes complex with hypertension	TBA	04/11/16
US9115116	27	Dual action inhibitors against histone deacetylases and 3-hydroxy-3-methylglutaryl coenzyme a reductase	Academia Sinica; National Taiwan University	04/11/16
US9115144	5	Fused heterocyclic derivative and pharmaceutical use thereof	KISSEI PHARMACEUTICAL CO., LTD.	04/11/16
US9115102	45	N-[2-hydroxycarbamoyl-2-(piperazinyl) ethyl] benzamide compounds, their preparation and their use as TACE inhibitors	GALDERMA RESEARCH & DEVELOPMENT	04/11/16
US9115117	280	Substituted piperidine compounds and their use as orexin receptor modulators	JANSSEN PHARMACEUTICA NV	04/11/16
US9102669	100	Substituted piperidinyl-pyridazinyl derivatives useful as SCD 1 inhibitors	Janssen Pharmaceutica NV	04/05/16
US9102686	152	5,6,7,8,9,10-hexahydro-6,10-epimino[1,2,4]triazolo[4,3-a]azocines as P2X7 modulators	Janssen Pharmaceutica NV	04/04/16
US9102591	244	Benzamides	H. Lundbeck A/S	04/04/16
US9102637	93	Bicyclic thiazole compounds	CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER	04/04/16
US9102622	63	Fatty acid amide hydrolase inhibitors	University of Connecticut	04/04/16
US9096627	6	Hydroxamic acid derivatives	Purdue Pharmaceutical Products L.P.	04/04/16
US9102599	15	N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases	Bristol-Myers Squibb Company	04/04/16
US9114126	10	Na/K-ATPase ligands, ouabain antagonists, assays and uses thereof	THE UNIVERSITY OF TOLEDO	04/04/16
US9115061	17	Naphthalene-based inhibitors of anti-apoptotic proteins	BURNHAM INSTITUTE FOR MEDICAL RESEARCH	04/04/16
US9102670	445	Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors	KUDOS PHARMACEUTICALS LIMITED	04/04/16
US9102656	12	Use of rosuvastatin lactols as medicaments	RedX Pharma Limited	04/04/16
US9096559	134	4-carboxybenzylamino derivatives as histone deacetylase inhibitors	Merck Sharp & Dohme Corp.	03/28/16
US9096595	51	7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin D2 receptor modulators	Actelion Pharmaceuticals Ltd	03/28/16
US9096579	258	Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments	Boehringer Ingelheim International GmbH	03/28/16
US9238653	54	Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM; MMV MEDICINES FOR MALARIA VENTURE; UNIVERSITY OF WASHINGTON	03/28/16
US9096601	108	Arylamino purine derivatives, preparation method and pharmaceutical use thereof	CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.; Sichuan University	03/28/16
US9096580	5	Benzofuran derivatives for the treatment of hepatitis C	Bristol-Myers Squibb Company	03/28/16
US9096589	112	Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitors	H. Lundbeck A/S	03/28/16
US9096541	28	Inhibition of memapsin 1 cleavage in the treatment of diabetes	Oklahoma Medical Research Foundation; Purdue Research Foundation	03/28/16
US9096594	15	Kinase inhibitors and methods of use thereof	The Broad Institute, Inc.; The General Hospital Corporation; Dana-Farber Cancer Institute, Inc.	03/28/16
US9096515	36	Methods of using cycloalkylmethylamine derivatives	REVIVA PHARMACEUTICALS, INC.	03/28/16
US9096596	332	P2X7 modulators	JANSSEN PHARMACEUTICA NV	03/28/16
US9096606	64	Quarternized buprenorphine analogs	Purdue Pharma, L.P.	03/28/16
US9096549	46	Selective HDAC3 inhibitors	ACETYLON PHARMACEUTICALS, INC.	03/28/16
US9089569	190	1,2,6-substituted benzimidazoles as flap modulators	JANSSEN PHARMACEUTICA NV	03/21/16
US9090564	130	5-alkynyl-pyridines	Boehringer Ingelheim International GmbH	03/21/16
US9090562	334	Aryl- or heteroaryl-substituted benzene compounds	Epizyme, Inc.	03/21/16
US9090628	126	Benzoxazepin compounds selective for PI3K P110 delta and methods of use	GENENTECH, INC.	03/21/16
US9090657	22	Compound and methods for its production	NEUROVIVE PHARMACEUTICAL AB	03/21/16
US9090596	84	Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies	GALDERMA RESEARCH & DEVELOPMENT	03/21/16
US9090589	25	Specific nNOS inhibitors for the therapy and prevention of human melanoma	Northwestern University; The Regents of the University of California	03/21/16
US9090618	172	Substituted benzimidazole-type piperidine compounds and uses thereof	Purdue Pharma L.P.	03/21/16
US9085584	356	Substituted pyrido[3,2-E][1,2,4]-triazolo[4,3-A]pyrazines for the treatment of central nervous system disorders	Boehringer Ingelheim International GmbH	03/21/16
US9090625	9	Therapeutic pyrazolyl thienopyridines	THESAN PHARMACEUTICALS, INC.	03/21/16
US9085572	10	4-(pyridin-3-yl)-2(pyridin-2yl)-1,2-dihydro-3H-pyrazol-3-one derivatives as specific HIF-pyrolyl-4-hydroxylase inhibitors for treating cardiovascular and haematological diseases	Bayer Intellectual Property GmbH	03/16/16
US9085531	117	Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin	Albany Molecular Research, Inc.; Bristol-Myers Squibb Company	03/14/16
US9085555	773	Complement pathway modulators and uses thereof	NOVARTIS AG	03/14/16
US9085549	48	Compounds for the treatment of neurodegenerative diseases	PROTEOTECH INC	03/14/16
US9079902	124	Heteroaryl sodium channel inhibitors	AMGEN INC.	03/14/16
US9085571	30	Nonpeptide HIV-1 protease inhibitors	Purdue Research Foundation	03/14/16
US9085576	846	Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use	AMGEN INC.	03/14/16
US9085540	31	Pyrazinecarboxamide compound	Astellas Pharma Inc.	03/14/16
US9079913	185	Spiro-oxindole MDM2 antagonists	THE REGENTS OF THE UNIVERSITY OF MICHIGAN	03/14/16
US9079929	29	Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors	Bristol-Myers Squibb Company	03/14/16
US9073940	429	Tricyclic pyrazol amine derivatives	MERCK SERONO SA	03/09/16
US9079866	833	Flap modulators	JANSSEN PHARMACEUTICA NV	03/07/16
US9079834	11	HIV protease inhibitors	Merck Canada Inc.	03/07/16
US9073926	105	Heterocyclic compounds containing a pyrrolopyridine or benzimidazole core	Boehringer Ingelheim International GmbH	03/07/16
US9073939	7	Indazolyl-substituted dihydroisoxa-zolopyridines and methods of use thereof	Bayer Intellectual Property GmbH	03/07/16
US9073931	108	Liver X receptor modulators	Vitae Pharmaceuticals, Inc.	03/07/16
US9079852	20	NMDA receptor antagonists for neuroprotection	Emory University; NeurOp, Inc.	03/07/16
US9073936	8	Organic compounds	INTRA-CELLULAR THERAPIES, INC.	03/07/16
US9079880	163	Rho kinase inhibitors	Boehringer Ingelheim International GmbH	03/07/16
US9079868	1	Selective glycosidase inhibitors and uses thereof	Simon Fraser University	03/07/16
US9079906	27	Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicaments	Sanofi	03/07/16
US9073893	60	3-Oxo-2,3-dihydro-1H-indazole-4-carboxamide derivatives as PARP-1 inhibitors	NERVIANO MEDICAL SCIENCES S.R.L.	02/29/16
US9073870	181	Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use	Boehringer Ingelheim International GmbH	02/29/16
US9073917	27	Anti-cancer compound and pharmaceutical composition containing the same	SANOFI	02/29/16
US9073925	10	Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof	Albany Molecular Research, Inc.	02/29/16
US9073881	153	Benzoic acid derivatives	HOFFMANN-LA ROCHE INC.	02/29/16
US9073876	335	Flap modulators	JANSSEN PHARMACEUTICA NV	02/29/16
US9073882	9	Inhibitors of the renal outer medullary potassium channel	Merck Sharp & Dohme Corp.	02/29/16
US9073869	37	Method of using substituted 2-Aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C	Boehringer Ingelheim International GmbH	02/29/16
US9073911	108	Pyrazole derivatives	HOFFMANN-LA ROCHE INC.	02/29/16
US9073922	368	Pyrrolo[2,3-B]pyridine CDK9 kinase inhibitors	AbbVie, Inc.	02/29/16
US9073906	44	Sulfamide derivative having an adamantyl group and its pharmaceutically acceptable salt	KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY	02/29/16
US9067924	24	1,4 thiazepines/sulfones as BACE1 and/or BACE2 inhibitors	HOFFMANN-LA ROCHE INC.	02/22/16
US9067937	113	1,5-naphthyridine derivatives and MELK inhibitors containing the same	OncoTherapy Science, Inc.	02/22/16
US9067931	20	2-heteroaryl carboxamides	BAYER INTELLECTUAL PROPERTY GMBH	02/22/16
US9067949	216	Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia	Albany Molecular Research, Inc.	02/22/16
US9067922	243	Chemical compounds	Pfizer Limited	02/22/16
US9073853	157	Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists	SANOFI	02/22/16
US9062043	371	Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators	SENHWA BIOSCIENCES, INC.	02/22/16
US9073821	60	Hydroxamic acid derivative	TAISHO PHARMACEUTICAL CO., LTD; TOYAMA CHEMICAL CO., LTD.	02/22/16
US9067935	114	Imidazo[1,2-α]pyridine sulfonamides as TRPM8 modulators	Janssen Pharmaceutica, NV	02/22/16
US9073833	17	Oxime-based compound, pharmaceutical composition containing the same and method for preparing the same	Chang Gung University	02/22/16
US9067945	10	Selective phosphodiesterase 9A inhibitors as medicaments for improving cognitive processes	Boehringer Ingehleim International GmbH	02/22/16
US9067917	220	1,2,5-substituted benzimidazoles as FLAP modulators	Janssen Pharmaceutica NV	02/16/16
US9067871	405	Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy	AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.	02/16/16
US9062066	13	Anti-inflammatory compound having inhibitory activity against multiple tyrosine kinases and pharmaceutical composition containing same	KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY	02/16/16
US9066954	107	Fused heterocyclic derivatives and methods of use	Amgen Inc.	02/16/16
US9067888	20	Inhibitors of protein kinases	AstraZeneca AB	02/16/16
US9062070	238	Inhibitors of the renal outer medullary potassium channel	Merck Sharp & Dohme Corp.	02/16/16
US9062059	20	Pyrimidine PDE10 inhibitors	Merck Sharp & Dohme Corp.	02/16/16
US9062078	702	Substituted 7-azabicyles and their use as orexin receptor modulators	JANSSEN PHARMACEUTICA NV	02/16/16
US9062060	11	Substituted imidazo[2,1-A]isoindoles as PDE10 inhibitors	H. Lundbeck A/S	02/16/16
US9067914	241	Tropomyosin-related kinase (TRK) inhibitors	Genzyme Corporation	02/16/16
US9061041	6	2′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases	Merck Sharp & Dohme Corp.	02/09/16
US9062004	58	Cannabinoid-2 agonists	Allergan, Inc.	02/09/16
US9062048	173	Cyclohexyl-azetidinyl antagonists of CCR2	Janssen Pharmaceutica NV	02/09/16
US9062026	89	Fused pyrimidines and substituted quinazolines as inhibitors of p97	Cleave Biosciences, Inc.	02/09/16
US9056859	11	Inhibitors of the renal outer medullary potassium channel	Merck Sharp & Dohme Corp.	02/09/16
US9061023	2	Management and treatment of benign prostatic hyperplasia	CSIR	02/09/16
US9056865	149	Pyridine-2-derivatives as smoothened receptor modulators	Pfizer Inc.	02/09/16
US9056863	3	Substituted 2,3,5,9,9B-pentaazacyclopenta[a]naphthalenes and uses thereof	H. Lundbeck A/S	02/09/16
US9062045	143	Triazolopyridine compounds	Novartis AG	02/09/16
US9056843	460	Trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease	NOVARTIS AG	02/09/16
US9056847	4	Activity based probes (ABPs) interacting with glycosidases	ACADEMISCH MEDISCH CENTRUM BIJ UNIVERSITEIT VAN AMSTERDAM	01/25/16
US9051313	18	Apoptosis signal-regulating kinase inhibitors	Gildead Sciences, Inc.	01/25/16
US9056836	11	Benzomorphan analogs and the use thereof	Purdue Pharma L.P.	01/25/16
US9051321	28	Heterocyclic acrylamides and their use as pharmaceuticals	FAB PHARMA S.A.S.	01/25/16
US9056857	7	Methods for treating or preventing cancer and neurodegenerative diseases	SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH	01/25/16
US9056832	152	Pyridine compounds and the users thereof	Purdue Pharma L.P.	01/25/16
US9051279	174	Substituted isoquinolinones and quinazolinones	Novartis AG	01/25/16
US9051311	173	Sulfamide sodium channel inhibitors	AMGEN INC.	01/25/16
US9051280	10	Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy	AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.	01/25/16
US9051329	8	Tricyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors	Merck Sharp & Dohme Corp.	01/25/16
US9108973	73	3,5-disubstituted alkynylbenzene compound and salt thereof	Taiho Pharmaceutical Co., Ltd.	01/19/16
US9108978	16	Antimicrobial compounds	Monash University; Adelaide Research & Innovation Pty Ltd	01/19/16
US9108983	174	Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them	LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD	01/19/16
US9108984	2	Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors	Incyte Corporation; Incyte Holdings Corporation	01/19/16
US9108950	12	1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as p38 MAP kinase inhibitors	Respivert, Ltd.	01/18/16
US9108956	11	Cyclic ether DGAT1 inhibitorscyclic ether DGAT1 inhibitors	NOVARTIS AG	01/18/16
US9051265	89	N-benzylindole modulators of PPARG	The Scripps Research Institute	01/18/16
US9051270	160	Pyridone amides as modulators of sodium channels	VERTEX PHARMACEUTICALS INCORPORATED	01/18/16
US9051240	7	Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators	Newron Pharmaceuticals S.P.A.	01/18/16
US9045501	28	5-HT3 receptor modulators, methods of making, and use thereof	Albany Molecular Research, Inc.	01/11/16
US9108903	76	Amides as modulators of sodium channels	VERTEX PHARMACEUTICALS INCORPORATED	01/11/16
US9107954	14	Bivalent ligands for the treatment of neurological disorders	Virginia Commonwealth University	01/11/16
US9107923	81	Heteroaromatic compounds and their use as dopamine D1 ligands	Pfizer Inc.	01/11/16
US9045498	25	Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds	Pfizer Inc.	01/11/16
US9045500	32	Inhibitors of beta-secretase	Vitae Pharmaceuticals, Inc.	01/11/16
US9108947	18	Inhibitors of the Renal Outer Medullary Potassium channel	Merck Sharp & Dohme Corp.	01/11/16
US9045524	160	Selective caspase inhibitors and uses thereof	NOVAGENESIS FOUNDATION	01/11/16
US9108951	16	Substituted 5,6,7,8-tetrahydro-1,6-naphthyridines as factor XIa inhibitors	Bristol-Myers Squibb Company	01/11/16
US9108905	19	TRPA1 antagonists	AbbVie Inc.	01/11/16
US9045468	186	2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin	Albany Molecular Research, Inc.; Bristol-Myers Squibb Company	12/21/15
US9045389	9	Biphenyl derivatives useful as glucagon receptor antagonists	Janssen Pharmaceutica NV	12/21/15
US9040694	20	Compounds and methods useful for directing stem cell differentiation	Vanderbilt University	12/21/15
US9040693	15	Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof	KISSEI PHARMACEUTICAL CO., LTD.	12/21/15
US9040727	36	Histone deacetylase inhibitor of benzamides and use thereof	Shanghai Institute of Pharmaceutical Industry; Sinopharm A-Think Pharmaceutical Co., Ltd.; Sinopharm A-Think Medical and Pharmaceutical Research & Development (Beijing) Co., Ltd.	12/21/15
US9040691	47	Hydroxymethylaryl-substituted pyrrolotriazines as ALK1 inhibitors	BAYER INTELLECTUAL PROPERTY GMBH	12/21/15
US9040714	139	IRE-1α inhibitors	MannKind Corporation	12/21/15
US9045483	13	Inhibition of small ubiquitin-like modifier enzymes with substituted pyrrolo[2,3-b]quinoxalines	City of Hope; Sanford-Burnham Medical Research Institute	12/21/15
US9045459	3	Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy	AbbVie Deutschland GmbH & Co. KG; AbbVie Inc.	12/21/15
US9040717	10	Pyrazole-amide compounds and pharmaceutical use thereof	JAPAN TOBACCO INC.	12/21/15
US9040518	72	Chemical compounds	GlaxoSmithKline LLC	12/14/15
US9040528	203	Chemical compounds 542	AstraZeneca AB	12/14/15
US9040501	5	Compositions and methods for treating cancer	Otsuka Pharmaceutical Co., Ltd.	12/14/15
US9040663	202	Melanocortin receptor-specific peptides	AstraZeneca AB	12/14/15
US9040509	6	Method of treating human skin and a skin care composition for use in such a method	Pantarhei Bioscience B.V.	12/14/15
US9035059	157	Nitrogen-containing condensed heterocyclic compound	TAISHO PHARMACEUTICAL CO., LTD.	12/14/15
US9035074	168	Pyrrolo[2,3-D]pyrimidine derivatives	Pfizer Inc.	12/14/15
US9040542	2	Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pryimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-yl]urea	VERTEX PHARMACEUTICALS INCORPORATED	12/14/15
US9040534	279	[1,2,4]triazolo[4,3-a]pyrazines as P2X7 modulators	Janssen Pharmaceutica NV	12/14/15
US9034921	203	Diphenylmethane derivatives as SGLT2 inhibitors	GREEN CROSS CORPORATION	12/08/15
US9035066	3	Method of using 4,5,6,7-tetrahydroimidazo[4,5-C]pyridine compounds	Proximagen Limited	12/08/15
US9035062	3	Process for preparing a compound useful for producing an optically active diazabicyclooctane compound	MEIJI SEIKA PHARMA CO., LTD.	12/08/15
US9034856	51	17-(1′propenyl)-17-3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative	Bayer Intellectual Property GmbH	12/07/15
US9034886	5	4-aminoquinazoline derivatives and uses thereof	Shanghai Institute of Pharmaceutical Industry; Jiangsu Hengyi Pharmaceutical Co., Ltd.	12/07/15
US9034574	20	Agents for reversing epigenetic silencing of genes	The Johns Hopkins University	12/07/15
US9034899	81	Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof	Albany Molecular Research, Inc.	12/07/15
US9034874	20	Carbamate/urea derivatives	NOVARTIS AG	12/07/15
US9034897	44	Indanyl-substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-C]pyridines, their use as medicament, and pharmaceutical preparations comprising them	SANOFI	12/07/15
US9034907	36	Inhibitors of glutaminyl cyclase	Probiodrug AG	12/07/15
US9034866	815	Tricyclic compounds and methods of use therefor	Genentech, Inc.	12/07/15
US9029399	54	17α-hydroxylase/C17,20-lyase inhibitors	Novartis AG	11/23/15
US9029364	34	2,5-disubstituted thiomorpholine orexin receptor antagonists	Merck Sharp & Dohme Corp.	11/23/15
US9029393	22	Adenosine receptor ligands and uses thereof	Kaldi Pharma, SAS	11/23/15
US9029381	55	Cyclopropyl amide derivatives	Astrazeneca AB	11/23/15
US9029362	23	Iminothiadiazine dioxide compounds as brace inhibitors, compositions, and their use	Merck Sharp & Dohme Corp.	11/23/15
US9034303	10	Neuroprotective and neuro-restorative iron chelators and monoamine oxidase inhibitors and uses thereof	TBA	11/23/15
US9034854	6	Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy	PANTARHEI BIOSCIENCE B.V.	11/23/15
US9029401	58	Sorafenib derivatives as sEH inhibitors	The Regents of the University of California	11/23/15
US9029370	276	Substituted benzamide derivatives	Hoffmann-La Roche Inc.	11/23/15
US9023767	2	γ-Secretase substrates and methods of use	Memorial Sloan-Kettering Cancer Center	11/16/15
US9023882	212	5-membered nitrogen containing heterocyclic derivatives and pharmaceutical compositions comprising the same	Kissei Pharmaceutical Co., Ltd.	11/16/15
US9029367	5	BACE inhibitors	Eli Lilly and Company	11/16/15
US9023865	687	Compounds that are ERK inhibitors	Merck Sharp & Dohme Corp.	11/16/15
US9024044	162	Heteroarylcarboxylic acid ester derivative	Ajinomoto Co., Inc.	11/16/15
US9029360	36	Pyrazolopyrimidines as metabotropic glutamate 5 receptor antagonists	Boehringer Ingelheim International GmbH	11/16/15
US9023849	22	Substituted fused imidazoles and pyrazoles and use thereof	Bayer Intellectual Property GmbH	11/16/15
US9029356	12	Substituted indazole derivatives active as kinase inhibitors	Nerviano Medical Sciences S.R.L.	11/16/15
US9018371	27	Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient	FM Therapeutics Co., Ltd.; The United States of America, As Represented by the Secretary, Department of Health and Human Services, The Office of Technology Transfer, National Institutes of Health	11/11/15
US9018381	66	Chemical compounds	AstraZeneca AB	11/11/15
US9023354	43	Combination therapy with MDM2 and EFGR inhibitors	TBA	11/11/15
US9018217	124	Phenylimidazole derivatives as PDE10A enzyme inhibitors	H. Lundbeck A/S	11/11/15
US9029559	503	Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals	SANOFI	11/11/15
US9018213	12	Alicyclic[c] benzopyrone derivatives and uses thereof	Huazhong University of Science & Technology; NHWA Pharma. Corporation	11/02/15
US9018214	370	Bicyclic heterocycle compounds and their uses in therapy	Astex Therapeutics Limited	11/02/15
US9011882	20	Dimethylarginine dimethylaminohydrolase inhibitors and methods of use thereof	The Board of Trustees of the Leland Stanford Junior University	11/02/15
US9018255	7	Esters of (acyloxymethyl)acrylamide, a pharmaceutical composition containing them, and their use as inhibitors of the thioredoxin—thioredoxin reductase system	Instytut Chemii Organicznej Polskiej Akademii Nauk; Warszawski Uniwersytet Medyczny	11/02/15
US9012461	132	FAK inhibitors	Cancer Therapeutics CRC Pty Ltd	11/02/15
US9018234	8	Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereof	Bayer Intellectual Property GmbH	11/02/15
US9018391	16	Inhibitors of beta-secretase	Boehringer Ingelheim International GmbH; Vitae Pharmaceuticals, Inc.	11/02/15
US9018211	9	Inhibitors of the renal outer medullary potassium channel	Merck Sharp & Dohme Corp.	11/02/15
US9012475	26	Method for enhancing anti-tumor effect of a microtubule-targeting drug, and a method for treatment of tumor	Taiho Pharmaceutical Co., Ltd.	11/02/15
US9012651	291	TRPV3 modulators	AbbVie Inc.	11/02/15
US9006269	19	Azetidine derivatives	Vernalis (R&D) Ltd.	10/26/15
US9006454	111	Dihydroorotate dehydrogenase inhibitors	Merck Serono S.A.	10/26/15
US9006244	14	Liver X receptor modulators	Vitae Pharmaceuticals, Inc.	10/26/15
US9006283	6	Methods of modifying amyloid β oligomers using non-peptidic compounds	Acumen Pharmaceuticals, Inc.	10/26/15
US9006268	10	Prolylcarboxypeptidase inhibitors	Merck Sharp & Dohme Corp.	10/26/15
US9006232	98	Pyrimidone derivatives	Mitsubishi Tanabe Pharma Corporation	10/26/15
US9006282	20	Rosuvastatin and atorvastatin derivatives	Redx Pharma Limited	10/26/15
US9006249	13	Substituted aminobutyric derivatives as neprilysin inhibitors	Novartis AG	10/26/15
US9006242	15	Substituted benzene compounds	Epizyme, Inc.	10/26/15
US9006246	15	Tetrahydrocarboline derivative	Ono Pharmaceutical Co., Ltd.	10/26/15
US9000182	41	2H-imidazol-4-amine compounds and their use as BACE inhibitors	AstraZeneca AB	10/19/15
US9000185	18	Cycloalkyl ether compounds and their use as BACE inhibitors	AstraZeneca AB	10/19/15
US9000183	21	Cyclohexane-1,2′-indene-1′,2″-imidazol compounds and their use as BACE inhibitors	Astrazeneca AB	10/19/15
US9000184	31	Cyclohexane-1,2′-naphthalene-1′,2″-imidazol compounds and their use as BACE inhibitors	AstraZeneca AB	10/19/15
US8999957	459	Heterocyclic compounds as ERK inhibitors	Merck Sharp & Dohme Corp.	10/19/15
US9000153	43	Imidazo[4,5-c]quinolines as DNA-PK inhibitors	Merck Patent GmbH	10/19/15
US9000043	4	Phenoxyethoxy compounds	Eli Lilly and Company	10/19/15
US9000029	118	Proline sulfonamide derivatives as orexin receptor antagonists	Actelion Pharmaceuticals Ltd.	10/19/15
US9000044	67	Substituted naphthylacetic acids	Hoffmann-La Roche Inc.	10/19/15
US9006187	34	Thiophene derivative as SGLT2 inhibitor and pharmaceutical composition comprising same	Green Cross Corporation	10/19/15
US8999981	252	3-amido-pyrrolo[3,4-C]pyrazole-5(1H, 4H,6H) carbaldehyde derivatives	Pfizer Inc.; Pfizer Products Inc.	10/12/15
US9012443	827	Bicyclic aryl and heteroaryl sodium channel inhibitors	Amgen Inc.	10/12/15
US9000008	5	Amides of acetic and propionic acids	Bayer Intellectual Property GmbH	10/05/15
US9000015	42	Compounds for the treatment of addiction	Gilead Sciences, Inc.	10/05/15
US8999994	36	Derivatives of propargylamine having neuroprotective capacity for the treatment of Alzheimer's and Parkinson's diseases	Consejo Superior de Investigaciones Cientificas; Universitat Autonoma de Barcelona; Universidad de Barcelona	10/05/15
US8999980	19	Oxazine derivatives	Shionogi & Co., Ltd.	10/05/15
US8999982	16	Pharmaceutically active compounds as Axl inhibitors	Lead Discovery Center GmbH; Max-Planck-Gesellschaft zur Förderung der Wissenschaften E.V.	10/05/15
US8993808	181	Phenylcyclopropylamine derivatives and their medical use	Oryzon Genomics, S.A.	10/05/15
US8999998	95	Pyrazolopyrimidine JAK inhibitor compounds and methods	Genentech, Inc.	10/05/15
US8999975	140	Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin C	Boehringer Ingelheim International GmbH	10/05/15
US8999955	14	Tetrahydrocyclopenta[c]acridine derivatives as kinase inhibitors and biological	Centre National de la Recherche Scientifique	10/05/15
US8993616	113	(aza)indole derivative and use thereof for medical purposes	Kissei Pharmaceutical Co., Ltd.	09/28/15
US8993596	3	4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics	Galderma Research & Development	09/28/15
US8993631	43	Method of treating contrast-induced nephropathy	Novartis AG	09/28/15
US8993612	10	Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer	Rhizen Pharmaceuticals SA	09/28/15
US8993568	6	Morpholinyl derivatives useful as MOGAT-2 inhibitors	Eli Lilly and Company	09/28/15
US8993586	248	N1/N2-lactam acetyl-CoA carboxylase inhibitors	Pfizer Inc.	09/28/15
US8993756	226	Pyrrolopyrimidines as janus kinase inhibitors	Merck Sharp & Dohme Corp.	09/28/15
US8993614	52	Substituted pyrrolidine-2-carboxamides	F. Hoffmann-La Roche AG	09/28/15
US8993765	26	Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof	Albany Molecular Research, Inc.	09/28/15
US8993575	12	[1,3,4] oxadiazole derivative and application thereof	Huazhong University of Science & Technology; NHWA Pharma Corporation	09/28/15
US8993565	161	(6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as AKT(PKB) phosphorylation inhibitors	Sanofi	09/03/15
US8993552	72	Compositions and methods for treatment of leukemia	The Regents of The University of Michigan; University of Virginia Patent Foundation	09/03/15
US8987474	133	Inhibition of Shp2/PTPN11 protein tyrosine phosphatase by NSC-87877, NSC-117199 and their analogs	University of South Florida; H. Lee Moffitt Cancer Center and Research Institute, Inc.	09/03/15
US8993557	10	Pyridinedione carboxamide inhibitors of endothelial lipase	Bristol-Myers Squibb Company	09/03/15
US8993556	18	Resorcinol derivatives as HSP90 inhibitors	Nerviano Medical Sciences S.R.L.	09/03/15
US8987473	72	Ring-fused compound	Sato Pharmaceutical Co., Ltd.	09/03/15
US8987457	595	Ring-substituted N-pyridinyl amides as kinase inhibitors	Novartis AG	09/03/15
US8987319	37	Selective androgen receptor modulators	Radius Health, Inc.	09/03/15
US8987335	35	Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors	University of Utah Research Foundation	09/03/15
US8987445	181	Sulfonamide compounds having TRPM8 antagonistic activity	Mitsubishi Tanabe Pharma Corporation	09/03/15
US8987314	725	Amide, urea or sulfone amide linked benzothiazole inhibitors of endothelial lipase	Bristol-Myers Squibb Company	08/25/15
US8987272	3	Compounds and method for treatment of HIV	Critical Outcome Technologies Inc.	08/25/15
US8987257	68	Heterocyclic derivatives	Novartis AG	08/25/15
US8987313	34	Inhibitors of cytochrome P450	Gilead Sciences, Inc.	08/25/15
US8987315	20	Metalloenzyme inhibitor compounds	Innocrin Pharmaceuticals, Inc.	08/25/15
US8981106	177	Pyrimidinecarboxamides as CXCR2 modulators	Syntrix Biosystems, Inc.	08/25/15
US8987268	121	Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases	Bristol-Myers Squibb Company	08/25/15
US8987287	25	Spirocyclic morphinans and their use	Purdue Pharma L.P.	08/25/15
US8987273	75	Substituted imidazo[1,2-B]pyridazines	Bayer Intellectual Property GmbH	08/25/15
US8987286	45	Substituted pyrimido[1,2-b]indazoles and their use as modulators of the Pi3K/Akt pathway	Bayer Intellectual Property GmbH	08/25/15
US8987239	20	19-nor-steroid derivatives with a 15α,16α-methylene group and a saturated 17,17-spirolactone ring, use thereof, and medicaments containing said derivatives	Bayer Intellectual Property GbmH	08/19/15
US8980938	7	CXCR2 inhibitors	Sanofi	08/19/15
US8980932	40	Cancer targeting using carbonic anhydrase isoform IX inhibitors	Stichting Maastricht Radiation Oncology “Maastro-Clinic”; Université Montpellier 2 Sciences et Techniques	08/19/15
US8981112	25	Inhibitors of β-secretase	Vitae Pharmaceuticals, Inc.; Boehringer-Ingelheim International GmbH	08/19/15
US8987247	3	Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders	Janssen Pharmaceutica NV	08/19/15
US8987242	15	Morpholinone compounds as factor IXA inhibitors	Merck Sharp & Dohme Corp.; Mochida Pharmaceuticals Co., Ltd.	08/19/15
US8987249	358	Substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C	Boehringer Ingelheim International GmbH	08/19/15
US8980954	13	Substituted cis- and trans-stilbenes as therapeutic agents	STC.UNM	08/19/15
US8987248	26	Substituted piperidines as Par-1 antagonists	Bayer Intellectual Property GmbH	08/19/15
US8987254	8	Tetrahydropyrrolothiazine compounds	Eli Lilly and Company	08/19/15
US8980887	7	2-aryl imidazo[1,2-a]pyridine-3-acetamide derivatives, preparation methods and uses thereof	Institute of Pharmacology; Toxicology Academy of Military Medical Sciences P.L.A., China	08/10/15
US8980901	5	5-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta	Icos Corporation	08/10/15
US8980829	56	Aryl glycoside compound, preparation method and use thereof	Shanghai Yingli Science and Technology Co., Ltd; Shanghai Chempartner Co., Ltd	08/10/15
US8980905	10	Benzodioxole or benzodioxepine heterocyclic compounds as phosphodiesterase inhibitors	Leo Pharma A/S	08/10/15
US8975415	367	Chromane compounds	CoMentis, Inc.	08/10/15
US8980916	3	Factor IXa inhibitors	Merck Sharp & Dohme Corp.; Mochida Pharmaceutical Co., Ltd.	08/10/15
US8980904	18	Heterocyclic substituted pyrimidine compound	Xuanzhu Pharma Co., Ltd.	08/10/15
US8975409	18	Phenyl derivative	ONO Pharmaceutical Co., Ltd.	08/10/15
US8975417	716	Pyrazolopyrrolidine derivatives and their use in the treatment of disease	Novartis AG	08/10/15
US8980906	50	Pyridonemorphinan analogs and biological activity on opioid receptors	Purdue Pharma L.P.	08/10/15
US8980929	14	Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes	Merck Sharp & Dohme Corp.	08/10/15
US8975250	13	5 oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives as CaMKII kinase inhibitors for treating cardiovascular diseases	SANOFI	08/03/15
US8975261	14	Aryloxmethyl cyclopropane derivatives as PDE10 inhibitors	Merck Sharp & Dohme Corp.	08/03/15
US8975249	94	Heterocyclic compounds and uses thereof	Celgene Avilomics Research, Inc.	08/03/15
US8975276	8	Inhibitors of PDE10	Bristol-Myers Squibb Company	08/03/15
US8962860	19	Inhibitors of glutaminyl cyclase	Probiodrug AG	08/03/15
US8975247	27	Methods and compositions of treating a flaviviridae family viral infection	The Board of Trustees of the Leland Stanford Junion University	08/03/15
US8975252	2	Morpholine derivative	Shanghai Pharmaceuticals Holding Co., Ltd.; Mitsubishi Tanabe Pharma Corporation	08/03/15
US8975260	12	Pyridazinones, method of making, and method of use thereof	Genetech, Inc; Gilead Connecticut, Inc.	08/03/15
US8975265	371	Substituted imidazo[1,2-a]pyrimidines and —pyridines	Bayer Intellectual Property GmbH	08/03/15
US8975282	8	Substituted pyrazolone compounds and methods of use	Sunshine Lake Pharma Co., Ltd.; Calitor Sciences, LLC	08/03/15
US8975267	51	Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors	Nerviano Medical Sciences S.r.l.	08/03/15
US8962637	76	Bicyclic compounds and their uses as dual c-SRC/JAK inhibitors	Debiopharm S.A.; Aurigene Discovery Technologies Ltd.	07/22/15
US8962651	8	Compounds for the treatment of hepatitis C	Bristol-Myers Squibb Company	07/22/15
US8962674	93	Curcumin derivative	Tokyo Institute of Technology; Kyoto University	07/22/15
US8962837	24	Nitrogen heterocycle derivatives, preparation thereof and application thereof in human therapeutics	Pierre Fabre Medicament	07/22/15
US8962646	38	Peripherally acting opioid compounds	Alkermes, Inc.	07/22/15
US8962659	4	Phenoxyethyl piperidine compounds	Eli Lilly and Company	07/22/15
US8962641	490	Pyrimidine-substituted pyrrolidine derivatives, pharmaceutical compositions and uses thereof	Boehringer Ingelheim International GmbH	07/22/15
US8962630	205	Pyrrolopyrimidine compounds and their uses	Novartis AG	07/22/15
US8962664	3	Selective glycosidase inhibitors and uses thereof	Simon Fraser University	07/22/15
US8962859	12	Spiro-amino-imidazo-fused heterocyclic compounds as beta-secretase modulators and methods of use	Amgen Inc.	07/22/15
US8962648	231	Tricyclic compounds and PBK inhibitors containing the same	OncoTherapy Science, Inc.	07/22/15
US8957084	9	7,8-cyclicmorphinan analogs	Purdue Pharma L.P.	07/15/15
US8957219	12	Acetic acid amide derivative having inhibitory activity on endothelial lipase	Shionogi & Co., Ltd.	07/15/15
US8957103	18	Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment	Johannes Gutenberg—Universitat Mainz	07/15/15
US8962608	1192	Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors	Merck Sharp & Dohme Corp.	07/15/15
US8962616	41	Heterocyclic substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds	Pfizer Inc.	07/15/15
US8957093	262	N-biphenylmethylindole modulators of PPARG	The Scripps Research Institute	07/15/15
US8962609	129	Pyrimidine compounds as inhibitors of protein kinases IKK epsilon and/or TBK-1, processes for their preparation, and pharmaceutical compositions containing them	Domainex Limited	07/15/15
US8962611	356	Substituted imidazopyridines as HDM2 inhibitors	Merck Sharp & Dohme Corp.	07/15/15
US8962619	36	Substituted imidazopyridinyl-aminopyridine compounds	ArQule, Inc.	07/15/15
US8962612	20	Tetrahydroisoquinoline derivative	Astellas Pharma Inc.	07/15/15
US8957075	28	O-GlcNAc transferase inhibitors and uses thereof	President and Fellows of Harvard College	07/10/15
US8957077	14	Pyrazolopyrimidine PDE 10 inhibitors	Merck Sharp & Dohme Corp.	07/10/15
US8957074	298	Pyrrolopyrimidine compounds as inhibitors of CDK4/6	Novartis AG	07/10/15
US8957083	31	Spiro-amino-imidazolone and spiro-amino-dihydro-pyrimidinone compounds as beta-secretase modulators and methods of use	Amgen Inc.	07/10/15
US8957068	870	3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH	Novartis AG	07/09/15
US8957064	185	Fused pyrimidines	Bayer Intellectual Property GmbH	07/09/15
US8957059	66	Modulators of serotonin receptors	Janssen Pharmaceutica NV	07/09/15
US8957073	378	Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors	Amgen Inc.	07/09/15
US8957057	4	Use of azaphilone compounds for the modulation of the activity of a nuclear hormone receptor	Food Industry Research and Development Institute	07/09/15
US8952177	191	1,2,6-substituted benzimidazoles as FLAP modulators	Janssen Pharmaceutica NV	06/29/15
US8952157	407	Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases	AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research	06/29/15
US8952036	5	Benzoic acid derivative MDM2 inhibitor for the treatment of cancer	Amgen Inc.	06/29/15
US8952037	98	Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors	Amgen Inc.	06/29/15
US8956589	22	Imaging diagnostic agent and extracorporeal diagnostic agent for incurable neurological diseases	Shiga University of Medical Science	06/29/15
US8952027	12	Inhibitors of syk and JAK protein kinases	Portola Pharmaceuticals, Inc.	06/29/15
US8952025	3	Multifunctional radical quenchers and their uses	Arizona Board of Regents, A Body Corporate of the State of Arizona Acting for and on Behalf of Arizona State University	06/29/15
US8952169	708	N-substituted benzamides and methods of use thereof	Xenon Pharmaceuticals Inc.; Genentech, Inc.	06/29/15
US8952150	30	Prostaglandin transporter inhibitors and uses thereof	Albert Einstein College of Medicine of Yeshiva University	06/29/15
US8952128	168	Somatostatin-dopamine chimeric analogs	Ipsen Pharma S.A.S.	06/29/15
US8969583	55	3-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisothiazole derivatives as kinase inhibitors	Allergan, Inc.	06/22/15
US8952002	3	Aminoheteroaryl compounds and preparation method and use thereof	Shanghai Allist Pharmaceuticals, Inc.	06/22/15
US8969358	54	Buprenorphine analogs	Purdue Pharma L.P.	06/22/15
US8952008	50	Chemical compounds	Pfizer Limited	06/22/15
US8969348	10	Chymase inhibitors	Boehringer Ingelheim International GmbH	06/22/15
US8969336	95	Diamino heterocyclic carboxamide compound	Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.	06/22/15
US8969578	13	Inhibitors of STAT3	University of Central Florida Research Foundation, Inc.	06/22/15
US8969376	43	Pyrazolopyrimidine compounds and their use as PDE10 inhibitors	Mitsubishi Tanabe Pharma Corporation	06/22/15
US8969586	18	Substituted bicyclic heteroaryl compounds	Bristol-Myers Squibb Company	06/22/15
US8969568	125	Substituted naphthyridines and their use as medicaments	Boehringer Ingelheim Pharma GmbH & Co. KG	06/22/15
US8969333	6	Therapeutic compositions and methods	The Penn State Research Foundation	06/22/15
US8969394	24	Thiophenecarboxamide derivatives as EP4 receptor ligands	Merck Frosst Canada Ltd.	06/22/15
US8969335	189	Benzonitrile derivatives as kinase inhibitors	MERCK PATENT GmbH	06/16/15
US8940739	190	Compound of a reverse-turn mimetic and a production method and use therefor	JW Pharmaceutical Corporation	06/16/15
US8940893	17	Heteroaromatic compounds as BTK inhibitors	Boehringer Ingelheim International GmbH	06/16/15
US8940748	21	Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use	Merck Sharp & Dohme Corp.	06/16/15
US8940720	77	Macrocycles as factor XIa inhibitors	Bristol-Myers Squibb Company	06/16/15
US8940771	29	Organic compounds	Novartis AG	06/16/15
US8940744	33	Pyrazolopyrimidine compounds as kinase inhibitors	Principia Biopharma Inc.	06/16/15
US8969341	345	Pyrazolopyrrolidine compounds	Novartis AG	06/16/15
US8969352	164	Substituted 2-azabicycles and their use as orexin receptor modulators	Janssen Pharmaceutica NV	06/16/15
US8969325	333	TRPV1 antagonists	AbbVie Inc.	06/16/15
US8937070	24	Inhibitors of protein kinases	Portola Pharmaceuticals, Inc.	06/15/15
US8937058	38	17-hydroxy-19-nor-21-carboxylic acid-steroid γ-lactone derivative, use thereof, and medicament containing the derivative	TBA	06/08/15
US8937095	12	Anticancer compounds	Boehringer Ingelheim International GmbH	06/08/15
US8937193	50	Apogossypolone derivatives as anticancer agents	Sanford-Burnham Medical Research Institute	06/08/15
US8937092	22	Aryl or N-heteroaryl substituted methanesulfonamide derivatives as vanilloid receptor ligands	Gruenenthal GmbH	06/08/15
US8940736	142	Imidazotriazinecarbonitriles useful as kinase inhibitors	Bristol-Myers Squibb Company	06/08/15
US8940719	16	Lithocholic acid analogues that inhibit sialyltransferase	Academia Sinica	06/08/15
US8937084	27	Nitrogen containing morphinan derivatives and the use thereof	Purdue Pharma L.P.	06/08/15
US8937068	220	Pyridopyrazine derivatives and their use	Zentaris GmbH	06/08/15
US8940738	11	Pyrimidone compounds	Mitsubishi Tanabe Pharma Corporation	06/08/15
US8933228	147	Respiratory formulations and compounds for use therein	Respivert, Ltd.	06/08/15
US8933224	248	Triazine derivatives	Pfizer Inc.	06/08/15
US8927738	26	2-arylimidazole derivatives as PDE10A enzyme inhibitors	H. Lundbeck A/S	06/01/15
US8933024	22	Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases	Sanofi	06/01/15
US8933098	4	Dimethyl-benzoic acid compounds	Eli Lilly and Company	06/01/15
US8933221	31	Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds	Pfizer Inc.	06/01/15
US8927730	16	Intramolecular hydrogen-bonded nitric oxide synthase inhibitors	Northwestern University	06/01/15
US8933095	29	KAT II inhibitors	Pfizer Inc.	06/01/15
US8927563	4	Kinase inhibitor	Respivert Limited; Topivert Pharma Limited	06/01/15
US8933099	139	Monocyclic pyridine derivative	Eisai R&D Management Co., Ltd.	06/01/15
US8933079	121	Pyridone and pyridazinone derivatives as anti-obesity agents	Boehringer Ingelheim International GmbH	06/01/15
US8927577	27	Quinolinyl glucagon receptor modulators	Pfizer Inc.	06/01/15
US8933040	7	Selective glycosidase inhibitors and uses thereof	TBA	06/01/15
US8933056	55	Soft protease inhibitors and pro-soft forms thereof	Trustees of Tufts College	06/01/15
US8921559	61	4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of CCR2	Janssen Pharmaceutica NV	05/26/15
US8927520	6	Antibacterial compounds	Institut Pasteur; Institut Curie	05/26/15
US8921397	263	Benzofurane-piperidine compounds	Hoffmann-La Roche Inc.	05/26/15
US8921412	16	C-aryl ansa SGLT2 inhibitors	Green Cross Corporation	05/26/15
US8927534	24	Compounds for the inhibition of integrins and use thereof	Shire Orphan Therapies GmbH	05/26/15
US8927539	10	Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure	Vitae Pharmaceuticals, Inc.	05/26/15
US8921424	13	Histone deacetylase inhibitors, process for preparation and uses thereof	Zhejiang Hisun Pharmaceutical Co. Ltd.; Central South University	05/26/15
US8921421	2	Inhibitors of dimethylarginine dimethylaminohydrolase	Christian-Albrechts-Universitaet Zu Kiel	05/26/15
US8921389	217	Naphthyridine derivatives as inhibitors of hypoxia inducible factor (HIF) hydroxylase	Fibrogen, Inc.	05/26/15
US8921410	175	Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes	Targacept, Inc.	05/26/15
US8927507	8	Selective glycosidase inhibitors and uses thereof	TBA	05/26/15
US8927536	14	Tetrahydrothiazepine derivative	Daiichi Sankyo Company, Limited	05/26/15
US8653304	10	2,3-dihydro-1H-indene-2-yl urea derivative and pharmaceutical application of same	Toray Industries, Inc.	05/18/15
US8916594	27	5-membered ring heteroaromatic derivatives having NPY Y5 receptor antagonistic activity	Shionogi & Co., Ltd.	05/18/15
US8921404	9	Azole derivatives in the form of lipase and phospholipase inhibitors	Sanofi	05/18/15
US8921370	20	Bicyclo[3.2.1]octyl amide derivatives and uses of same	H. Lundbeck A/S	05/18/15
US8921373	25	Compounds having TRPV1 antagonistic activity and uses thereof	Shionogi & Co., Ltd.	05/18/15
US8653257	5	Dibenzothiazepine derivatives and uses thereof—424	Astrazeneca AB	05/18/15
US8921364	56	Modulators of calcium release-activated calcium channel	Rhizen Pharmaceuticals SA	05/18/15
US8916600	20	Phenyl and benzodioxinyl substituted indazoles derivatives	Astrazeneca AB; Bayer Pharma Aktiengesellschaft	05/18/15
US8921368	103	Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases	Bristol-Myers Squibb Company	05/18/15
US8921319	60	Serine protease inhibitors	The Medicines Company (Leipzig) GmbH	05/18/15
US8653100	267	Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy	AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG	05/18/15
US8916577	22	Tricyclic derivatives, process for their preparation and their use as kinase inhibitors	Nerviano Medical Sciences S.R.L.	05/18/15
US8912208	4	(4-{4-[5-(benzooxazol-2-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid useful for treating or preventing conditions or disorders associated with DGAT1 activity	Novartis AG	05/11/15
US8916574	6	4-(substituted anilino)-quinazoline derivatives useful as tyrosine kinase inhibitors	Qilu Pharmaceutical Co., Ltd.	05/11/15
US8912219	10	Aryl sulfamide and sulfamate derivatives as RORc modulators	Genentech, Inc.	05/11/15
US8912221	44	Biaryl amide derivatives	Hoffmann-La Roche Inc.	05/11/15
US8912181	115	Bicyclic compound or salt thereof	Taiho Pharmaceutical Co., Ltd.	05/11/15
US8907086	8	Fused bicyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors	Merck Sharp & Dohme Corp.	05/11/15
US8916576	100	Pharmacokinetically improved compounds	Surface Logix, Inc.	05/11/15
US8912224	390	Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals	Sanofi	05/11/15
US8912173	121	Substituted quinolines and their use as medicaments	Boehringer Ingelheim International GmbH	05/11/15
US8916553	45	Sulfonamide compounds useful as CYP17 inhibitors	Bristol-Myers Squibb Company	05/11/15
US8912213	12	Synthesis and use of dual tyrosyl-DNA phosphodiesterase I (TDP1)- topoisomerase I (TOP1) inhibitors	Purdue Research Foundation	05/11/15
US8906943	19	Synthetic compounds and methods to decrease nicotine self-administration	TBA	05/11/15
US8895581	96	1H-imidazo[4,5-c]quinolines	Boehringer Ingelheim International GmbH	05/04/15
US8901140	7	6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof	Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd.	05/04/15
US8895745	17	Bicyclic heterocyclic compounds as FGFR inhibitors	Astex Therapeutics Limited	05/04/15
US8906911	68	Chemokine receptor antagonists	AbbVie Inc.	05/04/15
US8895592	76	Compounds as cannabinoid receptor ligands	AbbVie Inc.	05/04/15
US8901115	25	Cyclic P1 linkers as factor XIa inhibitors	Bristol-Myers Squibb Company	05/04/15
US8906933	30	Dihydropyrimidin-2(1H)-one compounds as neurokinin-3 receptor antagonists	N30 Pharmaceuticals, Inc.	05/04/15
US8901295	31	Inhibitors of cyclophilins and uses thereof	Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Montpellier 1; Universite Paris-EST Creteil val de Marne; Assistance Publique-Hopitaux de Paris; Centre National de la Recherche Scientifique	05/04/15
US8901087	39	Selective glycosidase inhibitors and uses thereof	Merck Sharp & Dohme Corp.	05/04/15
US8901315	337	Thienopyrazole derivative having PDE7 inhibitory activity	Daiichi Sankyo Company, Limited	05/04/15
US8901310	29	Tricyclic compounds, compositions, and methods	Pfizer Inc.	05/04/15
US8614223	561	Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof	Acetylon Pharmaceuticals, Inc.	05/03/15
US8895549	35	Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis	Bayer Intellectual Property GmbH	04/27/15
US8889684	10	Azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors	Boehringer Ingelheim International GmbH	04/27/15
US8889671	80	Compounds and methods for treating bacterial infections	AstraZeneca AB	04/27/15
US8889672	29	Compounds, formulations, and methods of protein kinase C inhibition	The Regents of The University of Michigan; The Penn State Research Foundation	04/27/15
US8614195	22	Glycoside derivatives and uses thereof	Novartis AG	04/27/15
US8895544	57	Indazoles	Pfizer Limited	04/27/15
US8895245	10	Inhibitors of human EZH2 and methods of use thereof	Epizyme, Inc.	04/27/15
US8889870	111	Kinase inhibitors	Allergan, Inc.	04/27/15
US8894989	59	PARP inhibitor compounds, compositions and methods of use	Eisai Inc.	04/27/15
US8889708	42	Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C	Boehringer Ingelheim International GmbH	04/27/15
US8889696	65	Substituted pyrido[2,3-d]pyrimidin-7(8H)-ones and therapeutic uses thereof	Temple University—Of The Commonwealth System Of Higher Education	04/27/15
US8889724	7	Tetrazole compounds for reducing uric acid	Wellstat Therapeutics Corporation	04/27/15
US8877733	2	1′-substituted pyrimidine N-nucleoside analogs for antiviral treatment	Gilead Sciences, Inc.	04/20/15
US8884017	21	2-heteroarylcarboxylic acid amides	Bayer Intellectual Property GmbH	04/20/15
US8883759	20	Anti-tumor effect potentiator	Taiho Pharmaceutical Co., Ltd.	04/20/15
US8883784	15	Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases	AbbVie Inc.	04/20/15
US8883771	150	Bivalent inhibitors of IAP proteins and therapeutic methods using the same	The Regents of the University of Michigan	04/20/15
US8614213	83	Cyclohexyl amide derivatives and their use as CRF-1 receptor antagonists	Novartis AG	04/20/15
US8883797	12	Metalloenzyme inhibitor compounds	Viamet Pharmaceuticals, Inc.	04/20/15
US8889668	31	Oxadiazole diaryl compounds	Merck Serono SA	04/20/15
US8877741	485	Pyrrolidine derivatives, pharmaceutical compositions and uses thereof	Boehringer Ingelheim International GmbH	04/20/15
US8614220	15	Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors	Nerviano Medical Sciences S.r.l.	04/20/15
US8883846	5	Synthesis of bicyclic compounds and method for their use as therapeutic agents	UVic Industry Partnerships Inc.	04/20/15
US8877798	71	1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders	Neurovance, Inc.	04/13/15
US8877944	96	3-oxo-2,3-dihydro-1H-isoindole-4-carboxamides as PARP inhibitors	Nerviano Medical Sciences S.R.L.	04/13/15
US8877778	285	Benzofurane compounds	Hoffmann-La Roche Inc.	04/13/15
US8877967	42	Compositions and methods for inhibition of cathepsins	OXiGENE, Inc.; Baylor University	04/13/15
US8871738	76	Fused bicyclic oxazolidinone CETP inhibitor	Merck Sharp & Dohme Corp.	04/13/15
US8877795	33	Identification of stabilizers of multimeric proteins	The Board of Trustees of the Leland Stanford Junior University	04/13/15
US8877791	8	Inhibitors of pyruvate kinase and methods of treating disease	Beth Israel Deaconess Medical Center, Inc.	04/13/15
US8871728	49	Non-peptide macrocyclic histone deacetylese (HDAC) inhibitors and methods of making and using thereof	Georgia Tech Research Corporation	04/13/15
US8877757	7	Pyrazine derivatives and use as PI3K inhibitors	Merck Serono SA	04/13/15
US8877775	37	Substituted 2-aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C	Boehringer Ingelheim International GmbH	04/13/15
US8877786	7	Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors	Novartis AG	04/13/15
US8871778	44	Substituted pyrimidine compounds and their use as SYK inhibitors	Genosco; Oscotec, Inc.	04/13/15
US8865911	180	Compounds and their use as BACE inhibitors	Astrazeneca AB	04/06/15
US8865655	4	Depsipeptides and their therapeutic use	Karus Therapeutics Limited	04/06/15
US8871934	680	Fluorene compound and pharmaceutical use thereof	Japan Tobacco Inc.	04/06/15
US8865706	30	Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds	Pfizer Inc.	04/06/15
US8871790	475	Heterocyclic modulators of lipid synthesis	3-V Biosciences, Inc.	04/06/15
US8865662	5	Macrolides and their use	Basilea Pharmaceutica AG	04/06/15
US8865698	105	Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds	Array BioPharma Inc.	04/06/15
US8865714	35	Piperazine compound capable of inhibiting prostaglandin D synthase	Taiho Pharmaceutical Co., Ltd.	04/06/15
US8865701	11	Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer'S disease	Merck Sharp & Dohme Corp.	04/06/15
US8871783	26	Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (cyano-methyl)-amides inhibitors of cathepsin C	Boehringer Ingelheim International GmBh	04/06/15
US8865726	144	Substituted pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors	Array BioPharma Inc.	04/06/15
US8865686	8	Tetracycline compounds as tyrosyl-DNA phosphodiesterase I inhibitors	The United States of America, as Represented by the Secretary, Dept. of Health and Human Services	04/06/15
US8859534	106	2-carboxamide-7-piperazinyl-benzofuran derivatives	Acturum Life Science AB	03/16/15
US8853224	62	Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases	Industrial Research Limited; Albert Einstein College of Medicine of Yeshiva University	03/16/15
US8859596	128	Compounds as cannabinoid receptor ligands	AbbVie Inc.	03/16/15
US8859586	50	Cyclohexyl isoquinolinone compounds	Novartis AG	03/16/15
US8853215	17	Derivatives of N-acyl-N′-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes	Takeda Pharmaceutical Company Limited	03/16/15
US8853203	366	Diazepinone derivatives	Novartis AG	03/16/15
US8853227	9	Methotrexate adjuvants to reduce toxicity and methods for using the same	Tosk, Incorporated	03/16/15
US8865750	10	Small molecule inhibitors of RGS proteins	The Regents of The University of Michigan; The University of Bath	03/16/15
US8853212	17	Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes	Merck Sharp & Dohme Corp	03/16/15
US8853193	170	Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions	Boehringer Ingelheim International GmbH	03/16/15
US8853206	11	Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments	Sanofi	03/16/15
US8853226	26	Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors	High Point Pharmaceuticals, LLC	03/16/15
US8853258	197	C-linked hydroxamic acid derivatives useful as antibacterial agents	Pfizer Inc.	03/09/15
US8853228	67	Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase	University of Connecticut	03/09/15
US8853207	12	Heterocyclic pyrazole compounds, method for preparing the same and use thereof	Development Center for Biotechnology	03/09/15
US8846601	142	Melanocortin receptor-specific peptides	Palatin Technologies, Inc.	03/09/15
US8853242	18	Nitrogenous-ring acylguanidine derivative	Astellas Pharma Inc.	03/09/15
US8846658	184	Oxazine derivatives and their use in the treatment of neurological disorders	Novartis AG	03/09/15
US8846698	511	Pyrrolo[2,3-d]pyrimidine tropomysin-related kinase inhibitors	Pfizer Limited	03/09/15
US8846000	35	Radiolabeled PDE10 inhibitors	Merck Sharp & Dohme Corp.	03/09/15
US8846657	356	Substituted imidazopyridines as HDM2 inhibitors	Merck Sharp & Dohme Corp.	03/09/15
US8846656	146	Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators	Novartis AG	03/09/15
US8846654	11	Therapeutic applications in the cardiovascular field of quinazolinedione derivatives	Sanofi	03/09/15
US8846673	38	Azaindazoles as kinase inhibitors and use thereof	Bristol-Myers Squibb Company	03/03/15
US8846730	132	Compounds as cannabinoid receptor ligands	AbbVie Inc.	03/03/15
US8846711	28	Heterocyclic acrylamides and their use as pharmaceuticals	Fab Pharma S.A.S.	03/03/15
US8846719	372	Isoxazolo-pyridine derivatives	Roche Palo Alto LLC	03/03/15
US8846741	9	N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy	AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG	03/03/15
US8846696	60	Purine derivatives	Cyclacel Limited; Cancer Research Technology Limited	03/03/15
US8846746	520	Pyrazole compound and pharmaceutical use thereof	Japan Tobacco Inc.	03/03/15
US8846699	346	Quinazoline derivatives as a multiplex inhibitor and method for the preparation thereof	Hanmi Pharm. Co., Ltd.	03/03/15
US8846660	29	Seven-membered ring compound and pharmaceutical use therefor	Daiichi Sankyo Company, Ltd.	03/03/15
US8846689	212	Substituted pyrimidines for the treatment of diseases such as cancer	Boehringer Ingelheim International GmbH	03/03/15
US8846929	836	Substituted-quinoxaline-type piperidine compounds and the uses thereof	Purdue Pharma L.P.; Shionogi & Co., Ltd.	03/03/15
US8835436	169	Arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same	Green Cross Corporation	02/23/15
US8841450	2	Compounds useful as inhibitors of ATR kinase	Vertex Pharmaceuticals Incorporated	02/23/15
US8846917	1	Compounds useful as inhibitors of ATR kinase	Vertex Pharmaceuticals Incorporated	02/23/15
US8835444	36	Cyclohexyl amide derivatives as CRF receptor antagonists	Novartis AG	02/23/15
US8835445	82	Dihydrofolate reductase inhibitors	Trius Therapeutics, Inc.	02/23/15
US8841312	749	Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors	Amgen Inc.	02/23/15
US8841453	36	Hybrid cholinesterase inhibitors	Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego	02/23/15
USRE45173	173	Inhibitors of CYP 17	Novartis AG	02/23/15
US8841288	10	Quinolin-4 (1H)-one derivatives as inhibitors of phosphatidylinositol 3-kinases	Universtà Degli Studi di Torino; Università Degli Studi del Piemonte Orientale “Amedeo Avogadro”	02/23/15
US8841455	165	Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitors	Array BioPharma Inc.	02/23/15
US8835464	53	Triazole compounds that modulate HSP90 activity	Synta Pharmaceuticals Corp.	02/23/15
US8835472	664	Compounds, pharmaceutical compositions and uses thereof	Boehringer Ingelheim International GmbH	02/16/15
US8828983	13	Macrocycles as factor XIa inhibitors	Bristol-Myers Squibb Company	02/16/15
US8835470	25	Mandelamide heterocyclic compounds	Bristol-Myers Squibb Company	02/16/15
US8829193	162	PIM kinase inhibitors and methods of their use	Novartis AG	02/16/15
US8835659	7	Polysubstituted benzofurans and medicinal applications thereof	Ikerchem, S.L.; Universidad del Pais Vasco	02/16/15
US8829010	57	Pyrazolo[3,4-d]pyrimidine compounds and their use as PDE2 inhibitors and/or CYP3A4 inhibitors	Pfizer Inc.	02/16/15
US8835465	3	Pyrazolylaminopyridine derivatives useful as kinase inhibitors	AstraZeneca AB	02/16/15
US8829009	6	Substituted 2-amino-3-(sulfonyl)pyrazolo[1,5-a]pyrimidines - serotonin 5-HT6 receptor antagonists, method for use thereof	TBA	02/16/15
US8829000	22	Substituted imidazo[1,5-A]quinoxalines as phosphodiesterase 9 inhibitors	ASKA Pharmaceutical Co., Ltd.	02/16/15
US8829190	28	Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases	Leo Pharma A/S	02/16/15
US8822479	7	6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines	Boehringer Ingelheim International GmbH	02/02/15
US8829199	333	Aminopyrazole derivative	Chugai Seiyaku Kabushiki Kaisha; F. Hoffmann-La Roche AG	02/02/15
US8822505	100	Azetidine derivatives	Genentech, Inc.	02/02/15
US8829200	30	Benzimidazole inhibitors of leukotriene production	Boehringer Ingelheim International GmbH	02/02/15
US8822460	15	Fused cyclopentyl antagonists of CCR2	Janssen Pharmaceutica NV	02/02/15
US8822494	47	Heteroaromatic compounds and their use as dopamine D1 ligands	Pfizer Inc.	02/02/15
US8822447	155	Indazole compounds useful as ketohexokinase inhibitors	Janssen Pharmaceutica NV	02/02/15
US8822457	4	Inhibitors of bruton's tyrosine kinase	Roche Palo Alto LLC	02/02/15
US8822448	100	Pyrazoloquinoline compound	Astellas Pharma Inc.	02/02/15
US8822510	15	Substituted 3-phenyl-1,2,4-Oxadiazole compounds	Bristol-Myers Squibb Company	02/02/15
US8822458	61	Substituted oxazolidinones and their use in the field of blood coagulation	Bayer Intellectual Property GmbH	02/02/15
US8822500	55	Tyrosine kinase inhibitors	Chembridge Corporation	02/02/15
US8815881	20	1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds	Hoffmann-La Roche Inc.; Siena Biotech S.p.A.	01/26/15
US8815845	10	1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties	The Regents of the University of Michigan	01/26/15
US8815927	11	Bivalent diazo bicyclic Smac mimetics and the uses thereof	The Regents of the University of Michigan	01/26/15
US8815852	34	Carbamoyloxy arylalkan arylpiperazine analgesics	SK Biopharmaceuticals Co., Ltd.	01/26/15
US8815840	94	Carbazole and carboline kinase inhibitors	Bristol-Myers Squibb Company	01/26/15
US8815918	14	Imidazo [2, 1-B] [1, 3, 4] thiadiazole derivatives	Centro Nacional de Investigaciones Oncologicas (CNIO)	01/26/15
US8815901	52	Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors	Novartis AG	01/26/15
US8822534	22	Substituted aminopropionic derivatives as neprilysin inhibitors	Novartis AG	01/26/15
US8815854	24	Substituted imidazopyridinyl compounds	ArQule, Inc.	01/26/15
US8815926	334	Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseases	Novartis AG	01/26/15
US8815891	114	Tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same	Je Il Pharmaceutical Co., Ltd.	01/26/15
US8815934	54	2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole and estrogen formulations	Wyeth LLC	01/19/15
US8802674	212	Aminopyrimidine derivatives as LRRK2 modulators	Genentech, Inc.	01/19/15
US8816088	96	Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity	Theravance Respiratory Company, LLC	01/19/15
US8802679	44	Glycine compound	Astellas Pharma Inc.	01/19/15
US8802673	421	Heterocyclic amine derivatives	Hoffmann-La Roche Inc	01/19/15
US8815951	300	Inhibitors of epoxide hydrolases for the treatment of inflammation	The Regents of the University of California	01/19/15
US8802663	45	Pyrazole oxadiazole derivatives as S1P1 agonists	Merck Serono SA	01/19/15
US8802712	80	Pyrazoloquinolines	Merck Patent GmbH	01/19/15
US8802672	27	Pyrimidinyl-piperazines useful as D3/D2 receptor ligands	Richter Gedeon Nyrt.	01/19/15
US8802665	48	Pyrrolidine derivatives	Genentech, Inc.	01/19/15
US8802686	63	Sulfone-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as a medicine	Bayer Intellectual Property GmbH	01/19/15
US8802711	155	TRPV1 antagonists	AbbVie Inc.	01/19/15
US8796280	46	2,3-disubstituted pyrazinesulfonamides as CRTH2 inhibitors	Merck Serono, S.A.	01/12/15
US8796284	21	4-aminopyrimidine derivatives and their as as adenosine A2a receptor antagonists	Palobiofarma, S.L.	01/12/15
US8796296	33	Aminopyrimidine derivatives as LRRK2 modulators	Genentech, Inc.	01/12/15
US8802695	41	Apoptosis signal-regulating kinase 1 inhibitors	Takeda Pharmaceutical Company Limited	01/12/15
US8796244	586	Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases	Astex Therapeutics Ltd	01/12/15
US8802724	5	Processes and intermediates for preparing substituted hexahydrofuro [2,3-b] furans	Purdue Research Foundation	01/12/15
US8796293	9	Purine and deazapurine derivatives as pharmaceutical compounds	Astex Therapeutics Limited; The Institute of Cancer Research: Royal Cancer Hospital; Cancer Research Technology Limited	01/12/15
US8796295	30	Substituted benzamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same	Vanderbilt University	01/12/15
US8802861	17	Thiazole derivatives and use thereof	Merck Serono SA	01/12/15
US8802721	9	Thiophene compounds for inflammation and immune-related uses	Synta Pharmaceuticals Corp.	01/12/15
US8802864	12	Triazolones as fatty acid synthase inhibitors	GlaxoSmithKline LLC	01/12/15
US8796297	46	4-substituted-2-amino-pyrimidine derivatives	AbbVie Inc.	12/22/14
US8796310	83	Amino-pyridine-containing spleen tyrosine kinase (SYK) inhibitors	Merck Sharp & Dohme Corp.	12/22/14
US8791130	46	Aminopyrimidine derivatives as LRRK2 modulators	Genentech, Inc.	12/22/14
US8791100	79	Aryl benzylamine compounds	Novartis AG	12/22/14
US8796457	1	Compound useful for the treatment of degenerative and inflammatory diseases	Galapagos NV	12/22/14
US8796330	80	Inhibitors of histone deacetylase and prodrugs thereof	Methylgene Inc.	12/22/14
US8791118	38	Pyridopyrazines as highly selective ras-Raf-Mek-Erk signal transduction pathway inhibitors	Aeterna Zentaris GmbH	12/22/14
US8791123	504	Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors	Array Biopharma, Inc.	12/22/14
US8796328	44	TRPV1 antagonists	TBA	12/22/14
US8796304	19	Tricyclic imidazole compounds as PDE10 inhibitors	H. Lundbeck A/S	12/22/14
US8785467	20	Alkoxy pyrimidine PDE10 inhibitors	Merck Sharp & Dohme Corp.	12/16/14
US8785489	97	Heteroaryl substituted indole compounds useful as MMP-13 inhibitors	Boehringer Ingelheim International GmbH	12/16/14
US8785477	9	Hexahydropyrrolo[3,4-b]pyrrole derivatives, preparation methods and pharmaceutical uses thereof	Shanghai Sun-Sail Pharmaceutical Science & Technology Co., Ltd.	12/16/14
US8791131	292	Imidazo[1,5]naphthyridine compounds, their pharmaceutical use and compositions	Pfizer Inc.	12/16/14
US8791272	215	Pyrazole compounds as CRTH2 antagonists	Boehringer Ingelheim International GmbH	12/16/14
US8785464	81	Pyrimidine derivatives that inhibit FAK/PTK2	Boehringer Ingelheim International GmbH	12/16/14
US8785459	386	Quinazoline compounds as kinase inhibitors	Development Center for Biotechnology	12/16/14
US8791257	60	Substituted pyrrolotriazines as protein kinase inhibitors	Bristol-Myers Squibb Company	12/16/14
US8791268	22	Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions	Gruenenthal GmbH	12/16/14
US8778932	5	Dihydro-oxazolobenzodiazepinone compounds, a process for there preparation and pharmaceutical compositions containing them	Les Laboratoires Servier; Egis Gyogyszergyar Nyrt	12/15/14
US8785634	9	Spiropiperidine prolylcarboxypeptidase inhibitors	Merck Sharp & Dohme Corp	12/15/14
US8785499	8	Targeting NAD biosynthesis in bacterial pathogens	University of Maryland, Baltimore; The Board of Regents of the University of Texas System; Sanford-Burnham Medical Research Institute	12/15/14
US8779142	157	Azabicyclo compound and salt thereof	Taiho Pharmaceutical Co., Ltd.	12/08/14
US8772304	33	Benzimidazole inhibitors of leukotriene production	Boehringer Ingelheim International GmbH	12/08/14
US8772285	2	Benzothiazoles having histamine H3 receptor activity	High Point Pharmaceuticals, LLC	12/08/14
US8778970	55	Benzyl piperidine compound	Dainippon Sumitomo Pharma Co., Ltd	12/08/14
US8778957	21	CGRP receptor antagonists	Merck Sharp & Dohme Corp.	12/08/14
US8778951	352	Heteroaryl compounds and their uses	Novartis AG	12/08/14
US8772283	128	Imidazo-oxazine compound or salt thereof	Taiho Pharmaceutical Co., Ltd.	12/08/14
US8778412	32	Methods for increasing the stabilization of hypoxia inducible factor-1 alpha	Aerpio Therapeutics Inc.	12/08/14
US8772288	36	Substituted spiro[cycloalkyl-1,3′-indo]-2′(1′H)-one derivatives and their use as P38 mitogen-activated kinase inhibitors	Almirall, S.A.	12/08/14
US8772297	20	TGF-β signal transduction inhibitor	Kyoto University	12/08/14
US8772282	6	Tetrahydropyrrolothiazine compounds	Eli Lilly and Company	12/08/14
US8785638	71	Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors	Katholieke Universiteit Leuven	12/08/14
US8772495	1	5-lipoxygenase-activating protein inhibitor	Panmira Pharmaceuticals, LLC	11/24/14
US8765733	21	Amine substituted methanesulfonamide derivatives as vanilloid receptor ligands	Gruenenthal GmbH	11/24/14
US8772481	21	Aza- and diaza-phthalazine compounds as P38 map kinase modulators and methods of use thereof	Amgen Inc.	11/24/14
US8772511	7	Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists	Bayer Intellectual Property GmbH	11/24/14
US8765744	129	Azaspirohexanones	Boehringer Ingelheim International GmbH	11/24/14
US8772478	21	Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics	Galderma Research & Development	11/24/14
US8772480	690	Inhibitors of PI3 kinase and/or mTOR	Amgen Inc.	11/24/14
US8772508	17	Inhibitors of glutaminyl cyclase	Probiodrug AG	11/24/14
US8765727	95	Macrocyclic compounds and their use as kinase inhibitors	Incyte Corporation	11/24/14
US8772510	65	PDE10 modulators	Hoffmann-La Roche Inc.	11/24/14
US8772316	84	Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A)	Allergan, Inc.; Exonhit Therapeutics SA	11/24/14
US8772305	292	Substituted pyridinyl-pyrimidines and their use as medicaments	Boehringer Ingelheim International GmbH	11/24/14
US8765972	19	3-oxo-2,3-dihydro-1H-isoindole-4-carboxamides with selective PARP-1 inhibition	Nerviano Medical Sciences S.r.l.	11/18/14
US8759537	85	3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents	Boehringer Ingelheim International GmbH	11/18/14
US8759366	48	Aminopyrimidines as SYK inhibitors	Merck Sharp & Dohme Corp.; Merck Canada Inc.	11/18/14
US8759341	15	Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof	Bayer Intellectual Property GmbH	11/18/14
US8765747	21	Fused 2-aminothiazole compounds	Dana-Farber Cancer Institute, Inc.	11/18/14
US8765940	162	Heterocyclic compounds and their uses	Amgen Inc.	11/18/14
US8759338	57	Heterocyclic kinase inhibitors	Novartis AG	11/18/14
US8759365	23	Organic compounds	Novartis AG	11/18/14
US8765750	27	Piperazine compound having a PGDS inhibitory effect	Taiho Pharmaceutical Co., Ltd.	11/18/14
US8759386	59	Pyrazole compounds as CRTH2 antagonists	Boehringer Ingelheim International GmbH	11/18/14
US8759532	266	Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors	Amgen Inc.	11/18/14
US8765820	21	Tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and/or LSD2	Universita Degli Studi di Roma “La Sapienza”; Fondazione IEO; Universita Degli Studi di Pavia; Universita Degli Studi di Milano	11/18/14
US8754075	87	1,3-oxazines as BACE1 and/or BACE2 inhibitors	Hoffmann-La Roche Inc.	11/11/14
US8748418	53	1,4-oxazepines as BACE1 and/or BACE2 inhibitors	Hoffmann-La Roche Inc.	11/11/14
US8748608	39	4-phenylpiperazine derivatives with functionalized linkers as dopamine D3 receptor selective ligands and methods of use	The United States of America as Represented by the Secretary of the Department of Health and Human Services; The University of North Texas Health Science Center at Fort Worth	11/11/14
US8748451	35	HDAC inhibitors and therapeutic methods of using same	The Board of Trustees of The University of Illinois	11/11/14
US8754089	32	Heterocyclic compounds and their uses	Amgen Inc.	11/11/14
US8754106	9	Macrocyclic inhibitors of hepatitis C virus	Janssen R&D Ireland; Medivir AB	11/11/14
US8754105	6	Macrocyclic inhibitors of hepatitis C virus	Medivir AB; Janssen R&D Ireland	11/11/14
US8754227	15	Metalloenzyme inhibitor compounds	Viamet Pharmaceuticals, Inc.	11/11/14
US8754099	5	Oxadiazole beta carboline derivatives as antidiabetic compounds	Merck Sharp & Dohme Corp	11/11/14
US8754113	39	Oxadiazole derivative having endothelial lipase inhibitory activity	Shionogi & Co., Ltd.	11/11/14
US8754233	151	Pyrazolylbenzothiazole derivatives and their use as therapeutic agents	Dermira (Canada), Inc.	11/11/14
US8748458	41	Scriptaid isosteres and their use in therapy	Karus Therapeutics Limited	11/11/14
US8741907	16	Alkyl-substituted pyrazolopyrimidines	Boehringer Ingelheim International GmbH	11/05/14
US8741944	37	Anti-infective agents against intracellular pathogens	The Ohio State University Research Foundation	11/05/14
US8741915	24	Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors	N30 Pharmaceuticals, Inc.	11/05/14
US8742106	172	Disubstituted heteroaryl-fused pyridines	Novartis AG	11/05/14
US8748618	36	Inhibitors of inv(16) leukemia	University of Virginia Patent Foundation	11/05/14
US8741926	10	Macrocyclic inhibitors of hepatitis C virus	Janssen R&D Ireland; Medivir AB	11/05/14
US8741923	19	Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis	Merck Serono SA	11/05/14
US8748626	8	Oxazole and thiazole compounds as KSP inhibitors	Novartis AG	11/05/14
US8748624	138	Picolinamido-propanoic acid derivatives useful as glucagon receptor antagonists	Janssen Pharmaceutica NV	11/05/14
US8748435	37	Pyrazolo pyrimidine derivatives	Novartis AG	11/05/14
US8742113	21	Furanone derivative	SBI Biotech Co., Ltd.; Carna Biosciences, Inc.	11/04/14
US8742110	170	Spiroxazolidinone compounds	Merck Sharp & Dohme Corp.	11/04/14
US8729113	97	4,5-dihydro-oxazol-2yl derivatives	Hoffmann-La Roche Inc.	10/28/14
US8742134	8	7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof	Theron Pharmaceuticals, Inc.	10/28/14
US8735386	429	Aminopyrazoloquinazolines	Boehringer Ingelheim International GmbH	10/28/14
US8735593	10	Aminopyridines useful as inhibitors of protein kinases	Vertex Pharmaceuticals Incorporated	10/28/14
US8742115	35	Co-crystals and salts of CCR3-inhibitors	Boehringer Ingelheim International GmbH	10/28/14
US8722692	731	Compounds and compositions as Syk kinase inhibitors	TBA	10/28/14
US8742138	35	Compounds as hypoxia mimetics, and compositions and uses thereof	Betta Pharmaceuticals Co., Ltd.	10/28/14
US8729074	47	Inhibitors of PI3 kinase	Amgen Inc.	10/28/14
US8729078	50	Inhibitors of bruton's tyrosine kinase	Hoffmann-La Roche Inc.	10/28/14
US8735395	13	Protease inhibitors	Medivir AB	10/28/14
US8742158	44	Protease inhibitors	TaiMed Biologies, Inc.	10/28/14
US8729061	248	Pyrrolidine derivatives	Hoffmann-La Roche Inc.	10/28/14
US8722877	5	7-deazapurine modulators of histone methyltransferase, and methods of use thereof	Epizyme, Inc.	10/20/14
US8722683	231	Benzodioxole piperazine compounds	Hoffmann LA-Roche Inc.	10/20/14
US8716478	12	Boron-containing small molecules	Anacor Pharmaceuticals, Inc.	10/20/14
US8729273	31	Compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same	LG Life Sciences Ltd.	10/20/14
US8722718	2	Inhibitors of C-FMS kinase	Janssen Pharmaceutica NV	10/20/14
US8716296	11	Inhibitors of protein kinases	Ingenium Pharmaceuticals GmbH	10/20/14
US8722709	57	Mineralocorticoid receptor antagonists	Boehringer Ingelheim International GmbH	10/20/14
US8716285	65	N-hydroxy-benzamids for the treatment of cancer	Hoffmann-La Roche Inc.	10/20/14
US8716287	65	Pharmaceutical compounds	Sentinel Oncology Limited	10/20/14
US8722896	588	Prokineticin receptor antagonists and uses thereof	The Regents of the University of California	10/20/14
US8722895	34	Prolyl hydroxylase inhibitors and method of use	Akebia Therapeutics, Inc.	10/20/14
US8722721	18	SEC-hydroxycyclohexyl derivatives	Hoffmann-La Roche Inc.	10/20/14
US8722890	54	Thieno[3,2-C]pyridine kinase inhibitors with improved CYP safety profile	AbbVie Inc.	10/20/14
US8710076	8	2,5-disubstituted piperidine orexin receptor antagonists	Merck Sharp & Dohme Corp.	10/14/14
US8703785	9	2-aminopyrimidin-4-one and 2-aminopyridine derivatives both having BACE1-inhibiting activity	Shionogi & Co., Ltd.	10/14/14
US8703807	12	Azaspirodecanone compounds	Hoffmann-La Roche Inc.	10/14/14
US8703947	11	Compounds for treatment of Alzheimer's disease	Purdue Research Foundation	10/14/14
US8703720	17	Galactoside inhibitors of galectins	Galecto Biotech AB	10/14/14
US8710232	17	Imidazole derivatives used as TAFIa inhibitors	Sanofi-Aventis Deutschland GmbH	10/14/14
US8703768	340	Nitrogen containing heteroaryl compounds	Hoffmann-La Roche Inc.	10/14/14
US8703761	15	Organic compounds	Novartis AG	10/14/14
US8703771	45	Preparation method of dihydroindene amide compounds, their pharmaceutical compositions containing compounds thereof and use as protein kinases inhibitor	Harbin Gloria Pharmaceuticals Co., Ltd.	10/14/14
US8703770	2	Pyridazine carboxamide orexin receptor antagonists	Merck Sharp & Dohme Corp.	10/14/14
US8703811	138	Small molecule inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase	Genzyme Corporation; Massachusetts Institute of Technology; President and Fellows of Harvard College	10/14/14
US8703767	18	Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors	University of Utah Research Foundation	10/14/14
US8716482	17	Substituted aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes	Merck Sharp & Dohme Corp.	10/14/14
US8697869	57	3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9H-carbazole derivatives and their use as prostaglandin D2 receptor modulators	Actelion Pharmaceuticals Ltd.	10/06/14
US8697868	10	8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions	Boehringer Ingelheim International GmbH	10/06/14
US8697708	16	Azabenzothiazole compounds, compositions and methods of use	F. Hoffmann-La Roche AG	10/06/14
US8697716	17	Method of inhibiting C-KIT kinase	Janssen Pharmaceutica NV	10/06/14
US8691753	866	Pseudodipeptides as MMP inhibitors	Commissariat A l'Energie Atomique et Aux Energies Alternatives	10/06/14
US8697911	172	Rho kinase inhibitors	Boehringer Ingelheim International GmbH	10/06/14
US8697715	42	Serine/threonine kinase inhibitors	Array BioPharma, Inc.; Genentech, Inc.	10/06/14
US8697696	11	Triazole compounds II	Roche Palo Alto LLC	10/06/14
US8691852	26	Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors	Amirall, S.A.	09/30/14
US8691827	9	Amino tetrahydro-pyridopyrimidine PDE10 inhibitors	Merck Sharp & Dohme Corp.	09/30/14
US8691986	34	Azetidine and piperidine compounds useful as PDE10 inhibitors	Amgen Inc.	09/30/14
US8691856	2	Glucagon receptor antagonists, preparation and therapeutic uses	Eli Lilly and Company	09/30/14
US8691840	5	N-biarylamides	Bayer Intellectual Property GmbH	09/30/14
US8691993	13	Piperidinyl naphthylacetic acids	Hoffmann-La Roche Inc.	09/30/14
US8685958	20	Therapeutic agents	AstraZeneca AB	09/30/14
US8691829	4	Treatment of liver disorders with PI3K inhibitors	Gilead Calistoga LLC	09/30/14
US8691832	20	Tricyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors	Merck Sharp & Dohme Corp.	09/30/14
US8680119	4	Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto	Arena Pharmaceuticals, Inc.	09/16/14
US8680275	351	Fused heterocyclic compounds as orexin receptor modulators	Janssen Pharmaceutica NV	09/16/14
US8686042	2	GSK-3 inhibitors	Neuropharma, S.A.	09/16/14
US8685992	120	Histone deacetylase inhibitors based simultaneously on trisubstituted 1H-pyrroles and aromatic and heteroaromatic spacers	Universidad del País Vasco; Ikerschem, S.L.	09/16/14
US8680120	31	Indole derivative or pharmaceutically acceptable salt thereof	Kissei Pharmaceutical Co., Ltd.	09/16/14
US8685986	12	Medical composition for treatment or prophylaxis of glaucoma	Ube Industries, Ltd.	09/16/14
US8686018	9	Pharmaceutical composition	Eisai R&D Management Co., Ltd.	09/16/14
US8680116	9	Quinolinone PDE2 inhibitors	Merck Sharp & Dohme Corp.	09/16/14
US8680132	72	Spiro-oxindole MDM2 antagonists	The Regents of the University of Michigan; Ascenta Licensing Corporation; Sanofi	09/16/14
US8673938	23	Chemical compounds	AstraZeneca AB	09/08/14
US8673906	102	Chromenone derivatives	AstraZeneca AB	09/08/14
US8673950	149	Dihydrooxazol-2-amine derivatives	Hoffmann-LaRoche Inc.	09/08/14
US8669380	8	Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives	Pfizer Inc.	09/08/14
US8673905	42	Imidazo pyrazines	Hoffmann-La Roche Inc.	09/08/14
US8669252	14	Prolylcarboxypeptidase inhibitors	Merck Sharp & Dohme Corp.	09/08/14
US8669361	86	Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use	F. Hoffmann-La Roche AG	09/08/14
US8669266	17	Quinoline-carboxamide derivatives as P2Y12 antagonists	Sanofi	09/08/14
US8673966	123	ALDH-2 inhibitors in the treatment of addiction	Gilead Sciences, Inc.	09/03/14
US8674113	185	Compounds	Boehringer Ingelheim International GmbH	09/03/14
US8653125	23	Cyclohexane derivative having NPY Y5 receptor antagonism	Shionogi Co., Ltd.	09/03/14
US8653263	733	Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators	Janssen Pharmaceutica	09/03/14
US8674100	93	Inhibitors of C-FMS kinase	Janssen Pharmaceutica, N.V.	09/03/14
US8653111	20	Substituted dihydropyrazolones for treating cardiovascular and hematological diseases	Bayer Intellectual Property GmbH	09/03/14
US8653092	188	Tetrahydro-pyrido-pyrimidine derivatives	Novartis AG	09/03/14
US8664236	35	1H-pyrrolo[2,3 b]-pyridine derivatives	Merck Patent GmbH	08/26/14
US8664219	26	Aminopyrimidines useful as inhibitors of protein kinases	Vertex Pharmaceuticals Incorporated	08/26/14
US8648092	144	Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications	MEI Pharma	08/26/14
US8664258	5	Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto	Arena Pharmaceuticals, Inc.	08/26/14
US8653091	46	Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof	Evotec AG	08/26/14
US8653087	741	Pyrido [5, 4-D] pyrimidines as cell proliferation inhibitors	Boehringer Ingelheim International GmbH	08/26/14
US8664230	18	Pyridopyrimidine derivatives and use thereof	The Asan Foundation	08/26/14
US8637558	130	Thiazolidinedione derivative and use thereof	Industry-Academic Cooperation Foundation, Chosun University	08/26/14
US8637502	75	2,3,4,5-tetrahydro-benzo{B}{1,4}diazepine-comprising compounds of formula(III) for treating pain	Purde Pharma L.P.; Shionogi & Co., Ltd.	08/22/14
US8633183	1192	5-alkynyl-pyrimidines	Boehringer Ingelheim International GmbH	08/22/14
US8637532	1511	Amino azaheterocyclic carboxamides	Merck Patent GmbH	08/22/14
US8637500	360	Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors	Amgen Inc.	08/22/14
US8637508	90	Heterocyclic derivatives and their use in the treatment of neurological disorders	Novartis AG	08/22/14
US8637526	40	Pyrazolopyrimidine JAK inhibitor compounds and methods	Genentech, Inc.	08/22/14
US8637504	37	Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity	Shionogi & Co., Ltd.	08/22/14
US8637528	8	Use of PDE7 inhibitors for the treatment of movement disorders	Omeros Corporation	08/22/14
US8633204	174	4-methylpyridopyrimidinone compounds	Pfizer Inc.	08/06/14
US8633208	48	6-1H-imidazo-quinazoline and quinolines derivatives, new MAO inhibitors and imidazoline receptor ligands	Rottapharm S.p.A	08/06/14
US8633188	60	Aminodihydrothiazine derivatives	Shionogi & Co., Ltd.	08/06/14
US8637501	113	Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine MCH-1 antagonists, methods of making, and use thereof	Albany Molecular Research, Inc.	08/06/14
US8633196	19	Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics	Galderma Research & Development	08/06/14
US8637507	15	Bicyclic compounds as inhibitors of diacylglycerol acyltransferase	Merck Sharp & Dohme Corp.	08/06/14
US8633212	166	Inhibitors of beta-secretase	Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH	08/06/14
US8633226	5	Piperidinyl derivative as a modulator of chemokine receptor activity	Bristol-Myers Squibb Company	08/06/14
US8633206	417	Pyrrolo[2,3-D]pyrimidine compounds	Pfizer Inc.	08/06/14
US8633231	20	Substituted imidazolones, compositions containing such compounds and methods of use	Merck Sharp & Dohme Corp.	08/05/14
US8629158	46	Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof	Albany Molecular Research, Inc.	07/28/14
US8623860	151	Azetidine derivatives, pharmaceutical compositions and uses thereof	Boehringer Ingelheim International GmbH	07/28/14
US8623863	24	Disubstituted azepan orexin receptor antagonists	Merck Sharp & Dohme Corp.	07/28/14
US8629282	13	Heterocyclic compounds as S1P1 agonists for the treatment of autoimmune and vascular diseases	Bristol-Myers Squibb Company	07/28/14
US8629135	14	Pharmaceutical compositions comprising RET inhibitors and methods for the treatment of cancer	Queen's University at Kingston	07/28/14
US8629167	93	Selective androgen receptor modulators	Radius Health, Inc.	07/28/14
US8628961	13	Small molecule antagonists of phosphatidylinositol-3,4,5-triphosphate (PIP3) and uses thereof	Tufts University; Council of Scientific and Industrial Research	07/28/14
US8629141	39	Spiro-oxindole MDM2 antagonists	The Regents of the University of Michigan; Sanofi	07/28/14
US8629154	10	Substituted cycloalcano[e and d] pyrazolo [1,5-a]pyrimidines/antagonists of serotonin 5-HT6 receptors and methods for production and the use thereof	TBA	07/28/14
US8623883	20	4-phenylamino-quinazolin-6-yl-amides	Warner-Lambert Company LLC	07/22/14
US8623865	3	Acylpiperazinones and their use as pharmaceuticals	Fab Pharma S.A.S.	07/22/14
US8623901	43	Compounds for the treatment of CNS disorders	Boehringer Ingelheim International GmbH	07/22/14
US8623885	48	Fused tricyclic dual inhibitors of CDK 4/6 and FLT3	Amgen Inc.	07/22/14
US8618103	236	Inhibitors of JAK	Hoffmann-La Roche Inc.	07/22/14
US8623892	13	Metalloenzyme inhibitor compounds	Viamet Pharmaceuticals, Inc.	07/22/14
US8618107	64	Pyridone and aza-pyridone compounds and methods of use	Gilead Connecticut, Inc.; Genentech, Inc.	07/22/14
US8623889	490	Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof	Genentech, Inc.	07/22/14
US8623906	70	Carboxy isatin hydrazones and their esters as Shp2 inhibitors	H. Lee Moffitt Cancer Center and Research Institute, Inc.	07/21/14
US8618114	79	Substituted 3-arylsulfonyl-pyrazolo[1,5-A]pyrimidines, serotonin 5-HT6 receptor antagonists and methods for the production and use thereof	TBA	07/09/14
US8618111	284	5-alkynyl-pyrimidines	Boehringer Ingelheim International GmbH	07/08/14
US8618286	87	Benzoxazines, benzothiazines, and related compounds having NOS inhibitory activity	NeurAxon, Inc.	07/08/14
US8618075	9	Certain compounds, compositions and methods	Eisai Inc.	07/08/14
US8623903	17	Indolecarboxylic acid derivative having PGD2 receptor antagonistic activity	Shionogi & Co., Ltd.	07/08/14
US8618098	4	Inhibitors of bruton's tyrosine kinase	Roche Palo Alto LLC	07/08/14
US8618147	16	Modified macrophage migration inhibitory factor inhibitors	The Feinstein Institute for Medical Research	07/08/14
US8624022	14	Substituted aniline derivatives	UCB Pharma, S.A.	07/08/14
US8618158	80	Therapeutic agents	Cancer Research Technology Limited	07/08/14
US8614253	302	IRE-1α inhibitors	MannKind Corporation	06/25/14
US8614234	165	Compounds as tyrosine kinase modulators	Allergan, Inc.	06/24/14
US8618290	17	HSP90 inhibitors	Takeda Pharmaceutical Company Limited	06/24/14
US8613914	197	Peptidomimetic sulfamide compounds and antiviral uses thereof	Novartis AG	06/24/14
US8614206	289	Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use	F. Hoffmann-La Roche AG	06/24/14
US8614215	103	Quinoxaline inhibitors of phosphoinositide-3-kinases (PI3Ks)	Merck Serono SA	06/24/14
US8618299	55	Azinone-substituted azapolycycle MCH-1 antagonists, methods of making, and use thereof	Albany Molecular Research, Inc.	06/16/14
US8609647	91	Nitrogen-containing spirocyclic compounds and pharmaceutical uses thereof	Japan Tobacco Inc.	06/16/14
US8618303	36	Pyrrolidine derivatives	Hoffmann-La Roche Inc.	06/16/14
US8609678	365	Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof	Acetylon Pharmaceuticals	06/16/14
US8609681	72	Spirocyclic nitriles as protease inhibitors	Sanofi	06/16/14
US8609708	141	Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer	Human BioMolecular Research Institute	06/16/14
US8604061	221	2-aminooxazolines as TAAR1 ligands	Hoffmann-La Roche Inc.	06/04/14
US8609666	67	2-morpholino-pyrido[3,2-D]pyrimidines	Merck Serono SA	06/04/14
US8609622	20	C-aryl glucoside derivatives, preparation process and pharmaceutical use thereof	Shanghai Hengrui Pharmaceutical Co., Ltd.; Jiangsu Hengrui Medicine Co., Ltd.	06/04/14
US8609710	29	Cycloalkyl-substituted imidazole derivative	Daiichi Sankyo Company, Limited	06/04/14
US8609715	258	Heteroarylcarboxylic acid ester derivative	Ajinomoto Co., Inc.	06/04/14
US8609698	8	Substituted dipyridyl-dihydropyrazolones and use thereof	Bayer Intellectual Property GmbH	06/04/14
US8604028	6	Furopyridinyl-substituted 1,4-dihydropyridine derivatives and methods of use thereof	Bayer Intellectual Property GmbH	05/13/14
US8609852	103	Thiazolyl mGluR5 antagonists and methods for their use	Merck Sharp & Dohme Corp.	05/13/14
US8604206	18	Compositions for preventing and/or treating degenerative disorders of the central nervous system	Amicus Therapeutics, Inc.	05/12/14
US8604016	694	Heterocyclic inhibitors of glutaminase	Calithera Biosciences Inc.	05/12/14
US8609688	36	Substituted imidazopyridinyl-aminopyridine compounds	ArQule, Inc.	05/12/14
US8604217	78	Compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent	Selvita S.A.	05/05/14
US8609892	2	Glucagon receptor antagonists, preparation and therapeutic uses	Eli Lilly and Company	05/05/14
US8598119	47	Methods and compositions for sleep disorders and other disorders	Intra-Cellular Therapies, Inc.	05/05/14
US8609833	18	Purine derivatives as adenosine A1 receptor agonists and methods of use thereof	Inotek Pharmaceuticals Corporation	05/05/14
US8604046	69	Substituted piperidine spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof	Sanofi	05/05/14
US8598157	90	5-alkynyl-pyridines	Boehringer Ingelheim International GmbH	04/28/14
US8598163	45	Derivatives of [1,3]Oxazin-2-one useful for the treatment of metabolic diseases such as lipid disorders	Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH	04/28/14
US8598184	5	Protein kinase inhibitors	Tiger Pharmatech	04/28/14
US8598172	6	Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors	Nerviano Medical Sciences S.r.l.	04/28/14
US8598206	241	Trypsin-like serine protease inhibitors, and their preparation and use	The Medicines Company (Leipzig) GmbH	04/28/14
US8604218	166	Cytoskeletal active rho kinase inhibitor compounds, composition and use	Inspire Pharmaceuticals, Inc.	04/18/14
US8598155	86	Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders	Pfizer Inc.	04/18/14
US8598217	20	Imidazole derivatives and their use as modulators of cyclin dependent kinases	Astex Therapeutics Ltd.; Novartis AG	04/18/14
US8598200	29	KAT II inhibitors	Pfizer Inc.	04/18/14
US8598210	55	Prolyl hydroxylase inhibitors and methods of use	Akebia Therapeutics, Inc.	04/18/14
US8592371	8	Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes	Merck Sharpe & Dohme Corp.	04/14/14
US8592426	124	Aryl-benzocycloalkyl amide derivatives	Hoffmann—La Roche Inc.	04/14/14
US8598357	237	Benzodioxole piperidine compounds	Hoffmann-La Roche Inc.	04/14/14
US8592432	61	Compounds and compositions as protein kinase inhibitors	TBA	04/14/14
US8592410	135	Cyclic inhibitors of 11BETA-hydroxysteroid dehydrogenase 1	Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH	04/14/14
US8575157	341	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1	Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International, GmbH	04/14/14
US8592431	151	Fused ring compound and use thereof	Takeda Pharmaceutical Company Limited	04/14/14
US8592425	5	Imidazo[1,2-a]pyridines and imidazo[1,2-b]pyridazines as mark inhibitors	Merck Sharp & Dohme Corp.	04/14/14
US8592423	3	Inhibitors of PDE10	Bristol-Myers Squibb Company	04/14/14
US8592379	11	Metastin derivative and use thereof	Kyoto University; Takeda Pharmaceutical Company Limited	04/14/14
US8592415	144	Selective kinase inhibitors	Reaction Biology Corp.; Synerga Limited	04/14/14
US8598345	91	Substituted heteroarylamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same	Vanderbilt University	04/14/14
US8592468	14	Bacterial thioredoxin reductase inhibitors and methods for use thereof	Thioredoxin Systems AB	03/17/14
US8592457	5	Isonicotinamide orexin receptor antagonists	Merck Sharp & Dohme Corp.	03/17/14
US8592455	417	Kinase inhibitors and methods of their use	Novartis AG	03/17/14
US8592454	32	Nitrogen-containing heterocyclic compound and use of same	Takeda Pharmaceutical Company Limited	03/17/14
US8592579	45	Pyrrolotriazine kinase inhibitors	Bristol-Myers Squibb Company	03/17/14
US8592581	36	Trisubstituted purine derivatives	Cyclacel Limited; Cancer Research Technology Limited	03/17/14
US8586580	8	2,7-substituted thieno[3,2-d] pyrimidine compounds as protein kinase inhibitors	Korea Institute of Science and Technology	03/12/14
US8586617	104	Aminomethyl-4-imidazoles	Hoffmann-La Roche Inc.	03/12/14
US8586579	423	Anellated pyridine compounds	Hoffmann-La Roche Inc.	03/12/14
US8586571	15	Heterocyclic compound	Takeda Pharmaceutical Company Limited	03/12/14
US8586600	34	Heterocyclic compounds and uses thereof	Celgene Avilomics Research, Inc.	03/12/14
US8586620	134	Substituted indole compounds having NOS inhibitory activity	NeurAxon, Inc.	03/12/14
US8580800	9	1,4-diaryl-pyrimidopyridazine-2,5-diones and their use	Bayer Intellectual Property GmbH	03/06/14
US8586597	5	6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta	ICOS Corporation	03/06/14
US8575203	258	Chemical compounds	Boehringer Ingelheim International GmbH	03/06/14
US8580788	21	Opioid antagonists	Adolor Corporation	03/06/14
US8575197	752	Pyrolinone derivative and pharmaceutical composition comprising the same	Shionogi & Co., Ltd.	03/06/14
US8580778	9	Substituted dihydropyrazolones and their use	Bayer Intellectual Property GmbH	03/06/14
US8580782	16	Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors	Merck Sharp & Dohme Corp.	03/06/14
US8575391	31	5-substituted-2-phenylamino benzamides as MEK inhibitors	Chugai Seiyaku Kabushiki Kaisha	02/24/14
US8575375	5	Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties	Research Triangle Institute; The United States of America, as represented by the Secretary, Department of Health and Human Services	02/24/14
US8569291	11	Bicyclic dihydroimidazolone CGRP receptor antagonists	Merck Sharp & Dohme Corp.	02/24/14
US8569281	119	Compounds and their administration for treating a neurodegenerative disease as well as a method for identifying a compound capable of inhibiting a kinase, such as LRRK	Medical Research Council Technology; Genentech, Inc.	02/24/14
US8580815	16	Derivatives of azaindoles as inhibitors of protein kinases ABL and SRC	Oribase Pharma	02/24/14
US8575186	219	Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof	Albany Molecular Research, Inc.	02/24/14
US8569306	18	JNK modulators	Hoffmann-La Roche, Inc.	02/24/14
US8569313	47	Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors	The Medicines Company (Leipzig) GmbH	02/24/14
US8575364	66	Modulators of serotonin receptor	Janssen Pharmaceutica NV	02/24/14
US8575201	175	Oxadiazole inhibitors of leukotriene production	Boehringer Ingelheim International GmbH	02/24/14
US8569299	10	Prolylcarboxypeptidase inhibitors	Merck Sharp & Dohme Corp	02/24/14
US8569311	48	Pyridyl piperidine orexin receptor antagonists	Merch Sharp & Dohme Corp.	02/24/14
US8569316	64	Pyrimido [5,4-D] pyrimidine derivatives for the inhibition of tyrosine kinases	Boehringer Ingelheim International GmbH	02/24/14
USRE44599	5	Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta	ICOS Corporation	02/24/14
US8575114	43	SGLT-2 inhibitors, methods of making them, and uses thereof	Albany Molecular Research, Inc.	02/24/14
US8569308	118	Substituted heteroarylamine carboxamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same	Vanderbilt University	02/24/14
US8569314	10	Triazolo and tetrazolo pyrimidine derivatives as HNE inhibitors for treating COPD	Bayer Intellectual Property GmbH	02/24/14
US8575145	329	Triazolopyridine compounds as PIM kinase inhibitors	Array BioPharma Inc.	02/24/14
US8569521	10	Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors	Merck Sharp & Dohme Corp.	01/21/14
US8569318	7	Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-HT6 receptors, methods for the production and use thereof	TBA	01/21/14
US8569338	3	Methods of using 4, 5, 6, 7-tetrahydroimidazo-[4,5-c]pyridine compounds	Proximagen Ltd.	01/20/14
US8563583	6	Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists	Bristol-Myers Squibb Company	01/20/14
US8569511	40	Substituted 3-(1H-benzo[d]imidazol-2-yl)-1H-indazole analogs as inhibitors of the PDK1 kinase	University of Utah Research Foundation	01/20/14
US8562945	22	Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof	Molecular Insight Pharmaceuticals, Inc.	01/20/14
US8551988	144	Benzimidazole derivatives: preparation and pharmaceutical applications	Mei Pharma, Inc.	01/14/14
US8563545	42	Compound useful for the treatment of degenerative and inflammatory diseases	Galapagos NV	01/14/14
US8563553	103	Compounds and compositions as protein kinase inhibitors	Novartis AG; IRM LLC	01/14/14
US8551978	95	Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity	Theravance, Inc.	01/14/14
US8551963	10	Imidazolothiazole compounds and methods of use thereof	Ambit Biosciences Corporation	01/14/14
US8563594	17	S1P3 receptor inhibitors for treating pain	Allergan, Inc.	01/14/14
US8552005	16	(EN) 3-sulfonyl-pyrazolo[1,5-a] pyrimidines / antagonists of serotonin 5-HT6 receptors, methods for the production and the use thereof	Avincuro Pharmaceuticals, Inc.	01/03/14
US8552017	4	2-amino-3-sulphonyl-tetrahydro-pyrazolo[1,5-A]pyrido-pyrimidine antagonists of serotonin 5-HT6 receptors, methods for the production and use thereof	TBA	01/03/14
US8552004	30	Chemical compounds	AstraZeneca AB	01/03/14
US8546370	24	Compounds and compositions as kinase inhibitors	IRM LLC	01/03/14
US8552023	5	Non-amidic linkers with branched termini as CGRP receptor antagonists	Merck Sharp & Dohme Corp.	01/03/14
US8551989	12	Substituted 4-(indazolyl)-1,4-dihydropyridines and methods of use thereof	Bayer Intellectual Property GmbH	01/03/14
US8546380	61	Aminodihydrothiazine derivatives	Shionogi & Co., Ltd.	12/22/13
US8552202	105	Furo[3, 2-B] pyrrol-3-ones as cathespin S inhibitors	Amura Therapeutics Limited	12/22/13
US8552033	2	Inhibitors of CXCR2	SANOFI	12/22/13
US8552057	12	Phytoestrogenic formulations for alleviation or prevention of neurodegenerative diseases	University of Southern California	12/22/13
US8552037	42	Tricyclic compound and pharmaceutical use thereof	Takeda Pharmaceutical Company Limited	12/22/13
US8546392	59	17Beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseases	Universitaet des Saarlandes	12/09/13
US8546404	17	Compounds that are ERK inhibitors	Merck Sharp & Dohme	12/09/13
US8552199	24	Substituted indanes, method for the production thereof, and use thereof as drugs	Sanofi	12/09/13
US8546434	14	Triazole compounds as KSP inhibitors	Novartis AG	12/09/13
US8546389	76	Viral polymerase inhibitors	Biota Scientific Management Pty Ltd.	12/09/13
US8541380	97	C-aryl glucoside SGLT2 inhibitors and pharmaceutical compositions comprising same	Green Cross Corporation	12/03/13
US8546451	20	Estrogen receptor ligands and methods of use thereof	GTx, Inc.	12/03/13
US8541363	4	Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use	St George's Hosptial Medical School; The University of Manchester	12/03/13
US8541407	230	Substituted benzo-pyrido-triazolo-diazepine compounds	ArQule, Inc.	12/03/13
US8546435	9	Triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors	AEterna Zentaris GmbH; Centre National de la Recherche Scientifique; University of Montpellier I; University of Montpellier II	12/03/13
US8541447	6	3-substituted-2-(arlyalkyl)-1-azabicycloalkanes and methods of use thereof	Targacept, Inc.	11/26/13
US8541408	48	Aminodihydrothiazine derivatives substituted with a cyclic group	Shionogi & Co., Ltd.	11/26/13
US8541572	292	Compounds for the treatment of inflammatory disorders	Merck Sharp & Dohme Corp.	11/26/13
US8541596	10	Inhibitors	Probiodrug AG	11/26/13
US8541427	45	Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use	Merck, Sharp & Dohme, Corp.	11/26/13
US8536165	55	Azabiphenylaminobenzoic acid derivatives as DHODH inhibitors	Almirall, S.A.	11/18/13
US8536158	8	Compounds having CRTH2 antagonist activity	Atopix Therapeutics Limited	11/18/13
US8536166	4	Inhibitors of Burton's tyrosine kinase	Roche Palo Alto LLC	11/18/13
US8536172	106	Inhibitors of JNK	Roche Palo Alto LLC	11/18/13
US8536175	50	Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors	Novartis AG	11/18/13
US8536173	10	Tetrahydroquinoxaline urea derivatives as modulators of 11-B-hydroxysteroid dehydrogenase type I	SANOFI	11/18/13
US8536192	53	6,7-unsaturated-7-carbamoyl substituted morphinan derivative	Shionogi & Co. Ltd.	11/11/13
US8536210	19	Compounds for inhibiting semicarbazide-sensitive amine oxidase (SSAO)/vascular adhesion protein-1 (VAP-1) and uses thereof for treatment and prevention of diseases	Semmelweis Egyetem	11/11/13
US8536193	14	Inhibitors of AKT activity	Merck Sharp & Dohme Corp.; MSD K.K.	11/11/13
US8536198	23	Piperidine derivatives as modulators of chemokine receptor activity	Bristol-Myers Squibb Company	11/11/13
US8536181	32	Prolyl hydroxylase inhibitors	Aerpio Therapeutics Inc.	11/11/13
US8530460	200	Azetidine derivatives	Boehringer Ingelheim International GmbH	11/04/13
US8530648	404	Diaza-spiro[5.5]undecanes	Novartis AG	11/04/13
US8536227	10	Modulators of protein kinase signaling	Novotyr Therapeutics Ltd.	11/04/13
US8530504	83	Pyrazolothiazole compound	Eisai R&D Management Co., Ltd.	11/04/13
US8530490	143	Uracil compound or salt thereof having human deoxyuridine triphosphatase inhibitory activity	Taiho Pharmaceutical Co., Ltd.	11/04/13
US8530494	94	Buprenophine analogs	Purdue Pharma LP	10/25/13
US8530670	5	Inhibitors	Probiodrug AG	10/25/13
US8524716	27	Macrocyclic indoles as hepatitis C virus inhibitors	Janssen R&D Ireland	10/25/13
US8524710	86	Pyrrolidine derivatives	Hoffmann-La Roche Inc.	10/25/13
US8530652	86	Pyrrolopyrazoles, potent kinase inhibitors	Agouron Pharmaceuticals, Inc.; Pfizer Inc.	10/25/13
US8524699	11	Substituted dihydropyrazolones and use thereof as HIF-prolyl-4-hydroxylase inhibitors	Bayer Intellectual Property GmbH	10/25/13
US8507477	10	3- and 6-quinolines with N-attached heterocyclic CGRP receptor antagonists	Merck, Sharp & Dohme, Corp.	10/18/13
US8524917	157	6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity	Allergan, Inc.	10/18/13
US8507479	48	Aminodihydrothiazine derivatives substituted with a cyclic group	Shionogi & Co., Ltd.	10/18/13
US8524717	175	Oxidase inhibitors and their use	Oryzon Genomics, S.A.	10/18/13
US8524722	21	Substituted tricyclic compounds and methods of use thereof	Bayer Intellectual Property GmbH	10/18/13
US8507510	190	Sulfoximine-substituted pyrimidines as CDK- and/or VEGF inhibitors, their production and use as pharmaceutical agents	Bayer Intellectual Property GmbH	10/18/13
US8524909	65	Tetrahydro-pyran derivatives	Hoffmann-La Roche Inc.	10/18/13
US8507714	18	7-membered ring compound and method of production and pharmaceutical application thereof	Daiichi Sankyo Company, Limited	10/07/13
US8501732	211	Aminomethyl quinolone compounds	Hoffmann-La Roche Inc.	10/07/13
US8507683	7	Compounds for the treatment of hepatitis C	Bristol-Myers Squibb Company	10/07/13
US8507533	84	Glucagon receptor modulators	Pfizer Inc.	10/07/13
US8507676	92	Heterocyclic oxime compounds	Novartis AG	10/07/13
US8507535	25	Methyl-pyrrolidine ether derivatives	Hoffmann-La Roche Inc.	10/07/13
US8501749	31	Azaquinazolinediones chymase inhibitors	Boehringer Ingelheim International GmbH	09/30/13
US8501981	6	CXCR2 inhibitors	SANOFI	09/30/13
US8501783	79	Conformationally restricted urea inhibitors of soluble epoxide hydrolase	The Regents of the University of California	09/30/13
US8501944	20	Inhibitors of protein kinases	Portola Pharmaceuticals, Inc.	09/30/13
US8501744	22	Piperazine compounds	Amura Therapeutics, Limited	09/30/13
US8501729	34	5-HT3 receptor modulators, methods of making, and use thereof	Albany Molecular Research, Inc.	09/16/13
US8501961	20	HIV protease inhibitors and methods for using	Purdue Research Foundation	09/16/13
US8501750	52	Heterocyclic compound and use thereof	Takeda Pharmaceutical Company Limited	09/16/13
US8501767	18	Imidazopyridines and imidazopyrimidines as HIV-1 reverse transcriptase inhibitors	CSIR	09/16/13
US8501991	6	P53 activating compounds	University Court of the University of Dundee; University Court of the University of St. Andrews	09/16/13
US8501936	1030	Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives	Cephalon, Inc.	09/16/13
US8497281	179	Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline	Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH	09/10/13
US8497274	6	Heterocyclic compound and use thereof	Takeda Pharmaceutical Company Limited	09/10/13
US8497368	79	Heterocyclic hydrazone compounds	Novartis AG	09/10/13
US8501768	36	Hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds	Hoffmann-La Roche Inc.	09/10/13
US8501708	57	Adenosine compounds and their use thereof	Inotek Pharmaceuticals Corporation	09/09/13
US8497265	327	Heteroaryloxyheterocyclyl compounds as PDE10 inhibitors	Amgen Inc.	09/09/13
US8497385	6	Bryostatin analogues, synthetic methods and uses	The Board of Trustees of the Leland Stanford Junior University	09/03/13
US8497288	40	Hexahydropyrroloimidazolone compounds	Hoffmann-La Roche Inc.	09/03/13
US8497277	12	Inhibitors of Bruton's tyrosine kinase	Pharmacyclics, Inc.	09/03/13
US8497376	27	Inhibitors of c-fms kinase	Janssen Pharmaceutica N.V.	09/03/13
US8497270	8	Macrocyclic integrase inhibitors	Elanco Animal Health Ireland Limited	09/03/13
US8497286	18	Organic compounds	Novartis AG	09/03/13
US8487093	224	ß-lactamase inhibitors	Merck Sharp & Dohme Corp.	09/03/13
US8470847	15	Derivatives of 7-alkynyl-1,8-Naphthyridones, Preparation Method Therefore and Use of Same in Therapeutics	Sanofi	08/29/13
US8476306	120	Urokinase inhibitors, production and use thereof	The Medicines Company	08/29/13
US8492394	16	(3-aryl-piperazin-1-yl), (2-aryl-morpholin-4-yl) and (2-aryl-thiomorpholin-4-yl) derivatives of 6,7-dialkoxy-quinazoline, 6,7-dialkoxyphtalazine and 6,7-dialkoxyisoquinoline as PDE10A enzyme inhibitors	H. Lundbeck A/S	08/28/13
US8492387	9	2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease	Merck, Sharp & Dohme, Corp.	08/28/13
US8492392	17	Alkoxy tetrahydro-pyridopyrimidine PDE10 inhibitors	Merck Sharp & Dohme Corp.	08/28/13
US8492408	4	Benzimidazole derivatives and their use for modulating the GABAA receptor complex	Aniona APS	08/28/13
US8492568	1	Chromane derivatives as TRPV3 modulators	Glenmark Pharamceuticals S.A.	08/28/13
US8492564	11	Salvinorin derivatives and uses thereof	The McLean Hospital Corporation; Temple University School of Medicine	08/28/13
US8486940	185	Inhibitors	Probiodrug AG	08/19/13
US8486989	1	Inhibitors of serine proteases, particularly HCV NS3-NS4A protease	Vertex Pharmaceuticals Incorporated	08/19/13
US8481733	348	Substituted imidazopyr- and imidazotri-azines	OSI Pharmaceuticals, LLC	08/19/13
US8487111	8	Substituted oxazolidinones and their use	Bayer Intellectual Property GmbH	08/19/13
US8492379	10	Translocator protein ligands	The University of Sydney	08/19/13
US8486966	24	9-(pyrazol-3-yl)-9H-purine-2-amine and 3-(pyrazol-3-yl) -3H-imidazo[4,5-B] pyridin-5-amine derivatives and their use for the treatment of cancer	Astrazeneca AB	08/12/13
US8481536	323	Benzotriazine inhibitors of kinases	TargeGen, Inc.	08/12/13
US8487096	5	Imidazo[1,2-B][1,2,4]triazines as C-MET inhibitors	Incyte Corporation	08/12/13
US8481743	8	Phenylpropionamide compounds and the use thereof	Purdue Pharma L.P.	08/12/13
US8481586	11	Pyrrolo[2,3-a] carbazoles and use thereof as PIM kinase inhibitors	Centre National de la Recherche Scientifique; Universite Blaise Pascal-Clermont-Ferrand II	08/12/13
US8486953	20	Thienopyrimidines for pharmaceutical compositions	Boehringer Ingelheim International GmbH	08/12/13
US8476225	66	Antiviral compounds	Gilead Sciences, Inc.	08/05/13
US8486964	9	Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors	Merck Patent GmbH	08/05/13
US8476267	8	Imidazo-, pyrazolopyrazines and imidazotriazines and their use	Bayer Intellectual Property GmbH	08/05/13
US8481564	14	Inhibitors of c-fms kinase	Janssen Pharmaceutica, N.V.	08/05/13
US8476271	28	Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulators	Purdue Pharma, L.P.; Shionogi & Co., Ltd.	08/05/13
US8476295	12	Bridged bicyclic RHO kinase inhibitor compounds, composition and use	Inspire	07/29/13
US8476255	38	Histone deacetylase inhibitors	Orchid Chemicals & Pharmaceuticals Limited	07/29/13
US8476284	14	Inhibitors of Bruton's tyrosine kinase	Pharmacyclics, Inc.	07/29/13
US8470843	15	Azacyclic compounds	Hoffmann-La Roche Inc.	07/24/13
US8470888	8	Botryllamides and method of inhibiting PGP in a mammal afflicted with cancer	The United States of America, as represented by the Secretary, Department of Health and Human Services	07/24/13
US8470836	40	Dipeptidyl peptidase-IV inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as active agent	LG Life Sciences, Ltd.	07/24/13
US8470841	39	Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof	Sanofi	07/24/13
US8470837	44	MAPK/ERK kinase inhibitors	Takeda Pharmaceutical Company Limted	07/24/13
US8470835	3	Pyrimidinecarboxamide derivatives as inhibitors of Syk kinase	Glaxo Group Limited	07/24/13
US8470825	17	Diazabenzo[de] anthracen-3-one compounds and methods for inhibiting PARP	Eisai Inc.	07/08/13
US8470800	10	Method of reducing intraocular pressure in humans	Inotek Pharmaceuticals Corporation	07/08/13
US8470820	64	Nitrogen-containing heteroaryl derivatives	Hoffman-La Roche Inc.	07/08/13
US8470816	43	Nitrogen-containing heterocyclic compound and use thereof	Takeda Pharmaceutical Company Limited	07/08/13
US20130102619	122	2-pyridyloxy-4-nitrile orexin receptor antagonists	TBA	06/25/13
US20130089624	1	Compounds useful as inhibitors of atr kinase	Vertex Pharmaceuticals	06/24/13